Clinical utility of risk markers for aggression and destruction in children with intellectual disability by Bamford, Charlie
CLINICAL UTILITY OF RISK MARKERS FOR AGGRESSION AND DESTRUCTION 







CHARLIE MARIE BAMFORD 
A THESIS SUBMITTED TO THE UNIVERSITY OF BIRMINGHAM FOR THE DEGREE 
OF DOCTOR OF CLINICAL PSYCHOLOGY 
 
Department of Clinical Psychology  
School of Psychology  
















This unpublished thesis/dissertation is copyright of the author and/or third 
parties. The intellectual property rights of the author or third parties in respect 
of this work are as defined by The Copyright Designs and Patents Act 1988 or 
as modified by any successor legislation.   
 
Any use made of information contained in this thesis/dissertation must be in 
accordance with that legislation and must be properly acknowledged.  Further 
distribution or reproduction in any format is prohibited without the permission 









This thesis is comprised of two volumes and is submitted by Charlie Bamford for the Clinical 
Psychology Doctorate at the University of Birmingham. Volume One presents the research 
component of the course and consists of three papers. The first paper is a meta-analytic review 
of risk markers relating to presence of self-injury, aggression and destruction in individuals 
with intellectual disability. The second paper is an empirical study exploring the clinical utility 
of risk markers for aggression and destruction in children with intellectual disability and 
develops an algorithm to predict current presence of these behaviours based on risk markers. 
The final paper is an executive summary that provides an accessible overview of the two 
preceding papers.  
Volume Two of the thesis consists of five clinical practice reports that were completed over 
the course of the doctorate. The first describes the assessment and formulation of a 21-year old 
male’s experience of anxiety and is formulated from cognitive and behavioural perspectives. 
The second is a service evaluation of Positive Behavioural Support Training for staff in a 
Learning Disability Service working with people displaying behaviour that challenges. The 
third report presents a single case experimental design to analyse the effect of a CBT 
intervention for social anxiety in a 38-year old male with personality disorder. The fourth 
details the assessment, formulation, intervention and evaluation of work conducted with a 70-
year-old gentleman presenting with anxiety, later diagnosed with high-functioning 
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CHAPTER 1 
15 years on: A meta-analytic study of risk markers for self-injurious 
behaviour, aggression and destruction in individuals with intellectual 
disabilities 
1.1 Abstract 
Rationale: Since the previous synthesis of data pertaining to risk markers for individual 
behaviours that challenge (McClintock et al., 2003), there has been an additional wealth of 
research, however no additional synthesis. A comprehensive understanding of risk markers for 
self-injury, aggression and destruction in people with intellectual disabilities has the potential 
to facilitate the development of strategies to identify at-risk individuals earlier and devise more 
well-informed interventions. Method: A meta-analysis was conducted incorporating the data 
from the previous meta-analysis ranging from 1968 to 2002 (McClintock et al., 2003), as well 
as additional data published between 2002 and 2018, totalling 60 papers. Results: Results 
indicated that level of intellectual disability and presence of autism was significant risk markers 
for all three behaviours. Additional risk markers for self-injury included: fragile X syndrome, 
increased repetitive behaviour, Cornelia de Lange syndrome, residing in paid care, tuberous 
sclerosis complex, visual deficit, expressive communication deficit, Prader Willi syndrome, 
Angelman syndrome, overactivity, hearing deficit, mobility deficit, adaptive behaviour deficit, 
epilepsy and female gender. Down syndrome represented decreased risk for self-injury and 
aggression. Additional risk markers for aggression included: living in paid care, epilepsy, 
expressive communication deficit and Smith Magenis syndrome. Conclusion: This meta-
analysis highlights that data pertaining to self-injury is far more comprehensive than for 
aggression or destruction. It emphasises the need for additional research within these areas, as 
well as within specific syndromes. As advancements are made in understanding risk markers 
for specific behaviours, these may be used to inform interventions or earlier identification of 
individuals at particularly increased risk. 




Intellectual disability (ID) is defined as a chronic, severe condition that limits an individual’s 
adaptive behaviour and intellectual functioning, with traits consistent with diagnosis identified 
before the age of four (World Health Organisation, 1992). Approximately one in 100 
individuals with ID will show behaviour that is considered challenging at some point during 
their lives (Emerson et al., 2001) that will persist without treatment (Totsika & Hastings, 2009). 
Self-injury, aggression and destruction have been a particular focus of research as these 
behaviours are often severe, and predictive of detrimental outcomes. The presence of 
behaviours that challenge is associated with psychiatric hospitalisation, reactive physical 
intervention and reduced quality of life (Beadle-Brown, Murphy & DiTerlizzi, 2009; Mandell, 
2008; Allen, Lower, Brophy & Moore, 2009). Moreover, presence of these behaviours 
increases parental stress, result in high staff burn out and exclusion from school settings 
(McIntyre, Blacher & Baker, 2002; Knapp et al., 2005). The Winterbourne View scandal 
resulted in increased commitment to reduced inpatient hospitalisation as a result of behaviours 
that challenge. The Transforming Care and Commissioning Steering Group implemented 
following this scandal, chaired by Stephen Bubb, reported in 2014 that emphasis should be 
placed on helping people return to their homes, specifically stating that hospitals are not homes 
for individuals with ID. To proactively reduce psychiatric hospitalisation, and to ameliorate the 
downstream consequences of behaviours that challenge to individuals and their wider social 
systems, there has been renewed interest in early intervention for behaviours that challenge 
(Cooper et al., 2014). Early intervention is predicated on understanding risk markers 
(correlates) associated with forms of behaviours that challenge. Such an understanding would 
help to identify those at greatest risk of developing behaviours that challenge and may also help 
to identify novel intervention targets. 
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The operant model of behaviour has been applied to self-injury, aggression and destruction 
within intervention approaches. As a result of this, interventions are often drawn from applied 
behavioural analysis (e.g., Gardner, 2002) and applied to social skill development (Carr, 1997) 
and parent training models (Matson, Mahan & Matson, 2009). This, approach, however, does 
not take into consideration whether interventions tailored towards specific behaviours will be 
more effective. Despite the significant social, economic and quality of life consequences of 
behaviours that challenge (Emerson et al., 2002; Fox & Emerson, 2002), there has been limited 
synthesis of the literature regarding key demographic, personal or behavioural variables that 
are associated with each of these behaviours that challenge. Moreover, consideration of risk 
for behaviours that challenge at a unitary category level, rather than the individual behaviours 
of self-injury, aggression and destruction, fails to isolate variables that may have specific 
influence on each form of behaviour (McClintock, Hall & Oliver, 2003), or recognise that 
individuals may engage in multiple different forms of behaviours that challenge (Matson et al. 
2008) with different risk pathways.  
1.2.2 Self-injury 
The term ‘self-injury’ or ‘self-injurious behaviour’ (SIB) includes behaviours that are self-
directed, and that have the potential to, or actually cause physical harm to the individual, such 
as biting oneself, pulling one’s hair, head banging and scratching one’s self (Rojahn et al., 
2008; Emerson et al., 2001; Bodfish et al., 1995). Reports of the prevalence of self-injurious 
behaviour among individuals with ID are diverse, ranging from 4% to 24% (Cooper et al., 
2009; Deb, Thomas & Bright, 2001). This heterogeneity in prevalence estimates is largely 
attributed to different definitions of self-injury, for example whether it results in tissue damage, 
and differences in who reported the incident of SIB (poor concordance is reported between 
parent and teacher reports of behaviours that challenge, e.g., Stadnick, Chlebowski & 
Brookman-Frazee, 2017). Moreover, many studies utilise small samples; heterogeneity in 
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smaller samples can have a more substantive effect on the reported prevalence estimate, leading 
to high variation. It is essential to synthesise data across studies to ensure the sources of 
heterogeneity, such as small samples and differing definitions of behaviours that challenge, are 
accounted for in interpretation.  
In individual cohorts, a number of risk markers for SIB  have been identified, including severity 
of ID (Chadwick et al., 2000; Holden & Gitlesen, 2006; McClintock, Hall & Oliver, 2003), 
physical health difficulties that result in pain (Symons, 2011; Richards et al., 2017), autistic 
spectrum disorder diagnosis (Richards, Oliver, Nelson & Moss, 2012; McClintock, Hall & 
Oliver, 2003) and repetitive or impulsive behaviours (Rojan, Matson, Naglieri & Mayville, 
2004; Bradley, Summers, Wood & Bryson, 2004; Cooper et al., 2009). In addition, a range of 
genetic syndromes have been identified as associated with SIB including Prader Willi 
syndrome (Holland et al., 2003) and Cri du Chat syndrome (Collins & Cornish, 2002), Smith 
Magenis syndrome (Arron et al. 2011) and fragile X fyndrome (Eden et al., 2014). The 
identification of valid risk markers confers the opportunity to develop theoretical models 
pertaining to the mechanisms underpinning SIB. For example, operantly derived models of SIB 
indicate that SIB serves a particular function for an individual with ID. Functional analyses 
(Iwata et al., 1994) can help to determine the exact function, however commonly identified 
social functions include communication, escape, avoidance and access to tangibles (Carr, 
1977). Thus, when an individual has limited expressive communication, which is a necessary 
feature of more severe ID, SIB may be more likely to form an effective functional 
‘communication’ in that behaviours may be reinforced by the environment and become learnt. 
In contrast, there are also risk markers that may be associated with internal mechanisms, for 
example by sensory stimulation (Carr, 1977). Evidence suggests there could be a correlation 
between pain and increased self-injury, with it possibly moderating people’s perception of pain 
(Wool & Salter, 2000). Moreover, some research indicates that genetic disorders correlated 
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with SIB may also have a higher threshold to pain (Priano et al., 2009).  These putative unique 
associations between risk markers and SIB further strengthen the rationale to evaluate risk 
markers for each form of behaviour separately.  
1.2.3 Aggression 
‘Aggression’ can be used to refer to an array of acts, including physical assaults on peers, 
family members or staff, hostility or verbal threats, making gestures others consider threatening 
and having tantrums (Rojahn et al., 2001). Similarly to SIB, the prevalence of aggressive 
behaviour among individuals with ID varies considerably, ranging from 30% to 60% (Crocker 
et al., 2006; Cohen et al., 2010). The presence of aggressive behaviour presents a number of 
social difficulties for children with ID as it can result in exclusion from school, placements 
away from the family home, psychiatric intervention and difficulty socialising with peers 
(Allen, 2008; Lowe et al., 2007; Posey et al., 2008). Notably, Davies & Oliver (2016) indicate 
that aggression is the most persistent of the three forms of behaviours that challenge, with 69% 
of young children with ID displaying aggression. This suggests that there is significant value 
in understanding risk markers that make an individual more likely to display aggressive 
behaviour, as it may be particularly important to develop pre-emptive interventions, or better 
tailor current interventions to ameliorate this persistent behaviour.  
Whilst a number of studies have postulated different risk markers for aggression, the results 
have been fairly contradictory. Some research indicates that severity of ID correlates with 
increased aggression (Meins, 1995; McTiernan et al., 2011), whilst alternative research 
indicates that higher ability evidenced through higher-level expressive communication is more 
closely associated with aggression (Emerson et al., 2001; Deb et al., 2001). Living 
accommodation has also been reported as a risk marker, with individuals living in their family 
home or alone being less inclined to act aggressively (Eyman et al., 1970). Moreover, studies 
considering specific syndromes linked with ID, such as Down syndrome (Collacott et al., 1998) 
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have considered whether the syndrome reduces or increases risk of aggression. Similarly to 
SIB, aggression has also been associated with overactivity/impulsivity (Davies & Oliver, 
2016), as well as factors that cause internal pain, such as headaches or ear infections (Gardner 
& Whalen, 1996).  
Some definitions of aggression encompass ‘destruction of property’. Whilst this is an act of 
aggression, it is not comprehensively understood whether destruction of property should be 
considered separately due to being associated with different risk markers. It is an aim of this 
review to examine them separately and draw conclusions on this. 
1.2.4 Destruction of property 
To date, research has often considered ‘destruction’ under the umbrella of aggression, making 
it difficult to isolate the two forms of behaviour and consider risk markers associated with 
destruction specifically. Furthermore, the Behaviour Problem Inventory (BPI; Rojahn et al., 
2001), which is a widely used measure to quantify behaviour that challenges, has subsections 
for SIB and aggression only; destruction of property forms part of the aggression subheading. 
This means that studies using this measure are unable to independently quantify prevalence 
and risk markers for this third subset of behaviours that challenge. For example, Croker et al. 
(2006) compared different forms of aggressive behaviour (verbal, property, physical, self and 
sexual). This indicated verbal aggression was considerably higher in males than property 
aggression and also showed that individuals with mild ID were more likely to show aggression 
than property destruction. These, and other divergent prevalence figures suggest that it is 
necessary to consider aggression and destruction as separate components of behaviours that 
challenge, as they may have different risk markers. Whilst there is limited evidence on risk 
markers for destruction specifically due to the conflation of aggression and destruction, 
presence of autism and overactivity/impulsivity have been presented as possible risk markers 
(Davies, 2010), gender (Crocker et al., 2007) and severity of ID (Crocker et al., 2006).  
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1.2.5 Meta-analyses 
 A previous meta-analysis by McClintock, Hall and Oliver (2003) synthesised risk data for SIB, 
aggression and destruction of property. The analysis included data available prior to 2002 that 
assessed each of these components of behaviours that challenge. The literature identified 
enabled the authors to examine the relative risk of a number of characteristics and the presence 
of SIB (gender, degree of ID, autism, receptive communication and expressive 
communication), aggression (gender, degree of ID, autism and expressive communication) and 
destruction of property (autism). This meta-analysis indicated that there were limited data 
available focussing on these specific forms of behaviours that challenge. Over forty papers 
have been published in the past decade that include data on risk markers and therefore there is 
significant clinical and scientific value in replicating and extending the original meta-analysis 
of risk markers relating to aggression, destruction and SIB (McClintock et al., 2003). 
Therefore, the present meta-analysis has the following aim: to synthesise and quantify data on 
a) demographic1, b) diagnostic2 and c) health and person/behavioural risk markers3 for SIB, 
aggression and destruction in people with ID and subsequently explore how each risk marker 




                                                             
1 Demographic risk markers: Gender, Level of ID, Adaptive behaviour, Living arrangements 
2 Diagnostic risk markers: Angelman syndrome, Autism, Cornelia de Lange syndrome, Down syndrome, fragile 
X syndrome, Prader Willi syndrome, Smith Magenis syndrome, Tuberous sclerosis complex 
3 Health/behavioural risk markers: Visual deficit, Hearing deficit, Mobility deficit, Epilepsy, Dental problems, 
Gastrointestinal problems, Skin problems, Expressive communication, Receptive communication, 
Overactivity/impulsivity, Repetitive behaviour 
4 Categorisations are pragmatic to allow segmentation of data and appraisal of each risk marker in turn 
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1.3 Method 
As the present study aimed to extend the meta-analysis conducted by McClintock, Hall & 
Oliver (2003), the search terms and methods used by McClintock and colleagues were used as 
the basis for the current study.  
1.3.1 Literature Search 
A search of published literature was conducted on 21st December 2018 to obtain a 
comprehensive overview of research focussing on ID and topographies of behaviours that 
challenge. The terms in Table 1.1 were used to form the search criteria and identify literature 
pertaining to each of the areas. To combine the search terms, boolean operator ‘OR’ was used 
to ensure the search contained all the variations of the terms indicated in Table 1 (e.g., Learning 
disab* OR Intellectual disab* OR Mental retardation OR Learning difficult*). Following this, 
the Boolean operator ‘AND’ was used to combine the behaviour search terms with intellectual 
disability search terms. These search terms were applied to the electronic databases: Ovid 
MedLine, Embase and Psyc Info. All search terms used (apart from ‘behav* that challenges’) 
were consistent with those used by McClintock and colleagues (2003). ‘Behav* that 
challenges’ was included due to progressive change in how ‘challenging behaviour’ is referred 
to; more recent papers may be more inclined to use this terminology. Attempts were not made 
to identify studies that were unpublished at the time of searching. This decision was made in 
line with the methodology used in McClintock et al. (2003). Whilst it is appreciated that this 
presents a risk of bias towards positive results, as these are more commonly published, only 
30% of meta analyses include unpublished data as there is a rationale that it hasn’t been peer 
reviewed and may be of a lower standard (Cook et al., 2003). Duplicates were removed during 
the electronic database search. As McClintock et al. (2003) ceased their search in late October 
2001, the current search was limited to papers published between October 2001 to December 
2018; to avoid excluding any studies published late in October 2001, this one-month overlap 
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was considered beneficial. The decision was made to continue the search from the cessation of 
the previous analysis, rather than repeating the previous search. Updating is considered more 
efficient than starting afresh when new evidence emerges (Garner et al., 2016). The previous 
review had clear and appropriate methods and search terms (that have not been significantly 
adjusted in the current analysis – only one addition has been made to represent progression in 
language use) and therefore this was deemed appropriate. Thus, the search was conducted 
focussing on papers published between October 2001 and 21st December. 
Table 2.1 Search terms used to identify relevant papers 
Search Term Variations 
Intellectual Disability Learning disab*; Intellectual disab*; Mental retardation; Learning 
difficult* 
Destruction Destruction of property; Destructive behav* 
Aggression Aggression; Aggressive behav* 
Self-Injurious Behaviour Self-injury; Self-harm 
Behaviour that challenges Challenging behav*; Aberrant behav*; Maladaptive behav*; Problem 
behav*; Behav* problem; Behav* disorder; Behav* disturbance; Disturbed 
behav*; Behav* that challenges   
 
1.3.2 Inclusion criteria 
Table 1.2 provides a comprehensive overview of the inclusion/exclusion criteria during the title 
and abstract screening stage, and Table 1.3 indicates additional criteria applied during the full 
text search. The main criteria in the initial stage were reference to the presence of ID and 
reference to behaviour that challenges of any kind. Restrictions were later introduced during 
the full text search to ensure that sufficient data were available to calculate an effect size for 
each risk marker.  
  Chapter 1: A meta-analysis of risk markers in ID 
 10 
1.3.2.1 Title and abstract Screening 
The use of the search terms indicated in Table 1.1 resulted in identification of 9985 papers. An 
initial title and abstract screen was conducted based on the inclusion/exclusion criteria outlined 
in Table 1.2.  
Table 1.2 Inclusion/exclusion criteria for title and abstract screening 
Inclusion Exclusion 
Publication date Oct. 2001 onwards Publication prior to Oct. 2001 
Reference to ID No reference to ID 
Reference to behaviour that challenges No reference to behaviour that challenges 
Empirical paper Not an empirical paper (e.g., review) 
Quantitative design Qualitative design 
 
1.3.2.2 Full text Screening 
107 papers met the title and abstract inclusion criteria. A full text screen was subsequently 
conducted for each of these 107 papers, following the inclusion/exclusion criteria outlined in 
Table 1.3. In order to quantify the magnitude of risk associated with each risk marker, papers 
were only included where data were presented which would allow an effect size to be derived. 
In line with McClintock et al. (2003), to quantify the risk associated with a particular diagnosis 
(e.g., autism or a genetic syndrome), the paper needed to report data on the group of interest 
and a relevant control group. To reduce error, a sample size of 25 or greater for each group was 
imposed to avoid bias caused by sampling error in the meta-analysis and interpretation of 
within study variance as actual variance (Lin, 2018). Lin (2018) suggests that samples of 50 
participants still present a risk of bias, however the incidence of some rare syndromes makes it 
almost impossible to achieve large sample sizes, therefore a sample of 25 was used. Whilst this 
does increase the risk of sampling error, it also reduces the potential to explore heterogeneity 
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and important sub-groups may not be analysed; therefore, a decision to include data from 
samples of 25 or greater was an appropriately conservative balance.  
Table 1.3 Inclusion/exclusion criteria for full text screen 
Inclusion Exclusion 
Sufficient data available to calculate an odds ratio 
or effect size 
Insufficient data available to calculate an odds 
ratio or effect size 
 
Control population used in cases of a population 
with autism or genetic syndromes 
No control population used in cases of a 
population with autism 
 
Specific risk markers mentioned (e.g., age, 
genetic syndromes, gender, impulsivity) 
No specific risk markers mentioned 
 
 
ID specified for target population ID not specified for target population 
 
Specific behaviour that challenges mentioned 
(self-injury, aggression, destruction) 






Not an empirical study (e.g., conference 
proceedings, review articles, books) 
 
Population not recruited for a primary 
characteristic that would be a covariate (e.g., 
recruited due to having epilepsy) 
Population recruited for a primary characteristic 
that would be a covariate (e.g., recruited due to 
having epilepsy) 
 
Sample size >25 Sample size <25 
 
Full text written or available in English Full text not available in English 
 
Unique sample Sample not unique – reported elsewhere 
 
1.3.3 Manual search 
The citations outlined in the included papers from the database search were manually searched 
to identify any relevant papers that had not arisen during the database search. These papers 
were subjected to the same two-stage inclusion/exclusion screening processes.  
1.3.4 Inclusion of McClintock, Hall & Oliver (2003) data 
The 20 papers from the previously published McClintock, Hall & Oliver (2003) meta-analysis 
were included were included prior to the full text screen to provide a complete meta-analysis 
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of studies published up to December 2018 relating to risk markers for SIB, aggression and 
destruction among individuals with ID that meet the inclusion criteria. These papers underwent 
the same inclusion/exclusion criteria screening as the newly added papers. No papers were 
excluded. 
1.3.5 Search Results 
The results of the systematic search are presented in Figure 1.1. The initial search produced 
11,241 articles, reduced to 9985 once duplicates were removed. Of the 107 full text articles 
examined, 38 were included in the study. The three most common reasons for exclusion were 
that a specific type of behaviour that challenges (self-injury, aggression or destruction of 
property) were not mentioned (n=29), there was insufficient data available to determine an 
effect size (n=15) and the article was not available in English (n=9). An additional 2 articles 
were added through the manual search process and the 20 McClintock, Hall & Oliver (2003) 
articles were included, equating to 60 studies suitable for meta-analysis. The search, screening 
and data extraction were conducted in line with the PRISMA (Moher et al., 2009) checklist. 




Figure 1.1: Results of systematic search and application of inclusion/exclusion criteria 
 
1.3.6 Quality rating 
The final 60 papers were rated for quality using the framework outlined in Table 1.4, adapted 
from Richards, Jones, Groves, Moss & Oliver (2015) and Surtees, Oliver, Jones, Evans & 
Richards (2018). The framework was developed based on factors considered to threaten the 
external and internal validity of the meta-analysis. Consistent with current diagnostic manuals 
McClintock et al. 
(2003) Papers added 
N= 20 
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(e.g., DSM-IV), determination of ID was considered to have two distinct components; adaptive 
functioning and cognitive functioning (World Health Organisation, 1992). The reliability of 
quality ratings were cross-validated by a second rater using a 25% random sample. Total inter-
rater reliability was 87% (based on the number of scores consistent out of total number scored). 
Discrepancies were reviewed and a consensus reached. The quality ratings were utilised for 
descriptive purpose and studies were not excluded or analysed on the basis of quality ratings 
in order to replicate the methodology adopted by McClintock, Hall & Oliver (2003).  
Table 1.4 Quality framework, colour coded for ease of visual inspection 
 0 Poor* 1 Adequate 2 Good 3 Excellent 
Sample 
Identification 
Unspecified Single restricted/ non-
random sample e.g. 













Unspecified Staff/carer anecdotal 
report 














Unspecified Clinician judgement 
Self/parent report 




with well validated 
measure 
Validated 








Unspecified Syndrome group 
known to be 






with well validated 
measure 
Formal IQ test 
(Wechsler 
Intelligence Scale 
for Children etc.) 
*No studies met criteria for zero, therefore the lowest rating (1) was colour coded red for ease of visual 
inspection 
  Chapter 1: A meta-analysis of risk markers in ID 
 15 
Of the studies included in the final analysis, 8.8% were considered adequate in terms of sample 
identification, 75.6% were good and 15.6% were excellent. In terms of measurement of 
behaviour that challenges, 15.5% used staff/carer anecdotal reports, 82.3% used an appropriate 
measure, whilst 2.2% observed the behaviour in question. 24.4% of included studies accepted 
participants with a known diagnosis as an indicator of adaptive behaviour difficulties, 60% 
used staff or carer reports and 15.6% were able to directly measure adaptive behaviour using a 
validated questionnaire/observation. Finally, 26.7% accepted a specified syndrome as 
indication that a deficit in intellectual functioning was present, 57.7% accepted parent or carer 
reports, and 15.6% assessed intellectual functioning with a validated measure. Given the time 
and cost restrictions of research, acceptance of a specific disorder as being known to be 
associated with intellectual disability or accepting parent/carer reports are the most common 
approaches to recruitment of individuals with intellectual disability. It is unlikely that parents 
would receive a diagnosis of intellectual disability without careful assessment from 
professionals. Whilst there is a concern that some participants included in samples may not be 
representative of the target population if they are not assessed by the research team, the means 
of inclusion do not raise considerable concern.  
1.3.7 Data Extraction 
In order to calculate relative risk (RR), event rates were reported as the number of participants 
with and without the condition of interest in both a control and exposure/risk group. Where 
event rates were not given, and RR was instead specified, this was included if associated 
confidence intervals for the RR were also provided. Authors were contacted to obtain original 
RR and confidence interval data to avoid using regression or where error bars were used to 
indicate confidence intervals, rather than exact numbers. In the case of multiple reporting of 
outcomes from one primary study, if it were possible, these were combined in a single 
quantitative outcome using the procedures described by Borenstein (2009). If it were not 
  Chapter 1: A meta-analysis of risk markers in ID 
 16 
possible to combine them, for example because they were separated into different age groups 
(e.g. Richards et al., 2017), each outcome was included. It should be noted that this method 
may result in a slight reduction in confidence intervals for the random effects model.  
Where a paper considered a risk marker that was absent in the whole sample, the data were not 
extracted from this paper. For example, in the study conducted by Wilde and colleagues (2017), 
100% of the participants had normal hearing, and thus it was not possible to include data from 
this paper on hearing deficits as a risk marker for behaviour as there was no event rate for 
hearing deficit to compare to those without. Where studies presented multiple forms of 
‘aggressive behaviour’ (e.g., verbal, physical, self and sexual), physical aggression only was 
used, consistent with the data reported by McClintock et al. (2003). If studies presented 
information on ‘aggressive-destructive’ behaviour, which was a typical outcome for those 
using the Behaviour Problems Inventory (Rojahn et al., 2001), these data were excluded due to 
confounding two of the primary outcome variables confounds. This resulted in the exclusion 
of data from six studies that focussed on aggressive-destructive behaviour. 
For risk markers that were not dichotomous (e.g. level of ID is usually categorised as profound 
severe, moderate and mild), data were grouped either in line with McClintock, Hall and Oliver 
(2003), or in the manner that maximised the data inclusion (for example mild/moderate and 
severe/profound). To determine the impact of severity of ID on behaviours that challenge, those 
with severe or profound ID were grouped together to form the target population, and levels of 
each behaviour that challenges within this target population were compared to the ‘control’, 
mild or moderate ID population in line with the methodology adopted by McClintock, Hall & 
Oliver (2003). All reports of severity of ID were included in the initial analysis, regardless of 
whether ID was measured by a validated measure or self-report. Living arrangement analysis 
compared those that were supported by individuals outside the immediate family (e.g., in a 
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supported group setting, residential facility or hospital) to community living arrangements 
(living independently or living with family or in a family-setting).  
In order to determine the impact of a deficit in adaptive behaviour on behaviours that challenge, 
a comparison was made between those demonstrating the behaviour with a deficit and those 
demonstrating the behaviour without a deficit. Any reporting of adaptive behaviour was 
included in the analysis, regardless of whether it was from an official measure or parent self-
report.  
In order to determine the RR of individual syndromes, the presence of SIB, aggression and 
destruction among the target syndrome population was compared to the presence in either a 
control ID population specified by the paper (e.g. Down Syndrome, ID of mixed aetiology), or 
was compared to those in the sample that did not display the specific syndrome if the syndrome 
was not recruited specifically (e.g. the sample contained individuals with specific syndromes 
by chance, rather than recruiting specifically to focus on this syndrome, and therefore could be 
compared to the rest of the population in the sample without this syndrome). 5 
Health risk markers were calculated by comparing the number of individuals engaging in a 
form of behaviour that challenges with a health deficit (e.g. hearing deficit) to the number of 
individuals engaging in the same behaviour without said deficit.  
For overactivity/impulsivity, data were included in analysis if studies reported on overactivity 
and/or impulsivity separately or overactivity/impulsivity combined as some measures collapse 
these variables. 
                                                             
5 Additional studies provided data that could have been included in analysis of Down syndrome (DS), however 
they used DS as a control population; it was not considered appropriate to reverse compare a control population 
to other populations in the study, therefore these studies were not included in analysis.  
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1.4 Data analysis 
1.4.1 Risk Markers Identified 
Appendix A provides a comprehensive overview of the risk markers identified in the studies 
included in the meta-analysis for each of the three types of behaviour (self-injury, aggression 
and destruction of property). In order to generate meaningful effect sizes, it was deemed 
necessary for at least two papers to measure the same construct. These two papers had to have 
measured the construct in different sub-populations to prevent a specific phenotypic focus. 
Thus if repetitive behaviour had only been studied as a risk marker for aggression in two 
studies, it would be included if one study sampled individuals with autism, and the other study 
sampled individuals with tuberous sclerosis complex. However, if both studies sampled 
individuals with tuberous sclerosis complex, the data on repetitive behaviour as a risk marker 
for aggression would have been excluded from meta-analysis, as it would not be possible to 
determine the extent to which this represented a sub-population specific risk marker. Thus, not 
all of the risk markers listed in Appendix A were explored in the current meta-analysis due to 
insufficient available data. Table 1.5 presents the risk markers with sufficient data for 
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Table 1.5 Risk markers included in meta-analysis for each behaviour subtype 
 Self-Injury Aggression Destruction 
of property 
Gender Ö Ö Ö 
Severity of ID Ö Ö Ö 
Adaptive behaviour deficit Ö Ö C 
Paid/congregate care Ö Ö C 
Ethnicity C Ö C 
Angelman syndrome Ö Ö C 
Tuberous sclerosis complex Ö Ö C 
Down syndrome Ö Ö C 
Fragile X syndrome Ö Ö C 
Autism Ö Ö Ö 
Smith Magenis syndrome Ö Ö C 
Cornelia de Lange syndrome Ö Ö C 
Prader Willi syndrome Ö Ö C 
Mobility deficits Ö Ö C 
Visual deficit Ö Ö C 
Skin problems Ö C C 
Gastrointestinal problems Ö C C 
Dental problems Ö C C 
Epilepsy Ö Ö C 
Hearing deficits Ö C C 
Expressive communication Ö Ö C 
Receptive communication Ö C C 
Repetitive behaviour Ö C C 
Overactivity/impulsivity Ö C C 
 
1.4.2 Preparation of data 
Where studies presented effect size in the form of Cliffs Delta (e.g. Richards et al., 2012), this 
was converted using RStudio (package=orddom) to Cohen’s Delta. It was subsequently 
possible to convert Cohen’s Delta to RR using the methodology outlined in Bornstein (2009). 
Complexities arose for studies that presented median scores with interquartile ranges for 
measures (e.g. Eden et al., 2014 and Wilde et al., 2017); data were not normally distributed 
making it impossible to convert interquartile ranges to standard deviation. Therefore, it was not 
possible to calculate RR based on the presented data and thus these data were excluded from 
analysis. Authors were contacted for further data; however no response was received at time 
of writing. Relative risk is the probability of an event occurring relative to an independent 
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variable (Bornstein, 2009). In this meta-analysis, it would be the probability of a form of 
challenging behaviour occurring in a population with a target risk marker (e.g. males or autism) 
comparison to the control population (e.g. females or ID without autism). Relative risk is used 
more frequently than odds ratios in cohort or randomised control studies, and was therefore 
deemed most appropriate for this meta-analysis, however it is important to note that it increases 
to risk of overestimation of the effect in the target population (Stegenga, 2015). For the majority 
of data, relative risk was calculated by dividing the reported cumulative incidence in the 
exposed group by the cumulative incidence in the unexposed group. In such an instance, log 
standard error of RR could be calculated using the square root of the log variance ((1/target n)-
(1/target N)+(1/control n)-(1/control N)). Where studies gave the RR rather than cumulative 
incidences, confidence intervals were used to calculate the log standard error of the RR by 
generating a mean, which was divided by square root of N. If confidence intervals were not 
available, and authors could not be reached, the study was removed from analysis.  
1.4.3 Omnibus test 
As the purpose of this meta-analysis was to synthesise data from multiple studies, 
methodological strengths and weaknesses between studies varied. It was therefore deemed 
beneficial to utilise a random effects model for analysis, as this does not assume a common 
effect size (as in a fixed-effects model). The goal was not to estimate one true effect but to 
estimate the mean of a distribution of possible effects, which may show true variation due to 
idiosyncratic characteristics of the individual or unique circumstances of the exposure. A 
random effects method adapts the weighting of each study according to its heterogeneity in 
comparison to the other studies included, as well as in accordance with sample size. The 
DerSimonian and Laird (1986) method was adopted to calculate the random effects model. 
This model was suitable as the effects are considered to be normally distributed within the 
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populations explored. Moreover, the trials are of different sizes, which would make the Sidik-
Jonkman (Sidik & Jonkman, 2007) estimator less effective. 
1.4.4 Forest plot and heterogeneity 
Individual forest plot outputs for each behaviour and risk marker pair, calculated using RStudio 
package designed by Dr Chris Jones at the University of Birmingham (“Meta-Analysis of 
Summary Effects using Generic Inverse Variance”) are presented in Appendix B for brevity. 
Each figure presents Te (effect) and seTE (standard error of the effect), as well as the RR, 95% 
confidence intervals (CI) and the percentage weight each study. RR using a random effect 
model is provided separately for each risk marker according to each form of behaviour (self-
injury, aggression and destruction). Heterogeneity was calculated using Higgins et al. (2003) 
I2 which measures the proportion of observed variance that reflects real differences in the true 
score. It provides a percentage score for heterogeneity. This method is recommended by 
Bornstein et al. (2009) for meta-analysis as it helps to indicate when subgroup or moderator 
analysis should be considered. Moreover, the alternative, Cochran’s Q has lower power to 
detect heterogeneity if the number of studies included in the analysis is small and increases risk 
of Type 1 error. This meta-analysis includes a number of analyses involving a small number 
of studies, so I2 was deemed more suitable. A small I2 value indicates low heterogeneity and 
no necessity for subgroup analysis (0-50%), whilst a large value indicates high heterogeneity 
(75-100%) and suggests that the studies included in the meta-analysis cannot be from the same 
population and further analysis is required. 50-75% is considered ‘moderate’ (Higgins et al., 
2003). To identify studies contributing most significantly to heterogeneity, the scatter plot 
devised by Baujat et al. (2002) was used; this presents studies in graphical form according to 
the extent they contribute to effect size, as well as extent they contribute to heterogeneity. This 
was used as the rationale for any exclusions when high heterogeneity was present; those 
contributing most substantively to heterogeneity were excluded one at a time to determine 
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impact. If heterogeneity could be reduced by 10% or greater with one or two studies, they were 
excluded. Where exclusion of a third study equated to a 10% or greater reduction in addition 
to the first one or two studies, this study was also excluded. Where heterogeneity remained 
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1.5 Results 
1.5.1 Sample Characteristics 
Following the procedure indicated in the methods, 51 of the 60 studies (85%) contained 
sufficient data to calculate RR and standard error suitable for meta-analysis.  
The dates of publication of the studies ranged from 1968 to 2018. Twenty studies were 
conducted in the UK, seven were conducted in the USA, two in Canada, two comprised mixed 
country samples, two were conducted in Japan and one study came from each Italy, Jersey, 
Spain, Norway, Sweden, Germany and the Netherlands. The various methodologies employed 
were questionnaires, observations, interviews, the review of case notes/databases and the 
administration of published assessments.  
1.5.2 Demographic Risk Markers 
In order to test Part A of the aim of the meta analysis, data relating to demographic risk markers 
(gender, severity of ID, adaptive functioning deficit and living arrangements) was compiled for 
self-injury, aggression and destruction (Tables 1.6-1.8 respectively). Following this, 10 forest 
plots were conducted to evaluate the risk of each demographic risk marker on self-injury, 
aggression and destruction (Appendix B1-B4). Table 1.9 summarises the outcomes of these 
forest plots.  
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Table 1.6 Demographic and comparison risk marker data indicting number of individuals showing self-injury (n) out of the population included for each risk 
marker (N) 



















Mild & mod  
 
n/N 















Arron et al. (2011) 101 CdLS     41:60 - - - - 33/54 37/46 - - 
Ballinger (1971) 626 Mixed ID     343:283 46 47 25/337 68/289 - - - - 
Bowring et al. (2017) 265 ID     134:131 RR: 1.466 - - RR:5.353 - - RR:3/02 - 
Crocker et al. (2006) 3165 Mixed ID     1633:1527 366 405 385/2169 387/996 - - 384/1044 113/791 
Crocker et al. (2007) 296 Mild/mod     162:134 10 9 - - - - 16/172 1/76 
Davies et al. (2016) 417 Severe ID     260:157 RR: 0.82 - - RR:0.78 - - - - 
Deb et al. (2001) 101 Mixed ID     51:50 6 18 16/90 8/11 - - 12/37 11/48 
Eden et al. (2014) 37 TSC     19:18 3 7 - - 5/29 5/8 - - 
Eyman & Call (1977) 6870 Mixed ID     Not reported - - 321/4184 725/2686 - - - - 
Folch et al. (2008) 833 Mixed ID      432:401 59 76 137/504 53/329 - - 78/419 57/414 
Griffin et al. (1986) 11891 Mixed ID     6664:5227 761 581 - - - - - - 
Hardan & Sahl (1997) 233 Mixed ID     168:75 - - 40/72 13/22 - - - - 
Hiraiwa et al. (2007) 29 PWS     14:14 - - - - - - - - 
Holden et al. (2002) 154 ID     89:61 - - 10/64 43/90 - - - - 
Jacobson (1982) 27023 Mixed ID     14862:12160 - - 386/12730 2315/17817 - - - - 
Kebbon et al. (1986) 28559 Mixed ID     Not reported - - 154/16746 1044/11812 - - - - 
Lundqvist (2013) 915 Mixed ID     504:411 152 131 196/752 82/143 - - - - 
Maisto et al. (1978) 1300 Mixed ID     725:575 81 101 8/306 174/994 - - - - 
Maurice et al. (1982) 3261 Mixed ID     1732:1529 223 180 - - - - - - 
Medeiros et al. (2013) 115 Mixed ID     80:35 20 12 - - - - - - 
Oliver et al. (2012) 970 Severe ID     589:381 - - - - - OR3.15 - - 
Quine (1986) 399 Severe ID     245:154 32 15 - - - - - - 
Richards et al. (2012) 148 ASD     132:17 65 9 - - 55/121 17/25 - - 
Richards et al. (2017) 207 Child ASD     181:26 RR:0.71 - - - RR1.46 - - - 
Richards et al. (2017) 
 
216 Adult ASD     152:64 RR:0.87 - - - RR:1.51 - - - 
Rojahn (1986) 529 Mixed ID     279:250 222 209 177/233 254/293 - - - - 
Ross (1972) 2678 Mixed ID     Not reported - - 410/2485 2268/8654 - - - - 
Schroeder et al. (1978) 1149 Mixed ID     517:632 109 99 14/155 194/995 - - - - 
Wilde et al. (2017) 29 TSC     18:9 6 3 - - 1/9 10/20 - - 
  Chapter 1: A meta-analysis of risk markers in ID 
 25 
Table 1.7 Demographic and comparison risk marker data indicting number of individuals showing aggression (n) out of the population included for each risk 
marker (N) 















Mild & mod 
 
n/N 









Arron et al. (2011) 189 PWS     100:89 64 32 - - 15/49 25/52 
Bowring et al. (2017) 265 ID     134:131 RR:1.173 - - RR:2.471 - - 
Cohen et al. (2009) 3547 Mixed ID     Not reported - - 357/1422 529/2060 - - 
Cooper et al. (2009) 1023 ID     562:461 42 58 43/646 57/377 - - 
Crocker et al. (2006) 3165 ID     1633:1527 839 799 371/1527 397/1633 - - 
Crocker et al. (2007) 296 Mild/mod ID     162:134 31 24 - - - - 
Davidson et al. (1994) 201 Mixed ID     126:79 89 42 82/129 49/70 - - 
Davies et al. (2016) 417 Severe ID     258:159 RR: 0.74 - RR:1.19 - - - 
Deb et al. (2001) 101 Mixed ID     51:50 8 15 18/80 5/11 - - 
Eden et al. (2014) 37 TSC     19:18 14 4 10/13 7/19 3/8 15/29 
Medeiros et al. (2014) 115 Mixed ID     80:35 41 17 - - - - 
Eyman & Call (1977) 6870 Mixed ID     Not reported - - 1229/4381 899/2489 - - 
Hardan & Sahl (1997) 233 Mixed ID     168:75 - - 14/72 13/22 - - 
Jacobson (1982) 30577 Mixed ID     14862:12160 - - 899/12730 2651/17847 - - 
Quine (1986) 399 Mixed ID     245:154 56 26 - 82/399 - - 
Ross (1972) 11139 Mixed ID     Not reported - - 731/2485 1885/8654 - - 
Tenneij et al. (2009) 108 Mild LD     40:48 16 23 - - - - 
Tyrer et al. (2005) 3065 Mixed ID     1735:1327 287 156 127/1317 299/1647 - - 
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Table 1.8 All risk marker data (Gender, IQ and Autism) indicting number of individuals showing destruction (n) out of the population included for each risk 
marker (N) 



















Mild & mod 
 
n/N 









Ando et al. (1979) 175 Mixed ID     Not reported - - - - 16/47 5/128 
Bhaumick et al. (1997) 2201 Mixed ID     Not reported - - - - 263/1044 344/1157 
Crocker et al. (2006) 3165 Mixed ID     1633:1527 - - 498/2169 283/996 - - 
Crocker et al. (2007) 296 Mixed ID     162:134 105 80 - - - - 
Davies et al. (2016) 417 Severe ID     258:159 RR: 0.81 - - RR: 0.84 - - 
Jacobson (1982) 32568 Mixed ID     Not reported - - 1456/13633 3128/18935 - - 
Matson et al. (2008) 320 ASD/ID     179:141 - - - - 15/62 15/159 











  Chapter 1: A meta-analysis of risk markers in ID 
 27 
Table 1.9 Synthesis of risk markers relating to Aim 1 (impact of demographic risk markers on three forms of behaviour that challenges) and results of prior 








et al. (2003) 
RR 
RR 
(95% CI) Z score p 
Heterogeneity 
(I2, %) Excluded studies 
Gender Self-injury 17 0.97  0.93 (0.87 – 0.99) -2.15 .031* 20.2 
Maisto et al. (1978); Schroeder et al. (1978); 
Deb et al. (2001) 
 Aggression 11 1.71* 1.04 (0.86 - 1.25) 0.36 .717 80.8 - 
 Destruction 3 Not assessed 1.07 (0.90 - 1.26) 0.73 .464 0.0 - 
IQ Self-injury 16 4.06** 2.39 (1.67 – 3.41) 4.90 <.001** 98.0 - 
 Aggression 9 1.28  1.24 (1.04 – 1.48) 2.43 .015* 84.0 
Jacobson et al. (1982), Ross et al. (1972), 
Tyrer et al. (2006) 
 Destruction 3 Not assessed 1.30 (1.03 - 1.64) 2.22 .026* 88.0 - 
Adaptive 
behaviour Self-injury 6 Not assessed 
1.48 
(1.20 – 1.82) 3.64 <.001** 9.2 - 
 Aggression 3 Not assessed 0.71 (0.47 – 1.08) 1.61 .110 0.0 - 
Living 
arrangements Self-injury 4 Not assessed 
2.36 
(1.63 – 3.42) 4.56 <.001** 17.8 Folch et al. (2018) 
 Aggression 5 Not assessed 1.86 (1.60 – 2.16) 8.16 <.001** 22.9 - 
*Sig at p<.05 level; **Sig at p<.001 level;  
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1.5.2.1 Gender 
SIB was the only form of behaviour that challenges to be associated with gender with the RR 
of SIB being 9% lower among males than females (RR=0.93, CI=0.87, 0.99; p<.05). Moderator 
analysis by age accounted for 16.13% of residual heterogeneity. There was no significant 
impact of gender on aggression or destruction. Given that only three studies were included to 
assess the impact of gender on destructive behaviour, these results should be interpreted with 
caution. 
1.5.2.2. Severity of ID  
Individuals with severe and profound levels of ID had 143% greater risk of self-injury than 
those with mild or moderate levels (RR=2.39, CI=1.67, 3.41; p<.001). A 24% increased risk 
was also identified for aggression (RR=1.24, CI=1.04, 1.48; p<.05). Heterogeneity could not 
be accounted for using study exclusion or using moderator variable of age for self-injury. There 
was a 30% increased risk of destruction among those with severe/profound ID (RR=1.30, 
CI=1.03, 1.64; p<.05), however as only based on three studies with high heterogeneity, the 
results should be interpreted with caution.  
1.5.2.3 Adaptive behaviour deficit  
Individuals with a deficit in adaptive behaviour had 48% greater risk of self-injury (RR=1.48, 
CI=1.20, 1.82; p<.001). There was no significant relationship between adaptive function and 
aggression, however this is only based on three studies. Insufficient data were available to 
assess the impact of adaptive behaviour on destruction. 
1.5.2.4 Living Arrangements (congregate/paid care) 
There was a 136% increased risk of self-injury among those living in paid/congregate care 
compared to those living with family (RR=2.36, CI=1.63, 3.42, p <.001) and an 86% increased 
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risk of aggressive behaviour (RR=1.86, CI=1.60, 2.16; p <.001), however this was only based 
on five studies with high heterogeneity, and therefore should be interpreted with caution. 
Insufficient data were available to assess the impact of paid/congregate care on destructive 
behaviour.  
1.5.3 Given diagnosis risk markers 
In order to address Part B of the aim of the meta-analysis, data relating to specific syndromes 
or diagnoses (Angelman syndrome (AS), Autism (ASD), tuberous sclerosis complex (TSC), 
Down syndrome (DS), fragile X syndrome (FXS), Autism, Smith Magenis syndrome (SMS), 
Cornelia de Lange syndrome (CdLS), and Prader Willi syndrome (PWS)) were compiled for 
self-injury, aggression and destruction (Tables 1.10, 1.11 & 1.86). 17 forest plots (Appendix 
B5-B12) were conducted to determine the RR of different syndromes on each of the three 
behaviours. These are summarised in Table 1.12. 
 
                                                             
6 All data pertaining to destruction is comprised in Table 8 due to so little being available. 
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Table 1.10 Syndrome and control (con) risk marker data indicting number of individuals showing self-injury (n) out of the population included for each risk 
marker (N) 
Author N Sample  
 
Quality AS TSC DS FXS ASD SMS CdLS PWS 

















































- - - - - - 
Arron et al. (2011) 892 CDLS/SMS/ 
AS/FXS1 




















Bowring et al. (2017) 265 Mixed ID2     - 
 
- - - RR 
0.34 
- - - RR 
1.20
8 
       




- - - - - - 
Eden et al. (2014) 441 TSC/DS/FXS/ 
ASD1 

















Emerson et al. (2001) 
 
95 Mixed ID2     - - - - - - - - RR 
1.7 
- - - - - - - 




- - - - - - 












- - - - 












- - - - 5/9 278/ 
816 




- - - - - - 













- - - - - - 
















- - - - - - - - - - - - 
1 Contrast group: Down syndrome 
2 Contrast group: Mixed ID 
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Table 1.11 Syndrome and control (con) risk marker data indicting number of individuals showing aggression (n) out of the population included for each risk 
marker (N) 
Author N Sample Quality AS DS TSC FXS ASD SMS CdLS PWS 









n/N n/N n/N n/N n/N n/N n/N n/N n/N n/N n/N n/N n/ N n/N n/N n/N 
Ando et al. 
(1979) 




- - - - - - 
























Bhaumik et al. 
(1997) 




- - - - - - 
Cooper et al. 
(2009) 








- - - - - - 
Davidson et al. 
(1994) 
201 Mixed ID2     - - - - - - - - 7/10 124/ 
189 
- - - - - - 



















Hiraiwa et al. 
(2007) 
178 Mixed ID2     - - - - - - - - - - - - - - 17/ 
29 
2/42 
Langthorne et al. 
(2011) 




- - 21/25 19/ 
30 
- - - - 
Lundqvist et al. 
(2013) 
915 Mixed ID2     - - - - - - - - - - - - - - 5/9 278/ 
906 
Matson et al. 
(2008) 




- - - - - - 
Oliver et al. 
(2009) 
 









    - - - - - - - - 21/36 11/ 
38 




Tyrer et al. 
(2005) 








- - - - - - 
Wilde et al. 
(2017) 








- - - - - - - - - - 
1 Contrast group: Down syndrome 
2 Contrast group: Mixed ID 
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Risk Marker Behaviour Number 
of studies  
McClintock 









Angelman syndrome Self-injury 2 Not assessed 1.77           
(1.13 - 2.78) 
3.52 <.001** 0.0 - 
 Aggression 2 Not assessed 2.20           
(0.95 – 5.50) 
1.85 .064 71.1 - 
Autism Self-injury 8 6.41** 2.86           
(2.18 – 3.75) 
7.56 <.001** 67.0 Ando et al. (1979) 
 Aggression 6 2.79* 2.04            
(1.79 – 2.34) 
20.37 <.001** 0.0 Davidson et al. (1994) 
 Destruction 3 5.60** 2.58            
(2.14 – 3.10) 
10.06 <.001** 0.0 Ando et al. (1979) 
Cornelia de Lange 
syndrome 
Self-injury 3 Not assessed 2.48            
(1.31 – 4.71) 
2.78 .005* 85.0 - 
 Aggression 3 Not assessed 0.87           
(0.68 – 1.07) 
-1.09 0.281 14.6 - 
Down syndrome Self-injury 3 Not assessed 0.46            
(0.33 – 0.63) 
-4.65 <.001** 0.0 - 
 Aggression 2 Not assessed 0.32           
(0.16 – 0.62) 
-3.33 <.001** 49.8 - 
Fragile X syndrome Self-injury 3 Not assessed 2.66           
(1.63 – 4.34) 
-3.93 <.001** 57.4 Langthorne et al. (2012); 
Lundqvist (2013) 
 Aggression 3 Not assessed 1.12            
(0.82 – 1.53) 
0.71 0.475 61.4 - 
Prader Willi syndrome Self-injury 4 Not assessed 1.91            
(1.47 – 2.48) 
4.82 <.001** 0.0 Hiraiwa et al. (2007) 
 Aggression 2 Not assessed 1.23            
(0.81 – 1.26) 
0.61 0.540 72.4 - 
Smith Magenis 
syndrome 
Self-injury 2 Not assessed 2.14           
(0.91 – 5.01) 
1.74 0.083 88.6 - 
 Aggression 2 Not assessed 1.43            
(1.13 – 1.81) 
3.01 .003* 0.0 - 
Tuberous sclerosis 
complex 
Self-injury 2 Not assessed 2.29           
(1.14 – 4.61) 
2.33 .020* 0.0 - 
 Aggression 2 Not assessed 1.35           
(0.87 – 2.10) 
1.35 .181 0.0 - 
Table 1.12 Synthesis of risk markers relating to Aim 2 (impact of diagnosis on three forms of behaviours that challenge) 
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1.5.3.1 Angelman syndrome 
There was a 76% risk of self-injury among individuals diagnosed with AS compared to those 
of mixed aetiology ID (RR= 1.77, CI = 1.13, 2.78; p = <.001). Whilst the RR of aggression 
among those with AS approached significance, it was not significant based on the two studies 
analysed. Insufficient information was available to assess destruction. 
1.5.3.2 Autism 
There was a 186% increased risk of self-injury among individuals with autism in addition to 
ID, compared to those with ID alone (RR=2.86, CI=2.18, 3.75; p<.001). Similar results were 
found for aggression, with individuals diagnosed with autism having 104% increased risk of 
aggressive behaviour (RR=2.04, CI=1.79, 2.34; p<.001). A significant impact of autism was 
also found for destructive behaviour, with a 158% increased risk (RR=2.58, CI=2.14, 3.10; 
p<.001).  
1.5.3.3 Cornelia de Lange syndrome 
The analysis indicated that those with CdLS have a 148% increased risk of self-injury 
(RR=2.48, CI=1.31, 4.71; p =.005). There was no significant effect of CdLS on aggressive 
behaviour, however both analyses were based on a small number of studies and should be 
interpreted with caution.  Insufficient information was available to assess destruction. 
1.5.3.4 Down syndrome 
Based on the three studies available, individuals with DS have a 54% reduction in risk of self-
injury compared to other forms of ID (RR=0.46, CI=0.33, 0.63; p<.001). A similar result was 
found for risk of aggression; individuals with DS has a 68% reduced risk (RR=0.32, CI=0.16, 
0.62; p<.001). Insufficient information was available to assess destruction. 
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1.5.3.5 Fragile X syndrome 
The analysis indicated that individuals with FXS have a 166% increased risk of self-injury 
above those with ID of other aetiology (RR=2.66, CI=1.63, 4.64, p<.001). Based on the three 
studies focussing on aggression, there was no significant impact of FXS on aggressive 
behaviour. Insufficient information was available to assess destruction. 
1.5.3.6 Prader Willi syndrome 
Based on the two studies included in the analysis, individuals with PWS have a 91% increased 
risk of self-injury than other ID aetiologies (R =1.91, CI=1.47, 2.48; p<.001). No significant 
effect of PWS was found on aggressive behaviour. Insufficient information was available to 
assess destruction. 
1.5.3.7 Smith Magenis syndrome 
Based on the two available studies, individuals with SMS were at no increased risk for self-
injury than individuals of mixed aetiology ID. The results however indicate a 43% increased 
risk of aggression among individuals with SMS (RR=1.43, CI=1.13, 1.81; p = .003). 
Insufficient information was available to assess destruction.  
1.5.3.8 Tuberous sclerosis complex 
Based on the two studies available, individuals with TSC had a 129% greater risk of self-injury 
than individuals of mixed aetiology ID (RR=2.29, CI=1.14, 4.61; p = .02). There was no 
significant impact of TSC on aggression and insufficient information available for destruction.  
1.5.4 Health Risk Markers 
In order to address Part C of the meta-analysis aim, data relating to specific health risk markers 
(mobility, vision, hearing, skin, gastrointestinal, dental and epilepsy) were compiled for self-
injury and aggression (Tables 1.13 & 1.14). These data were not available for destruction. 7 
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forest plots (Appendix B13-B19) were conducted to determine the RR of different health 
markers on each of the behaviours. These are summarised in Table 1.15. 
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Table 1.13 Deficit and typical health marker data indicting number of individuals showing self-injury (n) out of the population (N) 
Author N Sample Quality Mobility Vision Skin Gastro Dental Epilepsy Hearing 









n/N n/N n/N n/N n/N n/N n/N n/N n/N n/N n/N n/N n/N n/ N 
Bowring et al. (2017) 26
5 









Deb et al. (2001) 10
1 
Mixed ID     - - - - - - - - - - 8/25 15/76 - - 
Eden et al. (2014) 37 TSC     2/7 8/30 2/4 8/33 - - - - - - - - - - 
Folch et al. (2008) 83
3 
Mixed ID     - - - - - - - - 10/18 85/189 41/242 94/591 - - 
Kiernan et al. (1996) 34 Mixed ID     7/9 13/25 - - - - - - - - - - - - 
Lundqvist (2013) 91
5 
Mixed ID     - - 12/35 
 
270/880 - - - - - - 56/124 264/874 5/6 
 
271/881 
Richards et al. (2012) 14
8 
ASD     9/13 64/134 5/6 
 
69/141 - - - - - - - - 5/6 69/142 
Richards et al. (2017) 20
7 
ASD     - - 3/7 
 
92/200 24/35 71/172 18/36 77/104 10/18 85/189 - - - - 
Schroeder et al. (1978) 20
0 
Mixed ID     - - 45/52 55/148 - - - - - - - - 16/21 84/179 
Wilde et al. (2017) 29 TSC     4/10 
 
5/19 1/6 8/23 4/15 5/14 4/5 5/24 1/3 8/26 8/23 1/6 - - 
 
Table 1.14 Deficit and typical health marker data indicting number of individuals showing aggression (n) out of the population (N) 
Author N Sample Quality Vision Epilepsy Mobility Expressive  
Communication 









n/N n/N n/N n/N n/N n/N n/N n/N 
Cooper et al. (2009) 1023 Mixed ID     55/481 45/542 42/349 56/663 22/248 78/775 56/124 264/874 
Deb et al. (2001) 101 Mixed ID     - - 9/25 14/76 - - 9/25 14/76 




- - 1/9 1/16 - - 
Tyrer et al. (2005) 2062 Mixed ID     - - 152/812 291/2250 - - - - 
Wilde et al. (2017) 29 TSC     - - - - 4/10 6/19 5/15 4/14 
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Table 1.15 Synthesis of risk markers relating to Aim 3 (impact of health risk markers on all forms of behaviour that challenges) 
Risk Marker Behaviour Number of 
studies 
included 




Z score Significance Heterogeneity 
(I2) 
Excluded studies 
Visual deficit Self-injury 5 Not assessed 2.09                                 
(1.67 – 2.60) 
6.53 <.001** 5% Lundqvist (2013) 
 
 Aggression 2 Not assessed 1.37                               
(0.97-1.93) 
1.81 .07 0% - 
Hearing deficit Self-injury 3 Not assessed 1.54                                 
(1.24 – 1.90) 
4.0 <.001** 0% Bowring et al. 
(2017) 
Mobility deficit Self-injury 5 Not assessed 1.46                                 
(1.08 – 1.96) 
2.49 .013* 0% - 
 Aggression 3 Not assessed 0.95                                    
(0.63 – 1.42) 
-0.25 0.812 0% - 
Epilepsy Self-injury 4 Not assessed 1.37                                    
(1.15 – 1.64) 
3.58 <.001** 0% - 
 
 Aggression 3 Not assessed 1.46                                     
(1.25 – 1.71) 
4.80 <.001** 0% - 
Dental Problems Self-injury 3 Not assessed 0.94                                      
(0.75 – 1.19) 
-.48 .631 0% - 
Gastro problems Self-injury 2 Not assessed 1.39                                       
(0.31 – 6.33) 
.43 .673 0% - 
Skin problems Self-injury 3 Not assessed 1.34                                     
(0.67 – 2.69) 
.82 .412 0% - 
*Sig at p<.05 level; **Sig at p<.001 level;
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1.5.4.1 Visual deficit 
The analysis indicated that people with visual deficits and ID have a 109% increased risk of 
self-injury compared to those with ID and no deficit (RR =2.09, CI=1.67, 2.60; p<.001). The 
impact of visual deficit on aggressive behaviour approached significance but was not 
significant based on the two studies available. Insufficient data were available to determine 
impact on destructive behaviour. 
1.5.4.2 Hearing Deficit 
The analysis indicated that individuals with ID with a deficit in hearing have a 54% increase 
in risk of self-injury compared to those without this deficit (RR=1.45, CI=0.61-1.91; p = .006). 
Insufficient data were available to determine impact on aggression and destructive behaviour. 
1.5.4.3 Mobility Deficit 
The forest plots indicated that individuals with ID and a mobility deficit are at a 46% increased 
risk of self-injury (RR=1.46, CI=1.08, 1.96; p = .013). No significant effect of deficit in 
mobility was found on risk of aggression. Insufficient data were available to determine impact 
on aggression and destructive behaviour. 
1.5.4.4 Epilepsy 
The analysis indicated that individuals with epilepsy and ID have 64% greater risk of self-
injury compared to those with ID alone (RR=1.37, CI=1.15, 1.64; p = <.001). A similar result 
was identified for aggression; individuals with epilepsy and ID have a 46% increased risk of 
aggression compared to those with ID alone (RR=1.46, CI=1.25, 1.71; p<.001). Insufficient 
data were available to determine impact on destructive behaviour. 
1.5.5 Person Risk Markers 
To further address the Part C of the meta-analysis aim, data relating to specific person risk 
markers (receptive and expressive communication, repetitive behaviour and 
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overactivity/impulsivity) were compiled for self-injury and aggression (Tables 1.147 & 1.16). 
These data were not available for destruction in the literature. 5 forest plots (Appendix B20-
B23) were conducted to determine the RR of different person risk markers on self-injury. These 

















                                                             
7 Only one person risk marker was available for aggression (expressive communication), therefore data is 
included in previous aggression table, Table 1.14. 
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Table 1.16 Person specific risk marker data indicting number of individuals showing self-injury (n) out of the population (N) 

















n/N n/N n/N n/N RR RR 
Ando et al. (1979) 128 Mixed ID     3/99 4/29 5/118 2/11 - - 
Bott et al. (1997) 3662 LD     383/2994 173/668 - - - - 
Bowring et al. (2017) 265 ID     - RR: 3.68 - RR: 3.658 - - 
Davies et al. (2016) 417 Severe ID     - - - - RR: 4.87 RR: 3.51 
Eden et al. (2014) 37 TSC     8/33 2/4 - - -  
Emerson et al. (2001) 
 
95 Mixed ID     RR: 2.2  RR:1.7 - - - 
Hemmings et al. (2006) 214 ID     - - - - - - 
Kiernan et al. (1996) 42 ID     - - 7/24 8/18 - - 
Lundqvist (2013) 915 ID     234/769 78/146 - - - - 
McLean et al. (1996) 211 Mixed ID     23/166 6/45 - - - - 
Richards et al. (2012) 148 ASD     60/130 14/18 - - - *RR1.758 
*RR1.614 




Schroeder et al. (1978) 1153 Mixed ID     62/819 146/334 136/956 72/194 - - 
et al. (1968) 59 ID/Schizophrenia     4/21 18/38 - -   
Wilde et al. (2017) 29 TSC     3/14 6/15 - - - - 
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Table 1.17 Synthesis of risk markers relating to Aim 3 (impact of person risk markers on self-injury and aggression) 
Risk Marker Behaviour Number 
studies 
included 











Self-injury 8 3.37** 1.95                 
(1.70 – 2.23) 
9.74 <.001** 0% Schroeder et al. (1978); 
Lundqvist (2013) 
Aggression 5 0.46  1.44                  
(1.29 – 1.60) 
6.46 <.001** 0% McLean et al. (1996) 
Receptive 
communication 
Self-injury 4 3.43** 2.54                 
(2.03 – 3.17) 
8.21 <.001** 0% - 
Overactivity/impulsivity Self-injury 5 Not assessed 1.65                 
(1.49 – 1.84) 
9.37 <.001** 0% - 
Repetitive behaviour 
Self-injury 3 Not assessed 1.66                  
(0.97 – 2.84) 
1.85 .065 0% - 
*Sig at p<.05 level; **Sig at p<.001 level
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1.5.5.1 Expressive Communication Deficit 
The results indicate a 95% increase in risk of self-injury for individuals with a deficit in 
expressive communication compared to those without (RR=1.95, CI=1.7, 2.23; p = <.001). A 
similar result was identified for aggression; individuals with an expressive communication 
deficit have a 44% increased risk of aggressive behaviour compared to those without (RR=1.44, 
CI=1.29, 1.60; p<.001). 
1.5.5.2 Receptive Communication Deficit 
The analysis concluded that individuals with a deficit in receptive communication have 154% 
increased risk of self-injury than those without this deficit (RR = 2.54, CI = 2.03, 3.17; p <.001). 
Insufficient data were available to determine impact on aggression and destructive behaviour. 
1.5.5.3 Overactivity/Impulsivity 
The forest plot indicates that individuals who score more highly on measures as being 
overactive or impulsive are 65% more likely than those who do not to self-injure (RR=1.65, 
CI=1.49, 1.84; p<.001). Insufficient data were available to determine impact on aggression and 
destructive behaviour. 
1.5.5.4 Repetitive Behaviour 
Based on the two studies available for analysis, the impact of repetitive behaviour on self-
injury approached significance, however it not currently possible to conclude that repetitive 
behaviour impacts the risk of self-injury. Insufficient data were available to determine impact 
on aggression and destructive behaviour. 
1.5.6 Summary of significant results 
Figure 1.2 provides a synthesis of all statistically significant risk markers identified throughout 
the meta-analysis.  
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1.6. Discussion 
The current study sought to synthesise demographic, diagnostic and behavioural risk markers 
for three distinct forms of behaviour; SIB, aggression and destruction. It provided a synthesis 
of risk marker research from across 60 studies conducted between 1968 and 2018. It has 
highlighted considerable progression in the understanding of risk markers associated with SIB 
and has indicated that aggressive and destructive behaviour risk markers warrant considerable 
further research to meet the same level of understanding as risk markers for SIB. Moreover, 
this meta-analysis has indicated methodological concerns associated with conflating aggressive 
and destructive behaviour, as it results in lack of understanding about each specific topography. 
1.6.1 Self-injury 
This meta-analysis identified 18 risk markers that were significantly associated with SIB. A 
diagnosis of autism was associated with the greatest increase in risk of SIB (RR=2.86), along 
with a diagnosis of fragile X syndrome (RR=2.65), increased repetitive behaviour (RR=2.54) 
diagnosis of Cornelia de Lange syndrome (RR=2.48), lower level of intellectual ability 
(RR=2.39), living in paid care (RR=2.36), diagnosis of tuberous sclerosis complex (RR=2.29) 
and a visual deficit (RR=2.09). All of these risk markers are associated with over a 100% 
increase in risk of SIB when present, compared to individuals with ID that do not have these 
characteristics. This meta-analysis also identified expressive communication deficit 
(RR=1.95), diagnosis of Prader Willi syndrome (RR=1.91), Angelman syndrome (RR=1.77), 
overactivity (RR=1.65), hearing deficit (RR=1.54), mobility deficits (RR=1.46), low adaptive 
functioning (RR=1.48) and epilepsy (RR=1.37) as risk markers for SIB. Finally, male gender 
was associated with a decrease in risk of SIB (RR=0.93), as was diagnosis of Down syndrome 
(RR=0.46).  
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The previous meta-analysis identified diagnosis of autism as a risk marker for SIB, as well as 
severity of ID and deficits in receptive and expressive communication (McClintock et al., 
2003). The reliability of these risk markers has been upheld and refined with the addition of 
further research that has emerged, suggesting that these are robust and reliable risk markers. 
Many of the additional risk markers in the new analysis, however, represent emerging interests 
within the field of intellectual disability and SIB. In the same manner as the previous meta-
analysis, many of the new risk markers identified are based on a small number of studies, such 
as Angelman syndrome (N=2), Cornelia de Lange syndrome (N=3), Down syndrome (N=3), 
fragile X syndrome (N=3), Smith Magenis syndrome (N=2) and Tuberous sclerosis complex 
(N=2). The identification of these new risk markers provide guidance for future research focus, 
to enhance the robustness of these findings. 
1.6.2 Aggression 
The results of the meta-analysis of risk markers pertaining to aggression suggest that the 
research field has focused on similar risk markers to SIB. Importantly, however, many of the 
risk markers that are significantly associated with SIB have not been replicated for aggression. 
Seven risk markers were identified in this meta-analysis: diagnosis of autism (RR=2.04), living 
in paid care (RR=1.86), epilepsy (RR=1.46), deficit in expressive communication (RR=1.44), 
diagnosis of Smith Magenis syndrome (RR=1.43), severity of ID (RR=1.24) and Down 
syndrome (RR=0.32). Three of these were consistent with the McClintock et al. (2003) paper 
(autism, expressive communication and severity of ID), however gender was previously 
indicated as a significant risk marker that was not upheld in the current study. This was, 
however, previously based on two studies and is now based on eleven; it is likely the additional 
studies helped to increase the robustness of this finding and emphasises the importance of 
contributing additional studies to the field of aggression risk markers to help refine current 
understanding. Research pertaining to specific syndromes and their association with aggression 
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suggests a similar situation to SIB; the number of studies available is relatively small. There is 
considerable merit in more widespread research within these less well-studied syndromes, as 
well as consideration of more diverse risk markers that may be unique to aggression, rather 
than focusing solely on those identified in SIB research. 
1.6.3 Destruction 
This meta-analysis has emphasised the noticeable lack of research focussing on risk markers 
for destruction compared to both aggression and SIB. It was only possible to identify eight 
papers that provide sufficient data for analysis on destruction among individuals with ID, and 
these papers only explored three risk markers, of which two were significant: severity of ID 
(RR=2.58) and presence of autism (RR=2.58). There is considerable diversity in the proportion 
of individuals displaying destruction in the samples identified, with the highest being 48.5% 
(Crocker et al., 2007), a mid-range proportion being 24.7% (Crocker et al., 2006) and the 
smallest proportion being 14.1% (Jacobson et al., 1982). This suggests that there may be some 
inconsistencies in the definition of destruction and emphasises the importance of consistency 
in better understanding different topographies of behaviour. 
Across each of the three behaviours studies, the presence of autism and lower level of ability 
have been identified as significant risk markers. Interestingly, a recent meta-analysis indicated 
that individuals with autism and ID are often excluded from research, when this is arguably the 
population most in need (Russel et al., 2019). There are considerable clinical implications of 
being able to identify individuals that are at increased risk of developing either of these three 
behaviours. It is widely recognised that, once these behaviours are in a person’s repertoire, it 
is difficult to exclude them, resulting in incredibly high costs to the NHS (cost to services for 
adults with severe challenging behaviour was indicated as being between £89,335 and 
£358,415; Emerson et al., 2014). Future research should 1) consider how to use these risk 
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markers to identify individuals most at risk in a clinical setting and 2) devise intervention or 
prevention strategies tailored towards those with increased risk.  
1.6.4 Research progression 
The differences identified between the previous meta-analysis and the current meta-analysis 
provide a clear indication of the value of having multiple studies to assess.  Inclusion of a small 
number of studies increases the risk of both Type 1 and Type 2 errors. This meta-analysis 
provides an opportunity to appraise the updated literature base (Blettner et al., 1999), 
considering the impact the additional research has made to the previous findings presented by 
McClintock, Hall and Oliver (2003). In comparison to the 25.5% inclusion rate McClintock, 
Hall and Oliver (2003) indicate for identified studies containing sufficient data to calculate 
effect size, the current study had an 85% inclusion rate of identified studies. This suggests 
considerable improvement in the way that data are reported. There has been increased 
consideration for the inclusion of control groups and more comprehensive information 
regarding the ID population included in research, two factors highlighted by McClintock et al. 
(2003) as deficits in the literature base. This increased detail facilitates more reliable reporting 
on unique characteristics, rather than the general ID population. Despite this improvement, the 
analysis indicates that this is predominantly within self-injury; less researched fields of 
aggression and destruction of property still require advancements to enable direct comparisons, 
particularly in terms of measures used. 
1.6.5 Limitations 
A potential limitation of the current meta-analysis is that it elected not to rerun the search that 
was previously conducted by McClintock et al. (2003). It is possible, that choosing to extend 
the search opens up the possibility of missing valuable studies that the previous meta-analysis 
may have missed or excluded. Given that the search terms included in the current meta-
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analysis, however, were based on the previously used search terms, it is unlikely that a new 
search would have identified any additional papers. Moreover, the bibliographies of the 
included studies were reviewed for any additional studies that may have been overlooked. It is 
anticipated that this thorough approach would have identified any studies not identified in the 
database search. This decision was conducted in line with guidance on updating previous 
comprehensive reviews (Garner et al., 2016).  Similarly, the methodology could be criticised 
for limiting the search solely to peer reviewed, published studies, as this increases the risk of 
positive publication bias influencing the results. However it was considered of greater value to 
include studies that have been peer-reviewed as these represent a higher standard (Cook et al., 
2003). 
In line with the previous meta-analysis (McClintock et al., 2003), there was considerable 
heterogeneity (indicated by high I2 values) between studies focussing on specific risk markers, 
including gender (self-injury & aggression), IQ (self-injury, aggression & destruction), AS 
(aggression), Autism (self-injury), CdLS (self-injury), FXS (self-injury & aggression), PWS 
(aggression) and SMS (self-injury). This suggests considerable difference in the way the 
included studies review either the behaviour that challenges or the risk marker, or differences 
in the sample characteristics, such as age, proportion of a particular gender or severity of ID. 
The resultant impact is that the RR findings need to be interpreted with significant caution.  
Age represents an interesting methodological variation characteristic to consider for 
heterogeneity. Shanahan et al. (2008) indicated that behavioural profiles differ significantly 
between younger and older individuals with FXS. Interestingly, one of the studies excluded in 
the self-injury-FXS analysis had a higher mean sample age than the other studies included. 
Alternatively, this meta-analysis has indicated that individuals with severe/profound ID are 
more likely to engage in any one of the three forms of behaviour that challenges; comparison 
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of two studies with samples differing in severity of ID could create heterogeneity. This could 
also occur when comparing predominantly male and female samples.  
Consideration should also be made for lack of unanimity in control populations; there is a trend 
to select Down syndrome as a control population, however Down syndrome has been 
determined to be a ‘preventative’ risk marker, thus  comparison with this population will result 
in over-estimation of syndrome RR significance. Moreover, heterogeneity could occur when 
studies compare a syndrome to a different control population, e.g. one comparing to Down 
Syndrome and another comparing to mixed aetiology ID.   
Appendix A indicates the array of measures used to determine presence of self-injury, 
aggression and destruction, which include the Modified Overt Aggression Scale (Oliver et al., 
2007), Challenging Behaviour Questionnaire (Hyman et al., 2002), Behaviour Problem 
Inventory (Rojahn et al., 2001), Self-injury, Aggression and Destruction Screening 
Questionnaire (Davies & Oliver, 2016) and a number of self-determined measures. The 
discrepancies among these measures could result in considerable heterogeneity in results. The 
measures vary between the behaviour having to have occurred within the last week (Modified 
Overt Aggression Scale), to the last 6 months (Developmental Behaviour Checklist) or even 
occurred ever, with frequency being used to determine whether the behaviour is present (SAD-
SQ; Bhaumik et al. (1997) self-developed measure). Measures focussing on the last week are 
more likely to identify individuals with forms of behaviour that occur more frequently, whilst 
measures focussing on the last month could be identifying much more rare/infrequent 
behaviours.  
Generally, measures of self-injury are consistent in their definition that it is a self-directed, 
harmful behaviour. Discrepancies arise, however, for definitions of aggression and destruction. 
The BPI adopts a subscale of aggressive/destructive behaviour, with property destruction, 
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pushing and verbal outbursts all being part of the same subscale. In contrast, the MOAS 
fragments the term ‘aggression’ into verbal aggression, physical aggression, property 
aggression and self-aggression. The CBQ and SAD-SQ also consider subtypes of behaviour in 
this way. This approach provides a much richer insight into the specific topographies of 
different socially maladaptive behaviours. A review of aggressive behaviour in ID research by 
Benson & Brooks (2008) indicated a need for assessment instruments that address severity and 
topography of aggression in isolation. As previously indicated, data relating to aggression 
obtained using the BPI was excluded from this meta-analysis as it was not possible to remove 
incidences of destruction from the subscale. Based on the current meta-analysis, it is clear that 
there is insufficient knowledge regarding differences between aggressive and destructive 
behaviour and that condensing the two into one subscale is limiting the potential pool of 
knowledge regarding aggression and destruction. 
1.6.6 Conclusion 
In summary, this meta-analysis sought to identify demographic risk markers, specific 
syndromes or diagnoses and other risk markers that impact the risk of self-injury, aggression 
and destruction. Whilst it has made a comprehensive advance in achieving this aim, and has 
synthesised the available literature, there remains further advancements to be made. For 
example, syndromes such as Cri du Chat, Sotos and Rett syndrome have been associated with 
increased self-injury (Collins and Cornish, 2002; Sheth et al., 2015; Oliver et al., 1993), 
however insufficient data were available to conduct a meta-analysis to determine the impact of 
such syndromes. As the available data increases, it would be valuable to continue to 
quantitatively calculate the risk these syndromes present, as well as consistently re-evaluating 
the analyses presented based on a small number of syndromes. Furthermore, improved focus 
on aggression and destruction as two separate behaviours, adopting measures that embrace this 
concept, will facilitate more advanced understanding of aggression and destruction and 
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determination of whether they have different risk markers. Clinically, the results of this meta-
analysis could be translated to aid identification of individuals that are at elevated risk of 
developing a specific form of behaviour that challenges, based on the risk markers they present, 
and could facilitate development of early-identification and intervention strategies. 
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CHAPTER 2 
Clinical utility of risk markers for aggression and destruction in children 
with intellectual disability 
2.1 Abstract 
Rationale: The adverse effects of behaviours that challenge are vast, including reduced quality 
of life, institutionalisation, negative carer attitudes and financial cost. This study sought to 
determine if it is viable to consider an early intervention route, similar to that used in psychosis, 
for aggression and destruction in children with intellectual disability. Method: Using a large 
data pool as a modelling sample, a backward stepwise logistic regression was used to develop 
an algorithm that combined risk markers that most accurately predicted current presence or 
absence of aggression and destruction. An optimal cut off to maximise sensitivity whilst 
maintaining good specificity was established. This algorithm was then applied to a new test set 
of data for cross validation. Results: The most predictive risk markers included in the 
aggression algorithm were gender, autism, skin problems, health problems, overactivity, 
impulsivity and repetitive behaviour. This model achieved a sensitivity of 83.2% and 
specificity of 70.2% in the test sample. Presence of autism and impulsivity were the most 
significant predictors in the destruction algorithm, giving a sensitivity of 80.5% and specificity 
of 63.8% in the test sample. Conclusion: This study demonstrates that it is possible to develop 
an algorithm that predicts currently present behaviour. The next stage of considering early 
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2.2. Introduction 
2.2.1 Behaviours that challenge 
‘Behaviours that challenge8’ are a clinical concern for many individuals and families, with 
estimates of such behaviour in typically developing adolescents ranging from 5% to 20% 
(Marsee et al., 2014; Raine et al., 2006). The term ‘behaviours that challenge’ refers to any 
behaviour that presents a significant challenge to services, the individual, or those around them, 
regardless of the presumed cause of the problem. Among children with intellectual disability 
(ID), such behaviours typically comprise aggression, destruction of property (destruction) and 
self-injury (Lowe et al., 2007). However in typically developing children, the spectrum of 
behaviours is far broader, incorporating drug abuse, sexual promiscuity and vandalism 
(Newcomb & Bentler, 1989). ‘Aggression’, as defined by the Royal College of Psychiatrists 
(2007), includes physical aggression, verbal aggression and sometimes property destruction. 
Physical aggression can be used to refer to an array of acts, including physical assaults on peers, 
family members or staff, such as pushing, kicking or biting (Rojahn et al., 2001). ‘Destruction’ 
refers specifically to the intentional damage of property, such as breaking an object into two or 
more pieces, ripping things from walls or into parts, or denting/marking solid objects (Emerson 
et al., 2001). Of the proportion of typically developing children that engage in some form of 
aggressive behaviour (including destruction), only 5-10% are likely to continue this behaviour 
into adulthood (Moffitt, 1993; Tremblay et al., 2004) and only 5% of those with extreme 
behaviour in childhood are likely to experience adverse impacts, such as drug addiction and 
criminality by age 25 (Fergusson et al., 2005). In contrast, individuals with ID that engage in 
behaviours that challenge are more likely to experience reactive physical intervention, 
psychiatric hospital intervention, school exclusion and decreased quality of life (Beadle-
                                                             
8 The term ‘behaviours that challenge’ has been used instead of ‘challenging behaviour’ in line with 
adjustments in terminology within this field to reduce implications of blame towards the individual engaging in 
such behaviour. 
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Brown, Murphy & DiTerlizzi, 2009; Mandell, 2008; Allen, Lower, Brophy & Moore, 2009; 
Knapp et al., 2005). Moreover, staff members working with individuals showing behaviours 
that challenge are more likely to hold negative views or be more critical towards those showing 
such behaviour (Weigel, Langdon, Collins & O’Brien, 2006). This suggests there is 
considerable benefit in focusing research efforts on better understanding behaviours that 
challenge in the ID population, as they experience more adverse effects as a result. 
The prevalence of behaviours that challenge observed among individuals with intellectual 
disabilities (ID), autism and learning difficulties is significantly greater than that observed in 
typically developing children (21% compared to 4% in Britain specifically; Emerson & Hatton, 
2007). When individual topographies of behaviours that challenge are considered, specifically 
aggression and destruction, the prevalence is highly variable, ranging from 10% to 77% 
(Crocker et al., 2006; Emerson et al., 2001; Tyrer et al., 2006; Emerson et al., 2001). Aggressive 
behaviour is most common, with most estimates clustering around 30-40% (Davies & Oliver, 
2016; Lowe et al., 2007; Powis & Oliver, 2014) whilst the estimated prevalence of destructive 
behaviour is between 15-40% (Ruddick et al., 2015; Davies & Oliver, 2016). Aggressive and 
destructive behaviours are reported to emerge early in life for people with ID, with prevalence 
of behaviour problems ranging from 20-64% in preschool age children (Roberts, Mazzucchelli, 
Taylor & Reid, 2010). Furthermore, in contrast to the small proportion of typically developing 
children that are likely to continue to engage in behaviours that challenge into adulthood, 
behaviours that challenge are shown to be highly persistent among people with ID (Totsika & 
Hastings, 2009) and consistent in epidemiology (Davies & Oliver, 2016). The impact of such 
persistent, early emerging behaviours that challenge is substantive. In addition to the 
consequences to the individual, behaviours that challenge result in high financial cost to 
services; cost to services for adults with severe behaviours that challenge are estimated between 
£89,335 and £358,415 (Cooper, Emerson, Glover & Gore, 2014). Due to the adverse impacts 
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of these behaviours, it is necessary to devise comprehensive treatment approaches to ameliorate 
them, as once behaviours enter the repertoire, without treatment, problematic behaviour is 
likely to escalate (Emerson et al., 2001).  
2.2.2 Treatment approaches 
Operantly informed treatments emerged following empirical demonstration that presence and 
severity of these behaviours is influenced by social negative reinforcement, social positive 
reinforcement and sensory reinforcement (Carr, 1977). Studies have demonstrated that 
contingent delivery of a stimulus that is socially mediated (attention, preferred activities or 
tangibles) contributes to maintenance of aggression or destructive behaviour (Richman & 
Hagopian, 1999; Ringdahl et al., 2018). Similarly, social negative reinforcement may maintain 
behaviours that challenge though removal of socially negative reinforcers, such as task 
demands, on a contingent basis (Carr & Durand, 1985). A number of interventions based on 
these hypotheses have been devised, including differential reinforcement (reinforcement 
contingent on presence of alternative behaviour), noncontingent reinforcement (reinforcement 
based on a time schedule to reduce behaviours dependent on non-social reinforcement or 
socially determined consequences) and antecedent interventions (reducing aversiveness of a 
task by developing more adaptive skills). These strategies are effective among both children 
and adults with ID (Catania, 2013; Chowdury & Benson, 2011; Lindberg et al., 2003; Laraway 
et al., 2003; Shogren et al., 2004; Romaniuk & Miltenberger, 2001). Positive Behaviour 
Support (PBS) offers a combination of the conceptual framework of applied behaviour analysis 
within a person-centred approach. PBS has been indicated as effective in minimising 
behaviours that challenge (MacDonald & McGill, 2013; Langdon et al., 2017). Whilst these 
interventions are effective, they are responsive, and often expensive. 
One important limitation of current applications of differential and noncontingent 
reinforcement, and antecedent interventions is that they typically depend on the behaviour 
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already being present and the individual coming into contact with appropriate specialised, high-
cost services (Feldman et al., 2004). Moreover, there is risk of the behaviour re-emerging if the 
reinforcement schedule is not maintained; successful interventions often necessitate highly 
controlled environments and precise management of environmental contingencies (Goh et al., 
2000; Berg et al., 2007; Wacker et al., 2011). Thus, an alternative, complementary approach 
for these behaviours is to adopt an early intervention pathway (Emerson, 1995), similar to that 
in psychosis and dementia. 
2.2.3 Early-intervention 
Early intervention is characterised as an attempt to delay or prevent psychopathology by 
offering an intervention prior to symptoms becoming clinically significant (Ramey & Ramey, 
1998). Early intervention has proven effective for treatment of psychosis; randomised control 
trials have shown positive results from identifying and treating people in the prodrome phase 
(those with no symptoms of psychosis but considered at high risk of developing psychosis), 
with reduced chances of those treated transitioning to psychosis (McGorry et al., 2002). 
Moreover, early psychosis services are often more cost effective than standard services as there 
is less need for costly inpatient care (McCrone et al., 2009). 
The need for early recognition of behaviours that challenge has long been recognised due to 
their association with childhood onset and significant adverse effects (Emerson, 1995). Despite 
research indicating that risk of developing behaviours that challenge emerges early in 
childhood (Totsika et al., 2011; Einfeld et al., 2010), only a small volume of literature has 
sought to examine the practicality of early intervention (Cooper et al., 2014). This research has 
shown positive outcomes through skill replacement, derived from functional analysis, when 
implemented early (Harvey et al., 2009). There is a clear rationale for interventions to reduce 
the likelihood of children developing a repertoire of aggressive or destructive behaviours. It is 
not financially viable, however, in the current healthcare climate to offer all children such 
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intervention approaches. Systematic early identification of at-risk individuals and rapid 
response provides an alternative, more affordable route to ensuring behaviours do not develop. 
Chapter 1 demonstrates that there is a notable lack of research regarding risk markers (variables 
that correlate) for aggression, and an even greater lack of research on risk markers for 
destruction. Identification of risk markers for these specific behaviours that challenge would 
highlight targets for intervention strategies (for example, if communication deficits represented 
a risk marker for behaviours that challenge, interventions could focus on improving 
communication skills). Improved knowledge on risk markers for these behaviours would 
confer the opportunity to identify children before aggression/destruction occurs, to enable early 
intervention. 
2.2.4 Risk markers of aggression and destruction 
Literature concerning risk markers for self-injury is relatively robust, however the meta-
analysis outlined in Chapter 1 indicated that there is significantly less research into risk markers 
for aggression and destruction. Chapter 1 identified a number of significant risk markers for 
aggression (severity of intellectual disability, living in paid or congregate care, presence of 
autism, presence of Smith Magenis Syndrome and deficits in expressive communication, with 
Down Syndrome representing a protective marker). Additional genetic syndromes have been 
noted as risk markers by individual studies, such as Angelman Syndrome (Arron et al., 2011), 
as well as overactive or impulsive behaviour (Davies & Oliver, 2016), however an insufficient 
number of studies have presented findings to evaluate this reliably and this represents an 
important area for future exploration. The literature regarding destruction, however, was 
relatively limited. The results in Chapter 1 highlighted methodological concerns, where many 
studies conflated measurement of aggression and destruction, making it different to isolate 
factors that contribute solely to destruction. Thus, only intellectual disability and presence of 
autism were identified as risk markers for destructive behaviour; however, individual empirical 
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studies have highlighted age (Chadwick et al., 2000; Lowe et al., 2007), mobility (Chadwick 
et al., 2000), repetitive behaviours and impulsivity (Davies & Oliver, 2016) as markers of 
significant interest. Chapter 1 highlighted the need for further research in the areas of 
aggressive and destructive behaviour to contribute to the limited knowledge base.  
Giving professionals (Health Visitors, GPs, Early Years Practitioners) the tools to identify 
individuals with risk markers associated with increased risk of aggressive or destructive 
behaviour could facilitate earlier intervention, with the hope of reducing the likelihood of these 
behaviours developing and could help to determine children that would most benefit from a 
proposed intervention (Cooper et al., 2014). There has currently, however, been 1) poor 
identification of risk markers for aggression and destruction of property specifically, and 2) no 
translation of the known risk markers into a clinically viable tool that can predict which 
children would benefit most from early intervention. The Self-injury, Aggression and 
Destruction Screening Questionnaire (Revised; SAD-SQ(R)) was devised for the purpose of 
this research based on the SAD-SQ (Davies & Oliver, 2016). It incorporates risk markers 
thought to be associated with behaviours that challenge and is sufficiently brief for clinical 
application. The present study seeks to determine whether components of the SAD-SQ(R) 
could act as a low-cost and effective screening tool for identifying the risk of developing 
aggressive or destructive behaviour.  
2.2.5 Aims of current study 
The current study has the following aims: 
1) To identify and quantify the contribution of risk markers to the presence of aggressive 
and destructive behaviour  
2) To develop an algorithm capable of predicting current presence or absence of 
aggression and destruction. 
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3) To test the developed algorithm in a new data set to determine if this strategy has 
potential clinical utility to identify individuals who have risk markers that are 
suggestive of increased risk of aggressive or destructive behaviour. 
2.3. Method 
2.3.1 Ethics 
Ethical approval to complete the current study was provided by the North East Tyne & Wear 
South Research Ethics Committee. The Health Research Authority Number was: 235418 
(Protocol Number: RG_17 182; REC Number 18/NE/0249; Appendix C). Participants were 
contacted (Appendix D) and given sufficient time to review the information (Appendix E) prior 
to giving consent (Appendix F) and were welcome to take the information home to discuss 
with family. For details on data protection, potential distress and support offered, please review 
the participant information sheet (Appendix G).  
2.3.2 Recruitment 
2.3.2.1 Modelling Sample 
The first stage of the research utilised a rich set of pooled data from three previously published 
studies (Richards, Davies & Oliver, 2017; Davies & Oliver, 2016; Handley, 2014). The 
methodology for the collection of these data is reported in more detail in these publications. 
Handley (2014) recruited children with severe or profound intellectual disabilities aged 2-11 
attending a Child Development Centre, assessment group or school for children with 
intellectual disabilities in Birmingham. Richards et al. (2017) recruited 515 children and adults 
with a diagnosis of autism from schools and adult services linked to the National Autistic 
Society, whilst Davies and Oliver (2016) recruited 629 children diagnosed with a severe 
intellectual disability aged 2-12 from special schools in the Birmingham area. The total 
modelling sample therefore included 1550 participants, before cleaning. 
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2.3.2.2 Test Sample 
Recruitment of the test sample utilised three pathways to recruit a representative sample of 
children with neurodevelopmental disability or developmental delay from 1) a previously 
established participant database; 2) special education schools in the West midlands; 3) health 
services in the west midlands (including school nurses, child development centres, community 
paediatricians and health visitors. Table 2.1 presents the return rates for each route. 
2.3.3 Measures 
The current study used a revised version of the SAD-SQ (Davies & Oliver, 2013). The SAD-
SQ for the purpose of this study was revised to include questions regarding communication 
skills to inform future interventions, however the data was not analysed in this study. There are 
two versions of the SAD-SQ(R); a 54-item questionnaire for children under the age of 6 
(Appendix G), and a 64-item questionnaire for those 6 and over (Appendix H).  The under 6 
questionnaire obtained developmental delay information in line with the Denver 
Developmental Screening Test II (Frankenburg, Dodds & Archer, 1990), whilst the 6 and over 
questionnaire used the Wessex Behaviour Scale (Kushlick et al., 1973). Two different 
questionnaires for different age groups were necessary as the Wessex Behaviour Scale asks 
about abilities that younger children would not be able to do, for example being able to read. 
The SAD-SQ(R) focusses on simplicity and accessibility, achieving maximum information 
about risk markers in minimum time. This was achieved by reviewing all questionnaires 
devised that gather information on the target risk markers (Davies & Oliver, 2013). The SAD-
SQ(R) presents examples to aid completion and assesses health problems, ability, repetitive 
behaviour, level of ability and different types of behaviours that challenge (self-injury, 
aggression and destruction). Response scales are Likert, binary or short answer and the measure 
is informant report, completed by a carer or parent familiar with the child. For each behaviour 
that challenges, frequency (0 = never, 4 = very often), management difficulty (0 = not difficult, 
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4 = extremely difficult) and concern (0 = not at all concerned, 4 = extremely concerned) were 
assessed. The SAD-SQ is reported to have good concurrent and convergent validity, as well as 
good reliability (Davies & Oliver, in review). Inter-rater reliability was indicated as between 
.21 and.47, with overactivity/impulsivity representing the lowest reliability score, although 
other papers have found similar results with different measures (Amador-Campos et al., 2006). 
Moreover, those categorised as ‘high risk’ by the SAD-SQ also scored significantly higher than 
those categorised as ‘low risk’ on other standardized measures, e.g., overactivity (U = 33, p = 
.001), impulsiveness (Z = - 2.727, p < .008), repetitive (U = .49, p = .003) and restricted (U = 
61.5, p = .017). 
2.3.3.1 Classification of aggression and destruction 
The SAD-SQ(R) rated severity, concern and management of aggression and destruction on 
scales of 0 to 4, with 0 indicating never and 4 indicating very frequently. The current study 
sought to identify behaviours that would be considered clinically significant; sufficiently 
problematic that parents would be likely to seek support. Previous studies have taken this 
approach, classifying ‘clinically significant’ behaviours as those scoring either a 3 or 4 for 
severity (Richards et al., 2017; Davies & Oliver, in review). In order to produce binary 
responses of yes/no for presence of aggression and presence of destruction, responses of 3 and 
4 for severity were accepted as being indicative of behaviour likely to be deemed challenging 
in a clinical nature. Scores of 1 or 2 for frequency could be deemed very low-level difficult 
behaviour that would not reach clinical significance. In addition, however, in order to identify 
all clinically significant behaviour, the management and concern scores were reviewed when 
frequency was rated as 1 or 2. It may well be that a behaviour is infrequent, but is hard to 
manage when it does present, therefore this could still present a clinical concern. If both 
management and concern returned scores of 1 or 2, this behaviour was not considered 
‘challenging’ and therefore the data were coded as non-aggressive/non-destructive. Where 
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either management or concern gave a score of 3 or 4, the behaviour was considered to be 
clinically significant and coded as present.  
2.3.3.2 Categorising independent variables 
Where possible, to support analysis of risk, predictor variables were converted into binary data.  
Ability: For children under the age of six, ability was determined by summing Denver Score 
items (max score 20). Scores from 0-12 were considered to show a deficit in ability, whilst 
scores of 13 and above were considered to show no deficit. For children aged six and above, 
three items were added together from the Wessex Questionnaire (Can the child wash, dress and 
feed themselves; max score 9). Participants scoring 0-8 were considered to have a deficit in 
ability, whilst those scoring 9 were considered typical.  
Speech: For children under age 6, the Denver item ‘Can your child say two words?” was used. 
Only three children were one year old at the time of completion, whilst the remaining children 
were two years old or older. Language development literature suggests that most typically 
developing children are able to say two words together by 18 months and over (Luinge et al., 
2006), therefore this was considered an appropriate speech categorisation. If they could say 
two words, they were identified as having typical speech, whilst they were identified as having 
a speech deficit if they could not. For children age six and above, the Wessex question relating 
to speech was used, with responses of ‘never says a word’ and ‘odd words only’ being 
indicative of a speech deficit.  
Ordinal factors: Frequency of repetitive behaviour and frequency of obsessive/ritualistic 
behaviour remained ordinal scores (rated 0, never, to 4, extremely frequently). Impulsivity was 
calculated by adding together ‘does the individual find it difficult to wait?’ (rated 0, never, to 
4, extremely frequently) and ‘does the individual want things immediately?’(rated 0, never, to 
4, extremely frequently). Overactivity was calculated by adding ‘does the individual act as if 
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driven by a motor?’ (rated 0, never, to 4, extremely frequently) and ‘does the individual want 
things immediately?’ (rated 0, never, to 4, extremely frequently). Impulsivity and overactivity 
scores remained as scale scores as there is no clear cut off for what constitutes a clinical score 
for overactivity or impulsivity. This was scored in line with the validity paper on the SAD-SQ 
(Davies & Oliver, 2016). 
Health factors: For vision and hearing, if participants were blind/had poor sight or deaf/had 
poor sight, they were considered to have a problem in this area. For eye, skin, respiratory, 
dental, digestive and ear problems, a score of never or mild was considered to be indicative of 
no problem, whilst a score of severe or moderate was indicative of a problem being present.  
2.3.4 Procedure  
The current study was part of a wider, longitudinal research study. Participants included in the 
current study were recruited for the first stage (Time 1) of the study. Participation in the study 
equated to a maximum of 45 minutes of participant time; 30 minutes to carefully read the 
information pack and provide informed consent, 15 minutes to complete the questionnaire. 
Participants held on the Cerebra Centre database previously consented to be contacted 
regarding future research. To avoid priming, the study was described as aiming to ‘better 
understand the various behaviours of children with neurodevelopmental disabilities (Appendix 
E). An information pack was sent directly to eligible individuals with an opt-in consent form. 
181 participants were contacted through the database recruitment stream. If the team had not 
received a questionnaire response within two weeks, a follow up letter was sent. The option to 
compete the questionnaire over the phone was given, or for a researcher to visit their home to 
complete the questionnaire (within 10 miles of the university base). This stream returned 45 
questionnaires.  
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Special schools in the West Midlands area were contacted by phone or email and provided with 
information packs about the study. Consent was required from the Head Teachers or leads of 
schools and nurseries for their students to participate. 928 information packs for parents/carers 
were distributed via schools and placed in the book-bags of all pupils with developmental delay 
that met the age inclusion criteria. Reminder flyers were also provided to schools to be placed 
in book-bags two weeks after distribution of the information pack. 86 participants were 
recruited through this recruitment stream.  
For the third recruitment stream via the NHS, an invitation letter was distributed with routine 
pre-clinic appointment letters or by research nurses indicating that the research team would be 
present in the clinic. Research teams attended Child Development Clinics (CDCs) in the West 
Midlands and healthcare professionals were proactive in identifying individuals that met 
inclusion criteria directing them to the research team. These individuals were offered the same 
information pack previously described. Written consent was obtained from carers of eligible 
participants in the waiting room or in private rooms where available. If parents or carers 
expressed an interest but were not able to complete the questionnaire in the clinic, they were 
given a pack containing a pre-paid envelope to take home. Contact details were taken if the 
potential participant was happy to disclose, and they were contacted 2 weeks later for follow-
up if no questionnaire form was received within that time. Again, questionnaires could be 
completed over the phone or visits within 10 miles arranged. 1765 packs were distributed 
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Table 2.1 Return rates for each recruitment stream 
 Packs sent Packs completed Response rate 
Clinical 1765 194 11.0% 
School 928 86 9.3% 
Existing database 181 45 24.9% 
 
Due to multiple recruitment streams being used, there was a risk of participants being contacted 
multiple times, therefore all invitation letters indicated this risk and asked carers to disregard 
the information if they had already been contacted. All individuals in contact with researchers 
in this study, regardless of whether they chose to participate, were offered signposting to the 
FIND Website (www.findresources.co.uk), which contains helpful information about the 
difficulties children and their parents may face following diagnosis of developmental delay.  
2.3.5 Inclusion criteria 
Participants were eligible to take part in the study if they were aged between 2 and 11 years, 
thought to have a developmental delay, autism or genetic syndrome. Attending paediatric 
clinics for children with suspected neurodevelopmental disability or developmental delay, or a 
school for children with developmental delay was considered sufficient evidence for the child 
to meet this criterion. In addition, parents or carers needed to be both cognitively and physically 
able to complete the assessment and have necessary language skills to give informed consent 
and understand the questionnaire. Finally, the child and carer must live in the West Midlands 
or be part of a research participant database for children with rare genetic syndromes. 
Burderer’s (1996) methodology was utilised to calculate the target sample size for adequate 
(90%) specificity and sensitivity, which resulted in 346 participants being required. This was, 
however, on the basis of the larger study, which was longitudinal and had to account for 
attrition between Time 1 and Time 2. 325 participants aged between 2 and 11 years of age were 
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recruited via the three recruitment pathways who had either confirmed or suspected 
developmental delay. The slightly lower recruitment compared to target was due to delays in 
obtaining ethical approval, and for the longitudinal study, could slightly increase the risk of 
Type II error, however should not have any adverse impact on power for analyses in the present 
study (Moher et al., 1994).  
2.3.6 Participants and analysis approach 
The current study necessitated the use of an initial sample (preliminary sample) obtained from 
the compilation of data from the three previous studies. This sample includes data on every 
covariate included in the preliminary sample data. Due to the number of participants needed 
for the algorithm analysis to be effective (as indicated by a power analysis), covariates which 
had low response rates had to be removed, thus, a subset of the modelling sample was used for 
the development of the algorithm (Subset of Modelling Sample). During the regression analysis 
later conducted, covariates of interest were identified. In order to maximise the number of 
participants included in the development of the algorithm, a second modelling sample was 
created (Modelling Sample), removing covariates that were not of interest. Due to poor 
response rates on some of the removed covariates, this greatly increased the number of 
participants that informed the algorithm, improving the robustness of the subsequent data. To 
aid transparency in the data included in the study, the following sections will detail each of 
these samples and the processes involved in their compilation.  
2.3.6.1 Developing Subset of Modelling Sample 
Subset of Modelling Sample is based on the complete set of data obtained from the 
compilation of data from the three outlined studies.  
Aggression Subset of Modelling Sample: 1531 participants provided a response to aggression 
frequency that enabled classification of presence or absence of aggression. This is known as 
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the preliminary Aggression Modelling Sample. Based on the methodology presented by 
Peduzzi et al. (1996), the minimum number of cases necessary for logistic regression was 
calculated using the following equation: 
N = (10 * K) /P 
Where K = the number of covariates being assessed and P = the proportion of positive cases of 
the behaviour in the population. To provide an example; if a sample had 100 participants and 
20 showed self-injury, the proportion of positive cases would be 20%. If there were four 
covariates, K would be 4. N = (10*4) / 0.20; 200 participants would be needed. 
For the aggression sample, there were 20 covariates and the proportion of aggression was 27%: 
N = (10*20)/0.27 = 740. When all variables were included in the analysis, a backward 
conditional logistic regression using the preliminary Aggression Modelling Sample only 
resulted in 146 cases being included in the analysis, due to missing data. This was an 
insufficient number of cases. Conditional regression has multiple options for missing data; 
exclude the participant, replace the missing data with a mean based on the present data or 
weight the cases to bias those with data entered (Raghunathan, 2004). As the intention of this 
analysis is to develop an algorithm, exclusion was the most viable option to maintain 
robustness. Missing data were reviewed for each variable. Table 2.2 provides an overview of 
complete data for each variable obtained from the SAD-SQ(R). In the preliminary Aggression 
Modelling Sample, two variables had over 60% data missing (epilepsy and respiratory 
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Table 2.2 Summary of % complete responses for each variable in SAD-SQ(R) for Aggression 
and Destruction preliminary Modelling Samples  






(N = 1540) 
 N Valid % of N N Valid % of N 
Age 1464 95.6 1471 95.5 
Gender 1497 97.8 1504 97.7 
Autism 1333 87.1 1341 87.1 
Genetic Syndrome 994 64.9 1004 65.2 
Vision problems 1088 71.1 1094 71.0 
Hearing problems 1078 70.4 1083 70.3 
Eye problems 1467 95.8 1472 95.6 
Ear problems 1477 96.5 1483 96.3 
Dental problems 1480 96.7 1486 96.5 
Digestive problems 1475 96.3 1481 96.2 
Skin problems 1491 97.4 1497 97.2 
Respiratory problems 464 30.3 466 30.3 
Epilepsy 462 30.2 464 30.1 
Number of health problems 1500 98.0 1506 97.8 
Freq of Repetitive behaviour 1471 96.1 1474 95.7 
Obsessions/rituals 1472 96.1 1477 95.9 
Impulsivity 1477 96.5 1483 96.3 
Overactivity 1431 93.5 1437 93.3 
Speech deficit 1056 69.0 1061 68.9 
Ability deficit 1036 67.7 1040 67.5 
 
It was decided to exclude any factors that had less than 65% of completed cases. This resulted 
in the exclusion of epilepsy, respiratory problems and genetic syndromes and changed the 
minimum participant formula to: N = (10*17)/0.309= 531. Following the exclusion of the 
above 3 variables, 631 (41.2%) participants had complete data across all factors to be included 
in the regression. The demographics of this sample, Subset of Modelling Sample, are shown in 
Table 2.3. 
Destruction Subset of Modelling Sample: 1540 participants provided a response to destruction 
frequency that enabled the classification of presence or absence of destruction. Based on the 
calculation by Peduzzi et al. (1996), the minimum number of cases for the destruction model 
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regression was: N = (10*20)/0.21 = 952. Only 147 participants had sufficient data for 
regression analysis in the preliminary Destruction Modelling Sample. As with the preliminary 
Aggression Modelling Sample, both respiratory problems and epilepsy had less than 35% 
complete responses (see Table 2.2). Exclusion of respiratory problems, epilepsy and genetic 
syndromes, due to having less than 65% complete data, resulted in 633 participants having 
sufficient data for regression. This did not meet the minimum threshold criteria for 17 
variables: N = (10*17)/0.2310 = 739, however the remaining variables with a higher proportion 
of missing data (ability and speech) were considered important to include, based on the 
literature review, as these have been identified as potential risk markers, at the potential 
expense of power/ increase of Type 2 error. This is referred to as Destruction Subset of 
Modelling Sample (Table 2.3).  
Table 2.3 Demographic information for aggression and destruction Modelling Samples 1 
 Aggression Subset of 
Modelling Sample 
Destruction Modelling  
Sample 1 
Total Sample N=631 N=633 
Mean Age (SD) 15.8 (12.4) 15.7 (12.4) 
N Male (%) 460 (72.9%) 462 (73.0%) 
Autism Diagnosis (%) 481 (76.2%) 481 (76.0%) 
Visual problems 117 (18.5%) 117 (18.5%) 
Hearing Problems 36 (5.7%) 36 (5.7%) 
Eye Problems 0 (0.0%) 0 (0.0%) 
Ear Problems 16 (2.5%) 16 (2.5%) 
Dental Problems 27 (4.3%) 27 (4.3%) 
Digestive Problems 35 (5.5%) 35 (5.5%) 
Skin Problems 42 (6.7%) 41 (6.5%) 
Med. number of health problems (IQR) 1 (1) 0 (1) 
Med. Frequency repetitive behaviour (IQR) 1 (2) 1 (2) 
Med. Frequency obsessive behaviour (IQR) 2 (3) 2 (3) 
Med. Impulsivity (IQR) 2 (5) 2 (5) 
Med. Overactivity (IQR) 1 (3) 1 (3) 
Speech deficit 376 (59.6%) 379 (59.9%) 
Ability deficit 348 (55.2%) 349 (55.1) 
 
2.3.6.2 Modelling Sample 
After the identification of the risk markers to be included in the aggression algorithm (Section 
2.4.2), participants that were previously excluded from analysis due to missing data in one of 
the variables not selected in the model no longer had incomplete data. This resulted in an 
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increase in participants available for optimising the model (Section 2.4.3). The demographic 
information of the participants (N=1124) included in this stage of analysis, Aggression 
Modelling Sample, are described in Table 2.4. This process was replicated for the destruction 
data set, resulting in an increase to 1307 participants included in Destruction Modelling Sample 
(see Table 2.4 for a description of the participant characteristics).  
2.3.6.3 Test Sample 
Aggression: The test sample initially comprised 325 participants. Following the exclusion of 
participants with missing data for the variables in the relevant devised algorithm, 284 
participants remained in the Aggression Test Sample and 310 remained in the Destruction Test 
Sample. Table 2.4 presents the characteristics of these samples.  
Tests for statistical difference between the Modelling and Test samples were conducted (Table 
2.4). For non-parametric variables, median and interquartile range (IQR) were reported and 
independent samples Mann-Whitney U tests (z) were conducted. For categorical variables, Chi 
Square (X2) tests were conducted.  
Table 2.4 indicates that the majority of variables are significantly different between the two 
samples for aggression, with only gender (X2=1.262, p=.261) and presence of autism (X2=.004, 
p=.950) showing no significant difference across samples. The Aggression Test Sample has a 
significantly lower mean age (z= -6.202, p=<.001). Table 2.4 indicates that gender (X2=.020, 
p=.888) and diagnosis of autism (X2=.154, p=.695) were the only variables to not be 
significantly different between the two samples for destruction. The remaining variables all 
showed significant difference at the p<.001 level. Due to the intention of this study being test 
whether an algorithm can be created and be effective across different samples, this was not 
considered a problem; the Test Sample is representative of the sample a prospective 
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intervention/ need to identify individuals would be used in, whilst the Modelling Sample 
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Table 2.4 Statistical difference between Aggression Modelling Sample and Aggression Test Sample and statistical difference between Destruction 

















z x2 p 
N aggression (%) 339 (30.2%) 154 (54.2%) - 58.428 <.001* 302 (23.1%) 146 (47.1%) - 72.020 <.001* 
Mean age (SD) 11.9 (11.4) 6.7 (2.6) -6.202 - <.001* 11.9 (11.4) 6.7 (2.6) -6.430 - <.001* 
Males (%) 827 (74.0%) 201 (70.7%) - 1.262 .261 932 (71.3%) 220 (70.9%) - .020 .888 
Autism diagnosis (%) 736 (65.0%) 184 (64.8%) - .004 .950 853 (62.3%) 197 (63.5%) - .154 .695 
Med. Impulsivity 
score (IQR) 
4 (5) 6 (4) -10.024 - <.001* 3 (5) 6 (4) -10.790 - <.001* 
Med. Overactivity 
score (IQR) 








2 (3) 3 (3) -3.507 - <.001* 2 (3) 3 (3) -3.188 - .001* 
Med. number health 
problems (IQR) 
1 (2) 1 (2) -9.691 - <.001* 1 (2) 2 (2) -9.316 - <.001* 
Ability deficit (%) 489 (43.5%) 157 (55.3%) - 12.704 <.001* 469 (35.9%) 174 (56.1%) - 42.656 <.001* 
Speech deficit (%) 506 (45.0%) 38 (13.4%) - 95.430 <.001* 512 (39.2%) 101 (32.6%) - 4.633 .031* 
Skin Problems (%) 107 (9.5%) 59 (20.7%) - 27.388 <.001* 137 (10.5%) 64 (20.6) - 23.458 <.001* 
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2.3.7 Creating a new risk marker 
To identify variables associated with aggression and destruction, the variables obtained from 
the SAD-SQ(R) (Subset of Modelling Sample) were entered into a backward stepwise logistic 
regression. Aggression and destruction were examined separately, and therefore each was the 
dependent variable in the respective analysis. Following this, a new variable was calculated 
using the algorithm developed from Subset of Modelling Sample. This variable was then 
manipulated into an S curve and an optimal cut off determined using Modelling Sample. The 
same variable was then calculated in the Test Sample, and cut offs explored to determine if 
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2.4 Results 
2.4.1 Appraising current risk markers 
To identify and quantify the contribution of risk markers to the presence of aggressive and 
destructive behaviour (Aim 1), analyses were conducted comparing risk markers between 
children with and without aggression and destruction in the modelling sample. Tables 2.5 & 
2.6 present these data. For categorical risk markers (gender, speech deficit, autism, skin 
problems, genetic syndromes, vision problems, hearing problems, ear problems, dental 
problems, digestive problems and epilepsy), independent samples Chi Square tests were 
performed to determine whether there was a statistically significant difference between groups 
in terms of the presence of aggression and destruction respectively. For scale risk markers (age, 
repetitive behaviour, obsessive behaviour, impulsivity, overactivity and number of health 
problems), tests for normality indicated all data were not normally distributed, and therefore 
Mann-Whitney U tests were conducted to compare median scores for behaviour present and 
absent groups. Relative Risk (RR) for continuous data was calculated by standardizing z to 
Cohens d, then converting Cohens d to RR using the methodology outlined in Bornstein (2009). 
Standard Error was calculated for the variable to enable calculation of confidence intervals (CI) 
for the RR and determine significance.  
Increased frequency of repetitive behaviour, higher impulsivity, higher overactivity, higher 
obsessions and presence of autism were identified as increasing risk of both aggression and 
destruction. Comparisons in the Aggression Modelling Sample also highlighted increased risk 
associated with health problems, male gender and epilepsy. Comparisons in the Destruction 
Modelling Sample identified speech problems, health problems, and ear problems as 
significant contributors to increased risk of destruction. Bonferroni correction was used when 
using multiple comparisons (Shaffer, 1995). 
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Table 2.5 Overview of risk markers and associated difference in present and absent aggression groups (Aggression Modelling Sample) 




Independent Samples Tests Effect Size 
X2 z p RR (95% CI) p 
Age Mean (SD) 10.22 (10.3) 12.6 (11.7) - -3.782 <.001* 1.46 (0.745, 2.85) .263 
Repetitive  Med. (IQR) 2 (3) 1 (3) - -5.601 <.001* 1.77(1.60, 1.95) <.001* 
Impulsivity  Med. (IQR) 7 (3) 2 (5) - -17.017 <.001* 6.93 (5.83, 8.30) <.001* 
Overactivity Med. (IQR) 6 (5) 2 (3)  -15.121 <.001* 5.31 (4.54, 6.21) <.001* 
Obsessions  Med. (IQR) 3 (2) 1 (2) - 10.634 <.001* 3.06 (2.79, 3.38) <.001* 
Health problem Med. (IQR) 1 (2) 1 (1) - -3.909 <.001* 1.49 (1.41, 1.58) <.001* 
Speech deficit Yes 98 344 1.188 - .276 1.17 (0.87, 1.57) .286 
 No 54 233   
Gender Male 282 545 23.054 - <.001* 1.77 (1.37, 2.28) <.001* 
 Female 57 240   
Ability deficit Yes 99 306 8.048 - .005* 1.54 (1.12, 2.10) .007* 
 No 50 266   
ASD Yes 256 480 21.628 - <.001* 1.632 (1.32, 2.03) <.001* 
 No 83 305   
Skin Problems Yes 44 63 6.746 - <.001* 1.17 (0.90, 1.51) 2.18 
 No 295 722   
Genetic Syndrome Yes 16 72 11.303 - .004* 0.53 (0.34, 0.84) .006* 
 No 240 460    
Vision problem Yes 21 116 4.035 - .133 0.71 (0.46, 1.10) .122 
 No 132 478    
Hearing problem Yes 3 41 5.393 - .020* 0.32 (0.11, 0.96) .042* 
 No 150 551    
Ear problems Yes 29 33 8.831 - .003* 1.62 (1.23, 2.13) <.001* 
 No 304 745    
Dental problem Yes 22 40 .960 - .327 1.20 (0.84, 1.70) .317 
 No 311 739    
Digestive problem Yes 39 57 8.005 - 0.18 1.40 (1.09, 1.81) .009* 
 No 294 721    
Epilepsy Yes 24 31 7.038 - .008 1.67 (1.17, 2.37) .004* 
 No 88 248    
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Independent Samples Tests Effect Size 
X2 z p RR p 
Age Mean (SD) 9.8 (9.3) 12.6 (11.9) - -3.661 <.001* 1.45 (0.76, 2.76) .262 
Repetitive  Med. (IQR) 2 (4) 1 (3) - -3.982 <.001* 1.50 (1.35, 1.65) <.001* 
Impulsivity  Med. (IQR) 7 (3) 2 (5) - -16.382 <.001* 6.33 (5.38, 7.37) <.001* 
Overactivity Med. (IQR) 6 (5) 2 (4) - -15.080 <.001* 5.29 (4.54, 6.21) <.001* 
Obsessions  Med. (IQR) 3 (2) 2 (2) - -8.556 <.001* 2.42 (2.19, 2.66) <.001* 
Health problems  Med. (IQR) 1 (2) 1 (2) - -4.134 <.001* 1.52 (1.44, 1.61) <.001* 
Speech deficit Yes 76 437 .606 - .463 1.49 (1.05, 2.12) .026* 
 No 42 283   
Gender Male 239 693 9.299 - .002* 1.46 (1.13, 1.89) .004* 
 Female 61 287   
Ability deficit Yes 67 402 .077 - .781 1.02 (0.73, 1.42) .906 
 No 49 311   
ASD Yes 228 625 18.140 - <.001* 1.63 (1.29, 2.07) <.001* 
 No 74 380   
Skin Problems Yes 91 46 8.635 - .003* 3.06 (2.62, 3.59) .001* 
 No 255 888   
Genetic Syndrome Yes 21 94 6.180 - .045* 0.70 (0.47, 1.06) .096 
 No 212 604      
Vision problems Yes 12 153 8.326 - .016* 0.48 (0.27, 0.84) .011* 
 No 107 595      
Hearing problems Yes 3 51 3.591 - .166 0.38 (0.12, 1.16) .089 
 No 118 691      
Ear problems Yes 30 41 15.043 - <.001* 1.90 (1.41, 2.54) <.001* 
 No 265 928      
Dental problems Yes 23 50 2.673 - .102 1.36 (0.96, 1.94) .085 
 No 276 917      
Respiratory problems Yes 5 12 .798 - .372 1.43 (0.67, 3.80) .356 
 No 84 327      
Epilepsy Yes 7 51 3.193 - .074 0.54 (0.26, 1.11) .094 
 No 82 285      
Table 2.6 Overview of risk markers and associated difference in present and absent destruction groups (Destruction Modelling Sample 2) 
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2.4.2 Model identification 
To develop an algorithm that is able to determine current presence or absence of aggression or 
destruction (Aim 2), a backward stepwise logistic regression was conducted in Aggression 
Modelling Sample and Destruction Modelling Sample (a forward regression risks making 
previously included variables in the model no longer significant with each addition). 
Backwards was considered to be more effective. The same 17 variables were entered into the 
regression for each of the two behaviours: age, gender, autism, vision problems, hearing 
problems, eye problems, ear problems, dental problems, digestive problems, skin problems, 
number of health problems, frequency of repetitive behaviour, frequency of obsessive 
behaviour/rituals, impulsivity, overactivity, speech and ability.  
Omnibus tests of model coefficients are presented in Table 2.7 (aggression) and Table 2.8 
(destruction). Table 2.7 indicates that aggression was most significantly predicted by Step 9, 
which comprised gender, autism, skin problems, number of health problems, frequency of 
repetitive behaviour, frequency of obsessive behaviour/rituals, impulsivity and overactivity. 
Table 2.8 indicates that destruction was most significantly predicted by Step 15, which 
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Table 2.7: Omnibus tests of model coefficients from aggression-focussed logistic regression 
Step  Chi-square df Sig. 
Step 1a Step 166.551 16 <.001 
All variables Model 166.551 16 <.001 
Step 2b Step -.013 1 .911 
Variable removed: 
Eye problems 
Model 166.539 15 <.001 
Step 3c Step -.019 1 .889 
Variable removed:  
Age 
Model 166.519 14 <.001 
Step 4d Step -.201 1 .654 
Variable removed: 
Digestive problems 
Model 166.318 13 <.001 
Step 5e Step -.479 1 .489 
Variable removed: 
Dental problems 
Model 165.839 12 <.001 
Step 6f Step -.450 1 .502 
Variable removed: 
Hearing 
Model 165.389 11 <.001 
Step 7g Step -.606 1 .436 
Variable removed: 
Speech excluded 
Model 164.783 10 <.001 
Step 8h Step -1.909 1 .167 
Variable removed: 
Ability + Vision 
Model 162.874 9 <.001 
Step 9i Step -2.515 1 .113 
 Model 160.359 8 <.001 
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Table 2.8: Omnibus tests of model coefficients from destruction-focussed logistic regression 
  Chi-square df Sig. 
Step 1a Step 90.494 16 <.001 
All variables in 
model 
Model 90.494 16 <.001 
Step 2b Step .000 1 1.000 
Variable removed: 
Vision 
Model 90.494 15 <.001 
Step 3c Step -.001 1 .981 
Variable removed: 
Age 
Model 90.494 14 <.001 
Step 4d Step -.012 1 .911 
Variable removed: 
Dental problems 
Model 90.481 13 <.001 
Step 5e Step -.036 1 .849 
Variable removed: 
Speech 
Model 90.445 12 <.001 
Step 6f Step -.074 1 .785 
Variable removed: 
Ear problems 
Model 90.371 11 <.001 
Step 7g Step -.339 1 .561 
Variable removed: 
Digestive problems 
Model 90.032 10 <.001 
Step 8h Step -.426 1 .514 
Variable removed: 
Ability 
Model 89.606 9 <.001 
Step 9i Step -.364 1 .546 
Variable removed: 
Skin problems 
Model 89.241 8 <.001 
Step 10j Step -.377 1 .539 
Variable removed: 
Hearing 
Model 88.864 7 <.001 
Step 11k Step -1.095 1 .295 
Variable removed: 
Gender 
Model 87.769 6 <.001 
Step 12l Step -1.253 1 .263 
Variable removed: 
Overactivity 
Model 86.516 5 <.001 
Step 13m Step -2.160 1 .142 
Variable removed: 
Repetitive behaviour 
Model 84.356 4 <.001 




Model 82.081 3 <.001 
Step 15o Step -2.223 1 .136 
 Model 79.858 2 <.001 
 
Following the identification of the significant variables, the next stage in determining the model 
was to obtain the beta weights; this is the extent that each variable contributes to the model. 
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The significance tests and corresponding beta coefficients for the variables in the final 
predictive model are presented in Table 2.9 (aggression) and Table 2.10 (destruction). Table 
2.9 reveals that presence of autism (B=1.463, p=.001) has the greatest weighted contribution 
to constant (B= -4.537, p<.001), along with impulsivity (B=.294, p<.001) and obsessive 
behaviour/rituals (B=.296, p=.026). Table 2.10 indicates that autism (B=1.22, p=.006) also had 
the greatest contribution of the two values included in the destruction model (B=-4.206, 
p<.001). 
Table 2.9 Significance tests and corresponding beta coefficients for aggression risk marker 
model 
  B S.E Wald d.f Sig. 
Step 9 Gender -.582 .302 3.700 1 .054 
 Autism 1.463 .451 10.510 1 .001 
 Skin Problems -.926 .485 3.639 1 .056 
 Number Health Problems .261 .113 5.326 1 .021 
 Repetitive behaviour -.167 .090 3.479 1 .062 
 Obsessions and rituals .296 .096 9.466 1 .002 
 Impulsivity .294 .058 25.811 1 <.001 
 Overactivity .143 .064 4.975 1 .026 
 Constant -4.537 .510 79.214 1 <.001 
 
Table 2.10: Significance tests and corresponding beta coefficients for destruction risk marker 
model 
  B S.E. Wald df Sig. 
Step 15 Autism 1.220 .448 7.422 1 .006 
 Impulsivity .359 .049 53.659 1 <.001 
 Constant -4.206 .468 80.602 1 <.001 
 
2.4.3 Optimising the aggression and destruction models 
The second stage in addressing Aim 2 was to create the predictor variable and use this to 
determine the optimal cut off score for classification of behaviour present. To increase 
statistical power, this was conducted in Modelling Sample (for further detail and discussion 
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please see Section 2.5.2). The new variable (t) was created by summing the weighted B values 
for each behaviour: 
Aggression: 
t= -4.537 + (-0.582 * Gender) + (1.463 * Autism) + (-0.926 * Skin Problems) + (0.261 * 
Health Problems) + (-0.167 * Repetitive Behaviour) + (0.296 * Obsessions/Rituals) + (0.294 
* Impulsivity) + (0.143 * Overactivity) 
Destruction: 
t= -4.206 + (1.220 * Autism) + (0.59 * Impulsivity)  
In order to achieve a prediction that is consistently contained within 1 and 0, as this enables 
quantification of risk in a simplified manner, it was necessary to change the exponent of the 
new variable from a linear projection to an S-curve. This was achieved using: 
 
!"#$%&'%() = 	 11 + #./ 
Where e = exponent 
Logistic regressions, including that indicated above, are typically based on a cut off of 0.5 as 
this enables a balance between false negative/positive predictions. For the purpose of a clinical 
tool, however, it is more beneficial to adjust this cut off and maximise sensitivity, thereby 
increasing the risk of false positives. This is on the basis that individuals could miss out on 
beneficial interventions if the sensitivity is lowered. Thus, specificity is less essential in a 
clinical tool, however it is still required to prevent all individuals being categorised as ‘at risk’. 
Therefore, a range of different cut-offs were sampled, as indicated in Tables 2.11 and 2.12. A 
Receiver Operating Characteristic (Area Under Curve; AUC) value was included to show the 
diagnostic ability of the binary classifier system.  
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Table 2.11 indicated that the optimal compromise of sensitivity to specificity for a screening 
tool for aggression, based on data in Modelling Sample, was a cut-off level of 0.27. This 
achieved a sensitivity of 83.2%, and a specificity of 70.2%. Overall, this model would have 
74.1% overall accuracy and an AUC value of .767.  














0.1 313 26 92.3% 378 407 48.2% 61.5% .702 
0.2 291 48 85.8% 505 280 64.3% 70.8% .751 
0.25 286 53 84.4% 539 242 68.7% 73.4% .767 
0.26 283 56 83.5% 547 238 69.7% 73.8% .766 
0.27 282 57 83.2% 551 234 70.2% 74.1% .767 
0.28 279 60 82.3% 558 227 71.1% 74.5% .767 
0.29 274 65 80.8% 561 224 71.5% 74.3% .761 
0.3 273 66 80.5% 565 220 72.0% 74.6% .763 
0.4 250 89 73.7% 618 167 78.7% 77.2% .762 
0.5 216 123 63.7% 655 113 83.4% 77.5% .736 
 
Table 2.12 presents the different cut-offs trialled for the destruction algorithm in the Modelling 
Sample dataset. The results suggested that a cut-off level of 0.3 would be most beneficial. This 
achieved a sensitivity of 82.8% and a specificity of 69%. Overall accuracy was 72.1% and the 
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Table 2.12: Varying cut off levels to explore sensitivity and specificity of destruction risk 














0.1 276 26 91.4% 465 540 46.3% 57.0% .688 
0.2 265 37 87.7% 611 394 60.1% 67.0% .743 
0.25 250 52 87.7% 693 312 60.1% 67.0% .743 
0.3 250 52 82.8% 693 312 69.0% 72.1% .759 
0.31 250 52 82.8% 693 312 69.0% 72.1% .759 
0.32 250 52 82.8% 693 312 69.0% 72.1% .759 
0.33 250 52 82.8% 693 312 69.0% 72.1% .759 
0.332 250 52 82.8% 693 312 69.0% 72.1% .759 
0.335 250 52 82.8% 693 312 69.0% 72.1% .759 
0.337 250 52 82.8% 693 312 69.0% 72.1% .759 
0.34 236 66 78.1% 720 285 71.6% 73.1% .749 
0.35 215 87 71.2% 780 225 77.6% 76.1% .744 
0.4 215 87 71.2% 780 225 77.6% 76.1% .744 
 
2.4.4 Cross Validation 
Finally, to determine whether this model was effective outside of the modelling sample and 
achieve Aim 3 of the study, the weighted algorithms for aggression and destruction were 
calculated in the Test Data sets for cross validation. The cut-offs identified (0.27 for aggression, 
0.3 for destruction) were then applied to determine the sensitivity and specificity of the 
algorithm within the test data set.  
Table 2.13 shows that the optimal cut-off identified in the Modelling Sample was replicated in 
the Test Sample. The cut-off of 0.27 had a sensitivity of 80.5% and specificity of 63.8%. 
Overall accuracy was 72.9% with an AUC value of .719. This ensures 124 individuals known 
to show aggression were correctly identified, 43 were classified as aggressive that did not meet 
aggression criteria, 31 were considered not aggressive that were, and 87 were correctly 
identified as not aggressive. 
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Specificity Overall % 
accuracy 
AUC 
0.1 144 11 93.5% 49 81 37.8% 68.0% .653 
0.2 134 21 87.0% 65 65 50.0% 70.1% .682 
0.25 128 27 83.1% 79 51 60.8% 72.9% .717 
0.26 126 29 81.8% 81 49 62.3% 72.9% .718 
0.27 124 31 80.5% 83 47 63.8% 72.9% .719 
0.28 121 34 78.6% 87 43 66.9% 73.2% .725 
0.3 118 37 76.6% 88 42 67.7% 72.5% .719 
 
Cross validation of the destruction risk marker model (Table 2.14) indicated a cut off of 0.3 
maximised sensitivity to a sufficient level, without over-compromising specificity. This 
resulted in a model with 90% sensitivity and 61% specificity; 73.2% overall accuracy. This 
ensures 127 individuals known to show destruction were correctly identified, 64 were classified 
as destructive that did not meet destruction criteria, 19 were considered not destructive that 
were, and 100 were correctly identified as not destructive. 











Specificity Overall % 
accuracy 
AUC 
0.1 141 5 96.6% 43 121 26.1% 59.4% .614 
0.2 135 11 92.5% 77 87 47.0% 68.4% .697 
0.25 135 11 92.5% 77 87 47.0% 68.4% .697 
0.3 127 19 90.0% 100 64 61.0% 73.2% .740 
0.35 127 19 90.0% 100 64 61.0% 73.2% .740 
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2.5 Discussion 
The current study aimed to increase understanding of risk markers for aggressive and 
destructive behaviours, and translate these data into a clinical algorithm to model risk. The 
large dataset enabled the identification of a number of risk markers, contributing positively to 
the theoretical basis upon which interventions will be based and meeting the research need 
highlighted in Chapter 1. A particular strength of the current methodology is that it made use 
of a large sample that would be difficult to acquire without the support of three separate studies. 
This study also demonstrated that it was possible to translate these data into a statistical model 
of risk. The clinical algorithm developed showed good sensitivity and specificity both during 
modelling and cross validation. The high sensitivity showcased for both aggression and 
destruction algorithms suggests that, whilst this is only the preliminary stages in this area of 
research, it suggests it is a viable avenue to pursue to determine if it is truly possible to 
eventually identify children that are at greatest risk of showing aggression and destruction that 
may benefit from intervention.  
2.5.1 Risk markers 
Identification of risk markers has considerable clinical and theoretical utility. Risk markers 
help to identify mechanisms implicated in the development of aggressive and destructive 
behaviour thereby informing pathways for possible prevention of aggressive or destructive 
behaviours. The identification of autism and overactivity as significant risk markers for 
aggression is consistent with the literature base (Bamford et al., in review; Davies & Oliver, 
2016). Interestingly, previous research has noted that severity of intellectual disability (termed 
ability in this study) is significantly associated with aggression (Bamford et al., in review); 
however ability was not significant in the relative risk analysis or the regression model. The 
present study identified that frequency of repetitive behaviour, higher impulsivity, higher 
overactivity, higher obsessions and presence of autism, male gender, increased health problems 
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and epilepsy all increase risk of aggression. Regarding destruction, the present study identified 
risk markers of gender, autism, impulsivity, overactivity, obsessive behaviour, health problems 
and repetitive behaviour. The research base regarding risk markers for destruction is 
considerably smaller than for aggression, however autism and repetitive behaviour have 
previously been indicated as variables of interest (Bamford et al., in review; Davies, & Oliver, 
2016). It is interesting to note that, whilst there are similarities in the general risk markers 
associated with each behaviour (e.g. impulsivity, overactivity, autism, gender), the markers 
identified as most significant in each algorithm for aggression and destruction are different, 
which lends further support for the argument of studying the two behaviours separately, rather 
than as one conflated behaviour (Bamford et al., in review). 
2.5.2 Predicting behaviour 
Following the identification of the risk markers, the cut off range identified in the modelling 
sample for the weighted combination of these was tested in the test sample. For aggression, the 
results were very positive, with an AUC of .719 during cross validation, giving a sensitivity of 
80.5% and specificity of 63.8%. An AUC value of one indicates an exceptionally good 
classifier, and for medical diagnosis, values of .95 or higher are preferred (Rice & Harris, 
2005). A value of .70 and above is considered to be indicative of a strong effect for prediction 
of future behaviour in applied psychology (Rice & Harris, 2005). In the test sample, this cut 
off resulted in 43 participants being classified as likely being aggressive, despite their true score 
being ‘not aggressive’. This would mean that 47 people in a sample of 274 would be 
recommended to receive therapeutic intervention that may not be necessary for them and 31 
would miss out on the opportunity for intervention. The specificity of the developed algorithm 
is lower than would be desired; it would be considered more ideal to increase the specificity to 
ensure that funds are utilised in the most effective way possible. The specificity in the current 
study could be low for a number of reasons. One possibility is that there may be protective 
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factors involved that have yet to be understood in the current literature. An individual may have 
all the predictive covariates that would suggest they should demonstrate a particular behaviour, 
however their support network has been sufficiently robust to prevent this onset. Parents may 
have already received support to mitigate the behaviours. Similarly, it may be that an individual 
has all the covariates, however they have not yet started to demonstrate the expected behaviour. 
It is on this basis that it would be advantageous to consider a longitudinal study, to determine 
if the behaviours emerge later. 
It is important, to consider these results in the context of the likely formats for early 
intervention. Such intervention strategies would most likely focus on psychoeducation and 
parent training, and therefore would be a supportive and likely valuable experience, even if a 
child is not at significant risk of developing behaviours that challenge. It is on this basis that it 
was deemed more beneficial to maximise sensitivity with a compromise of specificity. Once 
aggressive behaviour enters a child’s behaviour repertoire, it is highly persistent, with the 
financial cost to services for adults with severe behaviour that challenges indicated as being 
between £89,335 and £358,415 (Emerson et al., 2014). The increased financial cost and 
decreased quality of life associated with these behaviours (Knapp et al., 2005) suggests that it 
is more important to identify as many individuals as possible to minimise the likelihood of 
individuals missing out on potentially beneficial interventions.  
Regarding the destruction model, whilst only two risk markers were combined to predict 
presence of destruction (autism and impulsivity), the results showed good consistency in cross 
validation. The initial cut-off range posed by the modelling sample was 0.3. This cut off 
showed good sensitivity and specificity in the modelling sample. When this was applied to the 
test sample, it offered 90% sensitivity and 61% specificity. This was an overall accuracy of 
73.2% and an AUC of .740. In this case, 64 participants out of 310 would have received an 
intervention that were not classified as showing destructive behaviour and 19 would miss out 
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on an intervention that may need it. Whilst it is necessary to test both of these models further 
in additional samples, using longitudinal designs to examine behaviour onset and changes in 
severity, the preliminary results for both the aggression and destruction model are promising 
and represent a significant advance in empirical research in this area, which has traditionally 
only described associations between risk markers and behaviours than challenge.   
2.5.3 Clinical utility 
This study has demonstrated that there is potential to be pursued regarding identifying 
individuals who are at greatest risk of aggressive and destructive behaviour. The SAD-SQ(R) 
is a brief questionnaire that participants were able to complete alone in a short space of time.  
This, therefore, represents a valuable tool for clinicians and a continuation of the current 
research to determine the predictive utility of this measure to identify ‘at risk’ individuals, 
rather than individuals with currently present behaviour, would be beneficial. The results also 
suggest that an early intervention pathway, similar to that seen in psychosis (where young 
people are identified as ‘Ultra High Risk’ for psychosis), may be viable for people with 
intellectual disabilities to ameliorate aggression and destructive behaviour.  
The need for prevention and early recognition of behaviours that challenge has long been 
recognised in this field, however Chapter 1 emphasised that there is a lack of understanding of 
the risk markers that may enable early identification in the future. The current study has 
commenced the first step in determining the feasibility of early identification and shows 
promising prediction of currently present behaviour, suggesting it is a positive avenue to 
pursue.  
In order for an intervention to be devised, it is necessary to have a cost-effective, efficient and 
relatively reliable strategy to identify individuals at risk. The cut-offs selected were chosen to 
ensure that valuable funds were not used to provide every individual with ID with an 
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intervention; rather it has demonstrated that it is possible to include as many individuals as 
possible without being over-inclusive. The impact of early intervention in other areas, such as 
psychosis, has been immensely positive, with Tsiachristas, Thomas, Lean and Lennox (2016) 
demonstrating that individuals in early intervention for psychosis services were 116% more 
likely to go on to be employed and 52% more likely to live in mainstream accommodation. 
Moreover, ratings of emotional well-being were 17% more likely to improve. In terms of 
finance, Tsiachristas et al. (2016) estimated that the saving in NHS costs would be £33.5 
million per annum, and societal cost savings could reach £63.3 million per annum. The 
financial relief that early intervention for aggressive and destructive behaviour has the potential 
to bring to the healthcare system is substantial, and therefore this represents an avenue with 
great potential. 
2.5.4 Additional considerations 
The current study is not without limitation. Statistical analysis between the Modelling and Test 
samples indicated that there were significant differences in terms of prevalence of aggression 
and destruction. The prevalence of aggression in the Modelling sample was 30.2%. This 
suggests that aggression was not highly frequent and the model designed had to be relatively 
accurate to correctly classify individuals. For the Test sample, however, prevalence was 54.2%. 
This is essentially half of the sample, which increases the likelihood of individuals being 
correctly classified based on chance, not an accurate model.  With this said, however, the Test 
Sample was recruited from a population specifically chosen as it represents the population most 
likely to be chosen for early intervention (young children) and also from locations where 
screening is more likely to take place (Child Development Centres, clinics and special schools). 
It is therefore most essential that the model is accurate within this population, however further 
analysis in similar samples will be beneficial to determine the consistency of the sensitivity 
and specificity of the identified model.  
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A further consideration is that within the Destruction Modelling Sample, a decision was made 
to include speech and ability deficits, despite this inclusion resulting in a smaller than ideal 
sample size and likely increasing the risk of Type 2 error. It is therefore possible that risk 
markers that were considered insignificant and excluded from the model may have been subject 
to a Type 2 error and additional research with larger sample sizes should be conducted using 
all variables before concluding that presence of autism and impulsivity are the most predictive 
markers. With this being said, the destruction model based solely on these two markers was 
effective in identifying individuals that currently show destructive behaviour, suggesting that 
they are robust markers. 
There could be an alternative argument for the method of deciding whether aggression or 
destruction was present in the samples; a score of 1, 2, 3 or 4 for frequency of behaviour all 
suggest that the behaviour has, at some point, occurred. A weakness of the SAD-SQ model, 
however, is that a score of 1 does not provide any additional space for the participant to 
elaborate on when the behaviour occurred or to what extent it would induce clinical concern. 
In order to ensure that the algorithm was based on identifying individuals that are likely to 
present at some point in clinics to request support for behaviour, the clinical decision was made 
to only consider scores of 1 or 2 if the parent was particularly concerned about the behaviour 
(scoring a 3 or 4 for concern, and therefore suggesting they would present for support). It is 
believed that the decision to categorise behaviour in this way is a strength of the research as it 
would promote increased specificity from the algorithm. 
2.5.5 Conclusion 
In summary, this study positively contributes to the deficit in research and knowledge regarding 
risk markers for aggressive and destructive behaviours. It also indicates that there is realistic 
potential to develop a quick, effective and reliable algorithm, based on stable risk markers, to 
identify individuals most at risk of developing aggressive and destructive behaviour. The 
                                                                                                 Chapter 2: Clinical utility of risk markers  
 91 
ability to identify current behaviour based on predictor risk markers could open up the 
possibility of an early-intervention approach for aggression and destruction, which has the 
potential to improve the quality of life of individuals with intellectual disabilities and alleviate 
the financial stress that such behaviours place on the healthcare system in the long-term. The 
next steps in research in this field will be looking at whether children can be classified as ‘at 
risk’ at an early age based on the risk markers, and then watch their progression to see if this 




















Intellectual disability (ID) is defined as a chronic, severe condition that limits an individual’s 
adaptive behaviour and intellectual functioning (World Health Organisation, 1992). 
Approximately one in 100 individuals with ID will show behaviour that is considered 
challenging at some point during their lives (Emerson et al., 2001) and this is unlikely to go 
away if it is not treated (Totsika & Hastings, 2009). Self-injury, aggression and destruction 
have been a particular focus of research and the presence of behaviours is associated with 
psychiatric hospitalisation, reactive physical intervention and reduced quality of life (Beadle-
Brown, Murphy & DiTerlizzi, 2009; Mandell, 2008; Allen, Lower, Brophy & Moore, 2009). 
The term ‘self-injury’ or ‘self-injurious behaviour’ (SIB) includes behaviours that are self-
directed and cause physical harm to the individual, such as biting self, pulling own hair or head 
banging (Rojahn et al., 2008). Research has predicted that between 4 in 100 and 24 in 100 
people with ID will engage in this behaviour (Cooper et al., 2009; Deb, Thomas & Bright, 
2001). ‘Aggression’ can be used to refer to an array of acts, including physical assaults on 
peers, family members or staff, hostility or verbal threats (Rojahn et al., 2001). Research 
predicts between 30 in 100 and 60 in 100 people with ID will do this (Crocker et al., 2006; 
Cohen et al., 2010). To date, research has often considered ‘destruction’ under the umbrella of 
aggression, making it difficult to isolate the two forms of behaviour and consider risk markers 
associated with destruction specifically. A previous meta-analysis by McClintock, Hall and 
Oliver (2003) summarised risk data for SIB, aggression and destruction of property prior to 
2002. They were able to look at the following risk markers for each behaviour: SIB (gender, 
degree of ID, autism, receptive communication and expressive communication), aggression 
(gender, degree of ID, autism and expressive communication) and destruction of property 
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(autism). The present meta-analysis aimed to update this research and summarise data on 
demographic, diagnostic and health/ person/behavioural risk markers for SIB, aggression and 
destruction in people with ID. 
3.1.2 What did the study do? 
The study conducted a large literature search and identified a total of 60 papers that provided enough 
information for statistical tests. This involved, for example, the number of males that showed aggression 
and the number that didn’t, to determine the risk of gender, in this example. It did this for all of the risk 
markers that could be identified (21 in total) for each of the three behaviours.  
3.1.3 What did the meta-analysis find? 
This meta-analysis found that there was a lot more research focussing on risk markers for self-injury 
than there was for aggression and destruction. This enabled a good understanding of risk markers for 
self-injury, however it is clear that more research needs to be done in the fields of aggression and 
destruction. The summary of the risk markers that were significant for each behaviour is presented in 
Figure 3.1. 
3.1.4 What does this mean? 
This meta-analysis shows that the research into risk markers for these behaviours has grown 
considerably in the past 15 years since the previous summary was conducted. This is incredibly useful 
to know, as understanding factors about people that increase their risk of particular behaviours can help 
us firstly to identify them as early as possible, and secondly to start looking at developing interventions 
that are informed by these risk markers, to ensure interventions are as good as they can be in this 
population. If it were possible to use these risk markers to identify people earlier, possibly before 
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3.2 Empirical paper 
3.2.1  Background 
Of the proportion of typically developing children that engage in some form of aggressive 
behaviour (including destruction), only 5-10% are likely to continue this behaviour into 
adulthood (Moffitt, 1993; Tremblay et al., 2004) and only 5% of those with extreme behaviour 
in childhood are likely to experience adverse impacts, such as drug addiction and criminality 
by age 25 (Fergusson et al., 2005). In contrast, individuals with ID that engage in behaviours 
that challenge are more likely to experience reactive physical intervention, psychiatric hospital 
intervention, school exclusion and decreased quality of life (Beadle-Brown, Murphy & 
DiTerlizzi, 2009; Mandell, 2008; Knapp et al., 2005). One important limitation of current 
interventions is that they typically depend on the behaviour already being present and the 
individual coming into contact with appropriate specialised, high-cost services (Feldman et al., 
2004) and successful interventions often necessitate highly controlled environments and 
precise management. 
Early intervention is characterised as an attempt to delay or prevent problems from developing 
by intervening before the problem emerges, based on factors about a person that suggest they 
are at risk (Ramey & Ramey, 1998). Early intervention has proven effective for treatment of 
psychosis, with reduced chances of those at-risk developing psychosis (McGorry et al., 2002). 
Moreover, early psychosis services are often more cost effective than standard services as there 
is less need for costly inpatient care (McCrone et al., 2009). Therefore, the current study sought 
to explore if this was an option for aggression and destruction in children with ID.  
3.2.2 What did the study do? 
In order to see if this route is possible, the study used two different samples of participants and 
had them complete a questionnaire about different known risk markers (age, gender, presence 
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of autism, among others). It also asked for the frequency at which aggression and destruction 
currently occur. This information was then used to statistically determine which risk markers 
were most predictive of the current presence or absence of aggression and destruction. Once 
these risk markers were established, the second data set was used to see if they were as good 
at predicting people that currently showed aggression and destruction in a different data set. 
The study needed to make correct identification of those with the behaviour as high as possible, 
whilst still maintaining a good level of accuracy of determining those that don’t (rather than 
just saying everyone has it). This is because future models would look to be used as the basis 
of an intervention – cost effectiveness requires this to be not over-inclusive, but also to be good 
at detecting people that would benefit from an intervention. 
3.2.3 What did the study find? 
The markers that were identified for as most effective in predicting aggression when combined 
together were: gender, presence of autism, skin problems, number of health problems, 
repetitive behaviour, obsessive behaviour and impulsivity. When these risk markers were 
applied to the second data set, they identified 80.5% (124 people) that were aggressive correctly 
and 63.8% (83 people) that were not correctly. 31 were considered not aggressive that were, 
and 47 were predicted to be aggressive that weren’t. For destruction, presence of autism and 
impulsivity were the only two risk markers that predicted presence of destruction well. In the 
second sample, this combination correctly identified 90% of those that were destructive 
correctly (127 people) and 61% of those that were not correctly (100 people). 64 people were 
classified as destructive that did not meet destruction criteria and 19 were considered not 
destructive that were. 
3.2.4 What does this mean? 
This result suggests that there may be some benefit in continuing to think about early 
intervention as a strategy for aggression and destruction in ID. The model was good at detecting 
                                                                                                  Chapter 3: Executive summary 
 97 
people with the behaviour, and not too many people were either included that should not have 
been, or were excluded that shouldn’t have been. This model is only a starting point, as it is 
looking at behaviour that is currently present. The next steps in research in this field will be 
looking at whether children can be classified as ‘at risk’ at an early age based on the risk markers, 
and then watch their progression to see if this prediction becomes accurate. 
                                                                                                                             Volume One: References 
 98 
Volume One References 
Allen, D. (2008). The relationship between challenging behaviour and mental ill-health in 
people with intellectual disabilities: A review of current theories and evidence. Journal 
of Intellectual Disabilities, 12(4), 267–294. 
Arron, K., Oliver, C., Moss, J., Berg, K. & Burbidge, C. (2011). The prevalence and 
phenomenology of self-injurious and aggressive behaviour in genetic syndromes. 
Journal of Intellectual Disability Research, 55(2), 109-120. 
Amador-Campos, J. A., Forns-Santacana, M., Guardia-Olmos, J., & Pero-Cebollero, M. 
(2006). DSM-IV Attention Deficit Hyperactivity Disorder Symptoms: agreement 
between informants in prevalence and factor structure at different ages. Journal of 
Psychopathology and Behavioural Assessment, 28, 23-32.  
American Psychiatric Association (2000). Diagnostic and statistical manual of mental 
disorders (4th ed., Text Revision). Washington, DC. 
Ando, H. & Yoshimura, I. (1979a). Comprehension skill levels and prevalence of maladaptive 
behaviours in autistic and mentally retarded children: A statistical study. Child 
Psychiatry and Human Development, 9, 131-136.  
Ando, H. & Yoshimura, I. (1979b). Speech skill levels and prevalence of maladaptive 
behaviors in autistic and mentally retarded children: A statistical study. Child 
Psychiatry and Human Development, 10, 85-90.  
Allen, D., Lowe, K., Brophy, S. & Moore, K. (2009). Predictors of restrictive reactive strategy 
use in people with challenging behaviour. Journal of Applied Research in Intellectual 
Disabilities, 22, 159-168. 
Arron, K., Oliver, C., Moss, J., Berg, K. & Burbidge, C. (2011). The prevalence and 
phenomenology of self-injurious and aggressive behaviour in genetic syndromes. 
Journal of Intellectual Disability Research, 55(2), 109-120.  
Ballinger, B.R. (1971). Minor self-injury. British Journal of Psychiatry, 118, 535-538.  
                                                                                                                             Volume One: References 
 99 
Barnard-Brak, L., Rojahn, J., Richman, D., Chesnut, S. & Wei, T. (2015). Stereotyped 
behaviours predicting self-injurious behaviour in individuals with intellectual 
disabilities. Research in Developmental Disabilities, 36, 419-427. 
Basile, E., Villa, L., Selicorni, A. & Molteni, M. (2007). The behavioural phenotype of 
Cornelia De Lange syndrome: A study of 56 individuals. Journal of Intellectual 
Disability Research, 51(9), 671-681. 
Baujat, B., Mahe, C., Pignon, J.P. & Hill, C. (2002). A graphical method for exploring 
heterogeneity in meta-analyses: Application to a meta-analysis of 65 trials. Statistics in 
Medicine, 30, 2641-2652. 
Berg, W., Wacker, D., Ringdhal, J., Stricker, J., Vinquist, K., Dutt, A., Dolezal, D., Luke, J., 
Kemmerer, L. & Mews, J. (2016). An integrated model for guiding the selection of 
treatment components for problem behaviour maintained by automatic reinforcement. 
Journal of Applied Behaviour Analysis, 49(3), 617-638. 
Berkson, G., McQuiston, S., Jacobson, J.W., Eyman, R. & Borthwick, S. (1985). The 
relationship between age and stereotyped behaviors. Mental Retardation, 23, 31-33.  
Bhaumik, S., Branford, D., McGrother, C., Thorp, C. (1997). Autistic traits in adults with 
learning disabilities. British Journal of Psychiatry, 170, 502-506.  
Beadle-Brown, J., Murphy, G. & Di Terlizzi, M. (2009). Quality of life for the Camberwell 
Cohort. Journal of Applied Research in Intellectual disabilities, 22, 380-390. 
Benson, B. & Brooks, W. (2008). Aggressive challenging behaviour and intellectual disability. 
Current Opinion in Psychiatry, 21(5), 454-458. 
Blettner, M., Saurbrei, W., Schlehofer, B., Scheuchenpflug, T. & Friedenreich, C. (1999). 
Traditional reviews, meta-analyses and pooled analyses in epidemiology. International 
Journal of Epidemiology, 28, 1-9.  
Bodfish, J. W., Crawford, T. W., Powell, S. B., Parker, D. E., Golden, R. N., & Lewis, M. H. 
(1995).  Compulsions in adults with mental retardation: Prevalence, phenomenology, 
and comorbidity with stereotypy and self-injury.  American Journal on Mental 
Retardation, 100, 183-192. 
                                                                                                                             Volume One: References 
 100 
Borenstein, M. (Ed.). (2009). Complex Data Structures. In Introduction to meta-analysis. 
Chichester, U.K: John Wiley & Sons. 
Bott, C., Farmer, R. & Rohde, J. (1997). Behaviour problems associated with lack of speech in 
people with leaning disabilities. Journal of Intellectual Disability Research, 41, 3-7.  
Bowring, D., Totsika, V., Hastings, R., Toogood, S. & Griffith, G. (2017). Challenging 
behaviours in adults with an intellectual disability: A total population study and 
exploration of risk indicies. British Journal of Clinical Psychology, 56, 16-32 
Bradley, E.A., Summers, J.A., Wood, H.L. &Bryson, S.E. (2004). Comparing rates of 
psychiatric and behaviour disorders in adolescents and young adults with severe 
intellectual disability with and without autism. Journal of Autism and Developmental 
Disorders, 34(2), 151-161.  
Bubb, S. (2014). Winterbourne View – Time to change. Available at: 
https://www.england.nhs.uk/wp-content/uploads/2014/11/transforming-
commissioning-services.pdf (Accessed 10th April 2019). 
Burder, N. (1996). Statistical methodology: 1. Incorporating the prevalence of disease into the 
sample size calculation for sensitivity and specificity. Academic Emergency Medicine, 
3(9), 895-900. 
Carr, E.G. (1977). The motivation of self-injurious behaviour: A review of some hypotheses. 
Psychological Bulletin, 84, 800-816.  
Carr, E.G. & Durand, V.M. (1985). Reducing behaviour problems through functional 
communication training. Journal of Applied Behaviour Analysis, 18(2), 111-126. 
Catania, C. (2013). A natural science of behaviour. Review of General Psychology, 17(2), 133-
139. 
Callacott, R., Cooper, S., Branford, D. & McGrother, C. (1998). Behaviour phenotype of Down 
Syndrome. British Journal of Psychiatry, 171(1), 85-89. 
                                                                                                                             Volume One: References 
 101 
Chadwick, O., Piroth, N., Walker, J., Bernard, S. & Taylor, E. (2000). Factors affecting the 
risk of behaviour problems in children with severe intellectual disability. Journal of 
Intellectual Disability Research, 44, 108-123.  
Chowdhury, M. & Benson, B. (2011). Deinstitutionalization and Quality of Life of Individuals 
with Intellectual Disability: A Review of the International Literature. Journal of Policy 
and Practice in Intellectual Disabilities, 8(4), 256-265. 
Crocker, A.G., Mercier, C., Lachapelle, Y., Brunet, A., Mornin, D. & Roy, M.-E. (2006). 
Prevalence and types of aggressive behaviour among adults with intellectual 
disabilities. Journal of Intellectual Disability Research, 50(9), 652-661. 
Cohen, I., Tsiouris, J., Floy, M., Kim, S., Freedland, R., Heaney, G., Pettinger, J. & Brown, T. 
(2009). A large-scale study of the psychometric characteristics of the IBR Modified 
Overt Aggression Scale: Findings and evidence for increased self-destructive 
behaviours in adult females with autism spectrum disorder. Journal of Autism and 
Developmental Disorders, 40, 599-609. 
Cooper, S-A., Smiley, E., Jackson, A., Finlayson, J., Mantry, D. & Morrison, J. (2008). Adults 
with intellectual disabilities: prevalence, incidence, and remission of self-injurious 
behaviour and related factors. Journal of Intellectual Disability Research, 53(3), 200-
216. 
Cooper, S.-A., Smiley, E., Allan, L. M., Jackson, A., Finlayson, J., Mantry, D. et al. (2009). 
Adults with intellectual disabilities: prevalence, incidence and remission of self-
injurious behaviour, and related factors. Journal of Intellectual Disability Research, 53, 
200-216.  
Cooper, V., Emerson, E., Glover, G., Gore, N. J., Hassiotis, A., Hastings, R., ... & Richards, C. 
(2014). Early intervention for children with learning disabilities whose behaviour 
challenges. Briefing Paper. Challenging Behaviour Foundation. 
Crocker, A., Mercier, C., Lachapelle, Y., Brunet, A., Morin, D. & Roy, M. (2006). Prevalence 
and types of aggressive behaviour among adults with intellectual disabilities. Journal 
of Intellectual Disability Research, 50(9), 652-661.  
                                                                                                                             Volume One: References 
 102 
Crocker, A., Mercier, C., Allaire, J. & Ray, M. (2007). Profiles and correlates of aggressive 
behaviour among adults with intellectual disabilities. Journal of Intelectual Disability 
Research, 51(10), 786-801. 
Davies, L.E. & Oliver, C. (2016). Self-injury, aggression and destruction in children with 
severe intellectual disability: incidence, persistence and novel, predictive behavioural 
risk markers. Research in Developmental Disabilities, 49, 291-301. 
Davidson, P.W., Cain, N.N., Sloane-Reeves, J.E., Van Speybroech, A., Segel, J., Gutkin, J., 
Quijano, L.E., Kramer, B.M., Porter, B., Shoham, I. & Goldstein, E. (1994). 
Characteristics of community-based individuals with mental retardation and aggressive 
behavioural disorders. American Journal on Mental Retardation, 98, 704-716.  
Deb, S., Thomas, M. & Vright, C. (2001). Mental disorder in adults with intellectual disability. 
2: The rate of behaviour disorders among a community-based population aged between 
16 and 64 years. Journal of Intellectual Disability Research, 45, 506-514. 
DerSimonian, R. & Laird, N. (1986). Meta-analysis in clinical trials. Controlled Clinical Trials, 
7, 177-188. 
Eden, K., de Vries, P., Moss, J., Richards, C. & Oliver, C. (2014). Self-injury and aggression 
in tuberous sclerosis complex: Cross syndrome comparison and associated risk 
markers. Journal of Neurodevelopmental Disorders, 6(10). 
Einfeld, S., Ellis, L., Doran, C. Emerson, E. (2010). Behaviour problems increase cost of care 
of children with intellectual disabilities. Journal of Mental Health Research in 
Intellectual Disabilities, 3(4), 202-209. 
Emerson, E. & Bromley, J. (1995). The form and function of challenging behaviours. Journal 
of Intellectual Disability Research, 39(5), 388-398. 
Emerson, E., Kiernan, C., Alborz, A., Reeves, D., Mason, H., Swarbrick, R. et al. (2001). The 
prevalence of challenging behaviours: a total population study. Research in 
Developmental Disabilities, 22, 77-93.  
Emerson, E. (2001) Challenging Behaviour: Analysis and Intervention in People with Severe 
Intellectual Disabilities (second edition). Cambridge University Press. 
                                                                                                                             Volume One: References 
 103 
Emerson, E. & Hatton, C. (2007). Mental health of children and adolescents with intellectual 
disabilities in Britain. British Journal of Psychiatry, 191, 493-499. 
Eyman, R.K. & Call, T. (1977). Maladaptive behavior and community placement of mentally 
retarded persons. American Journal of Mental Deficiency, 2, 137-144. 
Feldman, M.A., Atkinson, L., Foti-Gervais, L, and Condillac, R. (2004). Formal versus 
informal interventions for challenging behaviour in persons with intellectual 
disabilities. Journal of Intellectual Disability Research, 48, 60-68.  
Fergusson, D., Horwood, L., Ridder, E. (2005). Tests of causal linkages between cannabis and 
psychotic symptoms. Addiction, 100(3), 354-366. 
Folch, A., Cortés, M., Salvador-Carulla, L., Vicens, P., Irazábal, M., Muños, S., Rovira, L., 
Orejuela, C., Haro, J., Viella, E. & Martínez-Leal, R. (2018). Risk factors and 
topographies for self-injurious behaviour in a sample of adults with intellectual 
developmental disorders. Journal of Intellectual Disability Research, 62(12), 1018-
1029. 
Fox P. and Emerson E. (2002). Positive Goals: Interventions for people with learning disability 
whose behaviour challenges. Brighton, Pavilion Publishing.  
Frankenburg, W., Dodds, J. & Archer, P. (1990). Denver II Technical Manual. Denver 
Developmental Materials Inc. 
Gardner, W. I. (2002a). Aggression and other disruptive behavioral challenges: Biomedical 
and psychosocial assessment and treatment. Kingston, NY: NADD. 
 
Gardner, W. I., & Whalen, J. P. (1996). A multimodal behavior analytic model for evaluating 
the effects of medical problems on nonspecific behavioral symptoms in persons with 
developmental disabilities. Behavioral Interventions, 11, 147–161. 
 
Griffin, J.C., Williams, D.E., Stark, M.T., Altmeyer, B.K. & Mason, M. (1986). Self- injurious 
behavior: A state-wide prevalence survey of the extent and circumstances. Applied 
Research in Mental Retardation, 7, 105-116.  
                                                                                                                             Volume One: References 
 104 
Goh, H., Iwata, B. DeLeon, I. (2000). Competition between noncontingent and contingent 
reinforcement schedules during response acquisition. Journal of Applied Behaviour 
Analysis, 33(2), 195-205. 
Hall, S., Oliver, C. & Murphy, G. (2001). Early development of self-injurious behavior: An 
empirical study. American Journal on Mental Retardation, 106, 189-199.  
Handley, L. (2014). Aggressive and self-injurious behaviour: Towards a community early 
intervention strategy. Unpublished thesis.  
Hardan, A. & Sahl, R. (1997). Psychopathology in children and adolescents with 
developmental disorders. Research in Developmental Disabilities, 18, 369-382.  
Harvey, S., Boer, D., Meyer, L. & Evans, I. (2009). Updating a meta analysis of intervention 
research with challenging behaviour: Treatment validity and standards of practice. 
Journal of Intellectual and Developmental Disability, 34(1), 67-80. 
Hemmings, C., Gravestock, S., Pickard, M. & Bouras, N. (2006). Psychiatric symptoms and 
problem behaviours in people with intellectual disabilities. Journal of Intellectual 
Disability Research, 50(4), 269-276. 
Higgins, J., Thompson, S., Deeks, J. & Altman, D. (2003). Measuring inconsistency in meta-
analysis. British Medical Journal, 327(7414), 557-560. 
Hiraiwa, R., Maegaki, Y., Oka, A. & Ohno, K. (2007). Behavioural and psychiatric disorders 
in Prader-Willi syndrome: A population study in Japan. Brain and Development, 29, 
535-542. 
Holden, B., & Gitlesen. (2006). A total population study of challenging behaviour in the county 
of Hedmark, Norway: prevalence, and risk markers. Research in Developmental 
Disabilities, 27, 456-465.  
Holland, A.J., Whittington, J.E., Butler, J., Webb, T.,Boer, H. & Clarke, D. (2003). 
Behavioural phenotypes associated with specific genetic disorders: evidence from a 
population-based study of people with Prader-Willi syndrome. Psychological 
Medicine, 33(1), 141-153. 
                                                                                                                             Volume One: References 
 105 
Hyman P., Oliver C. & Hall S. (2002) Self-injurious behavior, self-restraint, and compulsive 
Behaviors in Cornelia de Lange syndrome. American Journal of Mental Retardation, 
107, 146–54.  
Iwata, B.A., Pace, G..M., Dorsey, M.F., Zarcone, J.R., Vollmer, T.R., Smith, R.G., Rodgers, 
T.A., Lerman, D.C., Shore, B.A., Mazeleski, J.L., Goh, H., Cowdery, G.E., Kalsher, 
M.J., MvCosh, K.C. & Willis, K.D. (1994). The functions of self-injurious behavior: 
An experimental epidemiological analysis. Journal of Applied Behavior Analysis, 27, 
215-240.  
Jacobson, J.W. (1982). Problem behavior and psychiatric impairment within a developmentally 
disabled population I: behavior frequency. Applied Research in Mental Retardation, 3, 
121-139.  
Kebbon, L. & Windahl, S.I. (1986). Self-injurious behaviour: results of a nation-wide survey 
among mentally retarded persons in Sweden. In J.M. Berg & J.M. Dejong (Eds.), 
Science and Service in Mental Retardation. London: Methuen.  
Kiernan, C. & Alborz, A. (1996). Persistence and change in challenging and problem 
behaviours of young adults with intellectual disability living in the family home. 
Journal of Applied Research in Intellectual Disabilities, 9, 181-193.  
Knapp, M., Comas-Herrera, A., Astin, J., Beecham, J. & Pendaries, C. (2005). Intellectual 
disability, challenging behaviour and cost in care accommodation: What are the links? 
Health and Social Care in the Community, 12, 297-306. 
Kushlick, A., Blunden, R., & Cox, G. (1973). Method of rating behavior characteristics for use 
in large-scale surveys of mental handicap. Psychological Medicine, 3, 466–478.  
Langdon, P., Dalton, D., Brolly, K. & Temple, P. (2017). Using positive behaviour support as 
a treatment for trauma symptoms with a man with intellectual disabilities. International 
Journal of Positive Behaviour Support. 
Langthorne, P. & McGill, P. (2012). An indirect examination of the function of problem 
behaviours associated with Fragile x syndrome and Smith-Magenis syndrome. Journal 
of Autism and Developmental Disorders, 42, 201-209. 
                                                                                                                             Volume One: References 
 106 
Laraway, S., Snycerski, S., Michael, J. & Poling, A. (2003). Motivating operations and terms 
to describe them: some further refinements. Journal of Applied Behaviour Analysis, 
36(3), 407-414. 
Lin, L. (2018). Bias caused by sampling error in meta-analysis with small sample sizes. PLoS 
ONE, 13(9). 
Lindberg, J., Iwata, B., Roscoe, E., Worsdell, A. & Hanley, G. (2003). Treatment efficacy of 
noncontingent reinforcement during brief and extended application. Journal of Applied 
Behaviour Analysis, 36(1), 1-19. 
Lowe, K., Allen, D., Jones, E., Brophy, S., Moore, K. & James, W. (2007). Challenging 
behaviours: Prevalence and topographies. Journal of Intellectual Disabilities Research, 
51(8), 625-636. 
Luingem M., Post, W., Wit, H. Goothuis-Brouwer, S. (2006). The ordering of milestones in 
language development for children from 1 to 6 years of age. Journal of Speech, 
Language and Hearing Research, 67. 
Lundqvist, L. (2013). Prevalence and risk markers of behaviour problems among adults with 
intellectual disabilities: a total population study in Örebro County, Sweden. Research 
in Developmental Disabilities, 34, 1346-1356. 
MacDonald, A. & McGill, P. (2013). Outcomes of staff training in Positive Behaviour Support: 
A systematic review. Journal of Developmental and Physical Disabilities, 25(1), 17-
33. 
Marsee, M., Frick, P., Barry, C. & Kimonis, E. (2014). Profiles of the forms and functions of 
self-reported aggression in three adolescent samples. Development and 
Psychopathology, 26(3), 705-720. 
Maisto, C.R., Baumeister, A.A. & Maisto, A.A. (1978). An analysis of variables related to self-
injurious behavior among institutionalised retarded persons. Journal of Mental 
Deficiency Research, 22, 27-36.  
Mandell, D. S. (2008). Psychiatric hospitalisation among children with autism spectrum 
disorder. Journal of Autism and Developmental Disorders, 38, 1059-168. 
                                                                                                                             Volume One: References 
 107 
Matson, J., Cooper, C., Malone, C. & Moskow, S.L. (2008). The relationship of self-injurious 
behavior and other maladaptive behaviors among individuals with severe and profound 
intellectual disability. Research in Developmental Disabilities, 9, 141–48. 
 
Matson, M,. Mahan, S. & Matson, J. (2009). Parent training: A review of methods for children 
with autism spectrum disorders. Research in Autism Spectrum Disorders, 3, 868-875. 
 
Matson, J. & Mayville, E. (2001). The relationship of functional variables and psychopathology 
to aggressive behaviour in persons with severe and profound mental retardation. 
Journal of Psychopathology and Behavioural Assessment, 23(1), 3-9. 
Maurice, P, & Trudel, G. (1982). Self-injurious behavior prevalence and relationship to 
environmental events. In J. Hollis and C.E. Meyers (Eds.), Life Threatening Behavior: 
Analysis and Intervention. Washington DC: American Association of Mental 
Deficiency.  
McLean, L.K., Brady, N.C. & McLean, J.E. (1996). Reported communication abilities of 
individuals with severe mental retardation. American Journal on Mental Retardation, 
100, 580-591.  
McClintock, K., Gall, S. & Oliver, C. (2003). Risk markers associated with challenging 
behaviours in people with intellectual disabilities: a meta analytic study. Journal of 
Intellectual Disability Research, 47, 405-416. 
McCrone, P., Knapp, M. & Dhanasiri, S. (2009). Economic impact of services for first-episode 
psychosis: A decision model approach. Early Intervention in Psychiatry, 3(4), 266-273. 
McGorry, P., Yung, A., Philips, L. et al., (2002). Randomized control trial of interventions 
designed o reduce the risk of progression to first episode psychosis in a clinical sample 
with subthreshold symptoms. Archives of General Psychiatry, 59(10), 921-928. 
McIntyre, L. L., Blacher, J. & Baker, B. L. (2002). Behavioural/mental health problems in 
young adults with intellectual disabilities: the impact on families. Journal of 
Intellectual Disability Research, 46, 239-249. 
                                                                                                                             Volume One: References 
 108 
McTiernan, A., Leader, G., Healey, O. & Mannion, A. (2011). Analysis of risk factors and 
early predictors of challenging behaviour for children with autism spectrum disorder. 
Research in Autism Spectrum Disorders, 5, 1215-1222. 
Medeiros, K., Rojahn, J., Moore, L. & van Ingren, D. (2014). Functional properties of 
behaviour problems depending on level of intellectual disability. Journal of Intellectual 
Disability Research, 58(2), 151-161. 
Meins, W. (1995). Symptoms of major depression in mentally retarded adults. Journal of 
Intellectual Disability Research, 39(1), 41-45. 
Moffitt, T. (1993). Adolescence-limited and life-course-persistent antisocial behavior: a 
developmental taxonomy. Psychological Review, 100(4), 674-701. 
Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009). Preferred Reporting 
Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS 
Medicine 6(7) 
Newcomb, M. & Bentler, P. (1989). Substance use and abuse among children and teenagers. 
American Psychologist, 44(2), 242-248. 
Newman, I., Leder, G., Chen, J. & Mannion, A. (2015). An analysis of challenging behaviour, 
comorbid psychopathology and attention-deficit/hyperactivity disorder in Fragile X 
syndrome. Research in Developmental Disabilities, 38, 7-17. 
Oliver, C., Murphy, G. & Crayton, L. (1993). Self-injurious behaviour in Rett Syndrome: 
Interactions between features of Rett Syndrome and operant conditioning. Journal of 
Autism and Developmental Disorders, 23(1). 
Oliver, P., Crawford, M., Rao, B., Reece, B. & Tyrer, P. (2007). Modified Overt Aggression 
Scale (MOAS) for people with intellectual disability and aggressive challenging 
behaviour: A reliability study. Journal of Applied Research in Intellectual Disabilities, 
20(4), 368-372. 
Oliver, C., Sloneem, J., Hall, S. & Arron, K. (2009). Self-injurious behaviour in Cornelia de 
Lange syndrome: 1. Prevalence and phenomenology. Journal of Intellectual Disability 
Research, 53(7), 575-589. 
                                                                                                                             Volume One: References 
 109 
Oliver, C., Petty, J., Ruddick, J. & Bacarese-Hamilton, M. (2012). The association between 
repetitive, self-injurious and aggressive behaviour in children with severe intellectual 
disability. Journal of Autism and Developmental Disorders, 42, 910-919. 
Peduzzi P, Concato J, Kemper E, Holford TR, Feinstein AR (1996) A simulation study of the 
number of events per variable in logistic regression analysis. Journal of Clinical 
Epidemiology, 49,1373-1379 
Posey, D.J., Stigler, K.A., Erickson, C.A. & McDougle, C.J. (2008). Antipsychotics in the 
treatment of autism. Journal of Clinical Investigation, 118(1), 6-14. 
Powis, L. & Oliver, C. (2014). The prevelance of aggression in genetic syndromes: a review. 
Research in Developmental Disabilities, 35(5), 1051-1071. 
Quine, L. (1986). Behaviour problems in severely mentally handicapped children. 
Psychological Medicine, 16, 895-907.  
Raine, A., Dodge, K., Loeber, R., Gatzke-Kopp, L., Lynam, D., Reynolds, C., et al. (2006). 
The reactive-proactive aggression questionnaire: Differential correlates of reactive and 
proactive aggression in adolescent boys. Aggressive Behavior, 32, 159–171.  
Ramey, C. & Ramey, L. (1998). Early intervention and early experience. The American 
Psychologist, 53(2), 109-120. 
R Core Team (2013). R: A language and environment for statistical computing. R Foundation 
for Statistical Computing, Vienna, Austria. URL http://www.R-project.org/. 
Rice, M. E. & Harris, G. T. (2005). Comparing effect sizes in follow-up studies: ROC Area, 
Cohen’s d and r. Law and Human Behaviour, 29, 615-620. 
Richards, C., Oliver, C., Nelson, L. & Moss, J. (2012). Self-injurious behaviour in individuals 
with autism spectrum disorder and intellectual disability. Journal of Intellectual 
Disability Research, 56, 476-489.  
Richards, C., Jones, C., Groves, L., Moss, J. & Oliver, C. (2015). Prevalence of autism 
spectrum disorder phenomenology in genetic disorders: a systematic review and meta-
analysis. Lancet Psychiatry, 2(10), 909-916. 
                                                                                                                             Volume One: References 
 110 
Richards, C., Davies, L. & Oliver, C. (2017). Predictors of self-injurious behavior and self-
restraint in Autism Spectrum Disorder: Towards a hypothesis of impaired behavioral 
control. Journal of Autism and Developmental Disorders, 47, 701-713. 
Richman, D. & Hagopian, L. (1999). On the effects of ‘quality’ of attention in the functional 
analysis of destructive behaviour. Research in Developmental Disabilities, 20(1), 51-
62. 
Ringdhal, J., Berg, W., Wacker, D., Crook, K., Molony, M., Vargo, K., Neurnberger, J., Zabala, 
K. & Taylor, C. (2018). Effects of response preference on resistance to change. Journal 
of the Experimental Analysis of Behaviour, 109(1), 265-280. 
Roberts, C., Mazzucchelli, T., Taylor, K. & Reid, R. (2010). Early intervention for behaviour 
problems in young children with developmental disabilities. International Journal of 
Disability, Development and Education, 275-292. 
Rojahn, J. (1986). Self-injurious and stereotypic behavior of noninstitutionalized mentally 
retarded people: prevalence and classification. American Journal of Mental Deficiency, 
91, 268-276.  
Rojahn, J., Matson, J., Lott, D., Esbenson, A. Smalls, Y. (2001). The Behaviour Problems 
Inventory: An instrument or the assessment of self-injury, stereotyped behaviour and 
aggression/destruction n individuals with developmental disabilities. Journal of Autism 
and Developmental Disorders, 31(6), 577-588.  
Rojahn, J. & Esbensen, A.J. (2002). Epidemiology of self-injury in mental retardation: A 
review. In S. Shroeder, M. Oster-Granite & T. Thompson, (Eds.). Self-injurious 
behavior: Gene-brain-behavior relationships. Washington DC: APA Press.  
Rojahn, J., Aman, M., Matson, J. & Mayville, J. (2003). The Abberrant Behaviour Checklist 
and the Behaviour Problems Inventory: Convergent and divergent validity. Research in 
Developmental Disabilities, 24(5), 391-404. 
Rojahn, J., Matson, J., Naglieri, J. & Mayville, E. (2004). Relationships between psychiatric 
conditions and behaviour problems among adults with mental retardation. American 
Journal of Mental Retardation, 101(1), 21-33. 
                                                                                                                             Volume One: References 
 111 
Rojahn, J., Schroeder, S.R. & Hoch, T.A. (2008). Self-injurious behavior in intellectual 
disabilities. New York, NY: Elsevier. 
Romaniuk, C. & Miltenberger, R. (2001). The influence of preference and choice of activity 
on problem behaviour. Journal of Positive Behaviour Interventions, 3(3), 152-159. 
Ross, R.T. (1972). Behavioral correlates of levels of intelligence. American Journal of Mental 
Deficiency, 79, 545-549.  
Royal College of Psychiatrists (2007). Challenging behaviour: A unified approach. Clinical 
and service guidelines for supporting people with learning disabilities who are at risk 
of receiving abusive or restrictive practices. College Report CR144. 
Ruddick, L., Davies, L., Bacarese-Hamilton, M. & Oliver, C. (2015). Self-injurious, aggressive 
and destructive behaviour in children with severe intellectual disability: Prevalence, 
service need and service receipt in the UK. Research in Developmental Disabilities, 45-
46, 307-315. 
Russel, G., Mandy, W., Elliot, D., White, R., Pittwood, T. & Ford, T. (2019). Selection bias on 
intellectual ability in autism research: a cross sectional review and meta-analysis. 
Molecular Autism, 10(9). 
Schroeder, S.R., Schroeder, C.S., Smith, B. & Dalldorf, J. (1978). Prevalence of self- injurious 
behaviors in a large state facility for the retarded: A three-year follow-up study. Journal 
of Autism and Childhood Schizophrenia, 8, 261-269.  
Shafer, J. (1995). Multiple Hypothesis testing. Annual Review of Psychology, 46, 561-584. 
Shanahan, M., Roberts, J., Hatton, D., Reznick, J. & Goldsmith, H. (2008). Early tempermant 
and negative reactivity in boys with Fragile X syndrome. Journal of Intellectual 
Disability Research, 52(10), 842-854. 
Sheth, K., Moss, J., Hyland, S., Stinton, C., Cole, T. & Oliver, C. (2015). The behavioural 
characteristics of Sotos syndrome. American Journal of Medical Genetics, 167A(12), 
2945-2956. 
Shodell, M.J. & Reiter, H.H. (1968). Self-mutilative behavior in verbal and nonverbal 
schizophrenic children. Archives of General Psychiatry, 19, 453-455.  
                                                                                                                             Volume One: References 
 112 
Shogren, K., Faggella-Luby, M., Bae, S. & Wehmeyer, M. (2004). The effect of choice-making 
as an intervention for problem behaviour: a meta-analysis. Journal of Positive 
Behaviour Interventions, 6(4), 228-237. 
Sidik, K. & Jonkman, J.N. (2007). A comparison of heterogeneity variance estimators in 
combining results of studies. Statistics in Medicine, 26(9), 1964-1981. 
Stadnick, N., Chlebowski, C. & Brookman-Frazee, L. (2017). Caregiver-teacher concordance 
of challenging behaviours in children with autism spectrum disorder in community 
mental health settings. Journal of Autism and Developmental Disorders, 47, (6), 1780-
1790. 
Stegenga, J. (2015). Measuring Effectiveness. Studies in History and Philosophy of Biological 
and Biomedical Sciences, 54: 62–71. 
Surtees, A. D. R., Oliver, C., Jones, C., Evans, D. & Richards, C. (2018) Shorter duration and 
poorer quality sleep in people with intellectual disabilities: A meta-analysis. Sleep 
Medicine Reviews. 
Symons, F. J. (2011). Self-injurious behavior and neurodevelopmental disorders: Relevance of 
nociceptive and sensory mechanisms. Neuroscience and Biobehavioural Reviews. 35, 
1266-74.  
Tenneij, N., Didden, R., Stolker, J. & Koot, H. (2009). Markers for aggression in inpatient 
treatment facilities for adults with mild to borderline intellectual disability. Research in 
Developmental Disabilities, 30, 1248-1257. 
Tremblay, R., Nagin, D., Seguin, J., Zoccolillo, M., Zelazo, P., Bovin, M., Perusse, D. & Japel, 
C.  (2004). Physical aggression during early childhood: Trajectories and predictors. 
Paediatrics, 114(1), e43-e50. 
Tsiachristas, A., Thomas, T., Leal, J. & Lennox, B. (2016). Economic impact of early 
intervention in psychosis services: results from a longitudinal respective controlled 
study in England. British Medical Journal Open, 6 (10) 
                                                                                                                             Volume One: References 
 113 
Tsiouris, J., Kim, S., Brown, W. & Cohen, I. (2011). Association of aggressive behaviours with 
psychiatric disorders, age, sex and degree of intellectual disability: a large-scale survey. 
Journal of Intellectual Disabilities Research, 55(7), 436-449. 
Totsika, V., Hastings, R. P. (2009). Persistent challenging behaviour n people with an 
intellectual disability. Current Opinions in Psychiatry, 22(5), 437-441. 
Tyrer, F., McGrother, C., Thorp, C., Donaldson, M., Bhaumik, S., Watson, J. & Hollin, C. 
(2006). Physical aggression towards others in adults with learning disabilities: 
prevalence and associated factors. Journal of Intellectual Disability Research, 50(4), 
295-304. 
Wacker, D., Harding, J., Berg, W., Lee, J., Schieltz, K., Padilla, Y., Nevin, J. & Shahan, T. 
(2011). An evolution of persistence of treatment effects during long-term treatment of 
destructive behaviour. Journal of Experimental Analysis of Behaviour, 96(2), 261-282. 
Weigel, L., Langdon, P., Collins, S. & O’Brien, Y. (2006). Challenging behaviour and learning 
disabilities: the relationship between expressed emotion and staff attributions. British 
Journal of Clinical Psychology, 42(2), 205-216. 
Wilde, L., Eden, K., De Vries, P., Moss, J., Welham, A. & Oliver, C. (2017). Self-injury and 
aggression in adults with tuberous sclerosis complex: frequency, associated person 
characteristics, and implications for assessment. Research in Developmental 
Disabilities, 119-130. 
World Health Organisation (1992). The International Classification of Diseases – Tenth 
revision (ICD10). World Health Organization, Geneva.
                                                                                                                                                                                                                                 
Volume One: Appendix 
 114 
Appendix A: Descriptions of studies included in meta-analysis 








Maladaptive behaviour checklist 
(Aman, 1994) 
Receptive/ expressive communication; ASD; 
Psychosis 
Japan 47 autistic children and 128 children with 
intellectual disabilities (age 6-14) 




Questionnaire (Hyman et al., 
2002) 
AS; CdLS; Adaptive function; CdCS; FXS; 
PWS; Lowe syndrome; SMS 
USA 741 participants recruited through specific 
syndrome societies, foundations and 
support groups. 
*Ballinger (1971) Self-injury: 
 




626 adult residents in a hospital/institution 
for ‘mentally subnormal’ 
Barnard-Brak et 
al. (2014) 
Self-injury Behaviour Problem Inventory 
(Rojan et al., 2001) 
Gender; Age; Degree of ID International 1871 cases from five regions around the 
world 
Basile et al. (2007) Self-injury 
 
Developmental Behaviour 
Checklist (Einfeld & Tonge 
(1992) 
Adaptive function Italy 56 individuals with CdLS. Recruited 
through the Italian Cornelia de Langue 
Association 





Self-determined measure Autism UK 2261 adults with intellectual disabilities 
served by a regional intellectual disability 
service 
*Bott et al. (1997) Self-injury; 
Destruction 
Self-determined measure Expressive communication UK Individuals in 13 health districts’ listed 
Registers for People with Intellectual 
Disabilities 




Behaviour Problem Inventory 
(Rojan et al., 2001) 
Degree of ID; Gender; ASD; DS; Incontinence; 
Visual impairment; Mobility impairment; Hearing 
impairment; Seizures; Dementia; Age; Receptive/ 
expressive communication; 
Epilepsy; Living arrangement 
Jersey 265 adults known to services and 
administratively defined as having ID.  
Cohen et al. (2010) Aggression Modified Overt Aggression Scale 
(Kay et al., 1988) 
Age; Gender; Level of ID; ASD USA 3547 individuals with ID and/or autism. 
897 comprising an aggression sample. 
Cooper et al. 
(2009) 
Aggression Diagnostic Criteria for 
Psychiatric Disorders for Use 
with Adults with Learning 
Disabilities/Mental Retardation 
 
Gender; Degree of ID; Expressive communication; 
ASD; ADHD; DS; Epilepsy; Visual impairment; 
Mobility impairment; Hearing impairment; Living 
status; Age; Incontinence 
Scotland, 
UK 
All adults with ID within a geographically 
defined area of Scotland, UK  
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Modified Overt Aggression Scale 
(Kay et al., 1988) 
Level of ID; Age; Living status Quebec, 
Canada 
1365 adult men and women receiving input 
from rehabilitation agencies 




Modified Overt Aggression Scale 
(Kay et al., 1988) 
 
 
Gender; Degree of ID; Mobility impairment; Living 




296 adults with mild/moderate ID 
interviewed and client files reviewed 
*Davidson et al. 
(1994) 
Aggression  Degree of ID; ASD; Gender UK 199 individuals referred to a crisis 
intervention program 






SAD-SQ (Davies & Oliver, 
2016) 
Gender; Degree of ID; Overactivity and impulsivity 
(SAD-SQ); Repetitive and restricted behaviours 
(SAD-SQ) 
UK 417 children with severe intellectual 
disability  
 
Deb et al. (2001) Self-injury; 
Aggression 
Disability Assessment Schedule 
(Holmes et al., 1982) 
Gender; Age; Living status; Degree of ID; Epilepsy; 
Expressive communication; Mobility impairment 
Wales, UK One hundred and one adults with ID aged 
between 16 and 64 known to the Vale of 
Glamorgan Social Services Department in 
South Wales, UK.  
 




Questionnaire (Hyman et al., 
2002) 
TSC; CdLS; FXS; ASD; DS; 
Age (not included); Gender; Interest/pleasure; 
Socialisation; Repetitive behaviour; Impulsivity/ 
compulsivity; Overactivity; Stereotyped behaviour; 
Pain; Health conditions 
UK 37 children aged 4 to 15 years, with TSC.  
 
Emmerson et al. 
(2001) 
Self-injury Unspecified interview schedule ASD; Age; Expressive/ receptive communication UK 95 men and women (age 12-65)  




 Degree of ID UK 6870 individuals from institutions and 
community centres 
Folch et al. (2018) Self-injury Aberrant Behaviour Checklist 
(Aman & Singh, 1994) 
Age; Gender; Degree of ID; Place of residence; Oral 
pain; Epilepsy; CARS scores; Psychiatric medication 
Spain 953 individuals with ID recruited from 66 
social care services for ID.  
*Griffin et al., 
(1986) 
Self-injury  Gender  Residents of all 13 state institutions 




Unspecified Degree of ID  Children and adolescents taking part in 12-
month program for intellectual disorders 






Disability Assessment Schedule 
(Holmes et al., 1982) 
Age; Degree of ID; Energy; Anhedonia; Mood; Social 
impairment; Sleep; Appetite 
  
UK 739 adults aged 18-85 known to a local 
register for people with ID in Southeast 
London 
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Unspecified questionnaire Gender, Age; BMI; Degree of ID Japan 177 participants with PWS recruited 
through connections with Japanese PWS 
Association called Takenoko-no-kai 
Holden et al. 
(2003) 
Self-injury Observation Degree of ID Norway 165 adults with ‘mental retardation’ 
receiving services from rehabilitation 
services in Oppland and Hedmark 
*Jacobson (1982) Self-injury; 
Aggression 
Unspecified Degree of ID  30,578 developmentally disabled 
individuals living in community and 
institutions in New York 
*Kebbon & 
WIndahl (1986) 
Self-injury Unspecified Degree of ID  All individuals in Sweden served by 
services for mental retardation 
*Kiernan & 
Alborz (1996) 







Aberrant Behaviour Checklist 
(Aman & Singh, 1994) 
FXS; SMS UK Individuals with ID aged 5-21 attending 
parental support groups for specific 
syndromes 
Lundgvist (2013) Self-injury Behaviour Problem Inventory 
(Rojan et al., 2001) 
Gender; Age; Degree of ID; Physical health 
difficulties; Epilepsy; Cerebral Palsy; PWS; DS; FXS; 
ASD; ADHD; Medication; Communication; 
Hypersensitivity; Dementia; Psychosis; Depression; 
Sweden 915 individuals over the age of 18 receiving 
at least minimum care from local health 
authorities. 
*Maisto et al. 
(1978) 
Self-injury Unspecified questionnaire Degree of ID; Gender USA 1,300 residents in a large residential 
training institution in US 





Autism Spectrum Disorders – 
Behaviour Problems for Adults. 
ASD USA 320 adult residents from two developmental 
centres in Louisiana. 
*Maurice & 
Trudel (1982) 
Self-injury  Gender  2,858 individuals with intellectual 
disabilities living in three institutions 




 Expressive communication  Total population of individuals with mental 
retardation in state of Kansas 
Medeiros et al. 
(2013) 
Self-injury Behaviour Problems Inventory 
(Rojan et al., 2001) 
Age, Gender, Ethnicity USA 115 adults with varying levels of ID 
engaged in a day training and rehabilitation 
placement in Minnesota. 
Newman et al. 
(2015) 
Self-injury Behaviour Problems Inventory 
(Rojan et al., 2001) 
FXS Ireland 47 children and adolescents with a 
diagnosis of FRX recruited through online 
forums and groups 
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Oliver et al. (2009) Self-injury 
Aggression 
Destruction 
Challenging Behaviour Interview 
(Hyman et al., 2002) 
CdLS UK and 
Ireland 
54 people with CdLS and 46 people with 
intellectual disabilities recruited through the 
CdLS Parent foundation group and local 
area 
Oliver et al. (2012) Self-injury 
Aggression 
Destruction 
5 items taken from the original 
Wessex scale. 
Stereotyped behaviour, Communication, Adaptive 
behaviour 
UK 1096 children attending 17 special schools 
for children with severe intellectual 
disabilities 
*Quine (1986) Self-injury 
Aggression 
Unclear Gender UK Individuals from two health districts with 
intellectual disabilities 
Richards et al. 
(2012) 
Self-injury Aberrant Behaviour Checklist 
(Aman & Singh, 1994) 
ASD, DS, FXS, Gender, Age, Ability, Mood, 
Interest/pleasure, Stereotyped behaviours, 
Overactivity/impulsivity 
UK 321 participants with ASD, Fragile X and 
Down syndrome recruited via National 
Autistic Society, Fragile X Society and 
Down Syndrome Association. 
Richards et al. 
(2017) 
Self-injury SAD-SQ; Challenging Behaviour 
Questionnaire (Davies & Oliver, 
2016) 
Gender, Age, Physical health difficulties, 
overactivity/impulsivity, Ability 
UK 515 individuals with ASD attending 
National Autism Society adult services and 
schools 
*Rojahn (1986) Self-injury Six-page survey instrument – SIB 
section adapted from Schroeder 
et al. (1978) and Rojan (1984). 
Degree of ID Germany 25,872 ‘mentally retarded’ individuals 
using schools/training centres, workshops 






 Degree of ID  
 
  
11,139 individuals with mental retardation 
living in state hospitals in California in 
1970 
*Schroeder et al. 
(1978) 
Self-injury Interview with social worker Degree of ID; Receptive/expressive communication USA 1,150 residents of Murdoch Centre, a state 
facility for ‘retarded persons’, aged 5-85 
years. 





Questionnaire (Hyman et al., 
2002) 
Sotos syndrome; PWS; DS, ASD UK 150 Participants with Sotos syndrome, 
Prader Willi syndrome, Autism or Down 
syndrome 




 Expressive communication  58 schizophrenic children attending 
daytime special education programmes 
Tenneij et al. 
(2009) 
Aggression Staff Observation Aggression 
Scale – Revised (Nijman & 
Palmstierna, 2002); Adult 
Age, Gender, Treatment duration,  Netherlands 108 adults recruited from four inpatient 
treatment facilities for adults with mild ID 
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Behaviour Checklist (Achenback 
& Rescorla, 2003) 
and severe behavioural and emotional 
problems 
Tsiouris et al. 
(2011) 
Aggression Modified Overt Aggression Scale 
(Kay et al., 1988)  
Psychiatric disorder USA Individuals with ID living in the community 
and receiving services from the New York 
State Office for People with Developmental 
Disabilities between 2006-2007. 
Tyrer et al. (2005) Aggression Disability Assessment Schedule 
(Holmes et al., 1982) 
Gender, Age, Ethnicity, Living status, Degree of ID, 
Epilepsy, DS, ASD 
UK Cross sectional study of 3062 participants 
using the Leicestershire LD Register for 
adults over the age of 19 with LD. 
Wilde et al. (2017) Self-injury 
Aggression 
Challenging Behaviour 
Questionnaire (Hyman, Oliver & 
Hall, 2002) 
TSC, Age, Gender, Communication, Socialisation, 
Impulsivity, AS 
UK 30 individuals with TSC recruited through 
Tuberous Sclerosis Association, matched to 
21 individuals with DS and 29 people with 
ASD 









                                                                                                                                                                                                                                 
Volume One: Appendix 
 119 
Appendix B: Forest plots of individual risk marker outputs 
B1 Gender 
B1.1 Forest plot for all studies included for RR of gender and self-injury
 










B1.3 Forest plot for all studies included for RR of gender and destruction 
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B2 Level of ID 
B2.1 Forest plot for all studies included for RR of level of ID and self-injury
 
B2.2 Forest plot for all studies included for RR of level of ID and aggression 
 
B2.3 Forest plot for all studies included for RR of level of ID and destruction 
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B3 Adaptive Behaviour 
B3.1 Forest plot for all studies included for RR of adaptive behaviour and self-injury 
 
B3.2 Forest plot for all studies included for RR of adaptive behaviour and destruction 
 
B4 Paid/Congregate care 
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B4.2 Forest plot for all studies included for RR of paid/congregate care and aggression 
 
B5 Angelman syndrome 
B5.1 Forest plot for all studies included for RR of Angelman syndrome and self-injury 
 









                                                                                                                                                                                                                                 




B6.1 Forest plot for all studies included for RR of autism and self-injury 
 
B6.2 Forest plot for all studies included for RR of autism and aggression 
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B7 Cornelia de Lange syndrome 
B7.1 Forest plot for all studies included for RR of Cornelia de Lange syndrome and self-injury 
 








for RR of 
Down 
syndrome and self-injury 
 
B8.2 Forest plot for all studies included for RR of Down syndrome and aggression 
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B9 Fragile X syndrome 
B9.1 Forest plot for all studies included for RR of fragile X syndrome and self-injury 
 







B10 Prader Willi syndrome 











                                                                                                                                                                                                                                 














for RR of 
Smith Magenis syndrome and aggression 
 
B12 Tuberous sclerosis complex 
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B14 Hearing deficit 
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B16.1 2 Forest plot for all studies included for RR of epilepsy and self-injury 
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B17 Dental problems 






B18 Gastrointestinal problems 
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B21.1 Forest plot for all studies included for RR of receptive communication and self-injury 
B22 
Overactivity/impulsivity 












B23 Repetitive behaviour 
B23.1 Forest plot for all studies included for RR of repetitive behaviour and self-injury 
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Professor Chris Oliver 
Professor of Neurodevelopmental Disorders 
Director of the Cerebra Centre for Neurodevelopmental Disorders  
School of Psychology  
University of Birmingham  
B15 2TT 
 
15 August 2018 
 
Dear Professor Oliver 
Study title: The Identification of young children at highest Risk for 
developing Severe Challenging behaviour (i-RISC): Proof of principle and appraisal of 
feasibility. 
IRAS project ID: 235418 
Protocol number: RG_17-182 
REC reference: 18/NE/0249 
Sponsor University of Birmingham 
 
I am pleased to confirm that HRA and Health and Care Research Wales (HCRW) Approval has 
been given for the above referenced study, on the basis described in the application form, protocol, 
supporting documentation and any clarifications received. You should not expect to receive anything 
further relating to this application. 
HRA and Health and Care 
Research Wales (HCRW) 
Approval Letter 
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How should I continue to work with participating NHS organisations in England and Wales? 
You should now provide a copy of this letter to all participating NHS organisations in England and 
Wales, as well as any documentation that has been updated as a result of the assessment. 
Following the arranging of capacity and capability, participating NHS organisations in England and 
Wales that are hosting all site activities should formally confirm their capacity and capability to 
undertake the study. How this will be confirmed is detailed in the “summary of assessment” section 
towards the end of this letter. You should then work with each organisation that has confirmed capacity 
and capability and provide clear instructions when research activities can commence. 
 
   Participating NHS organisations in England and Wales that are acting as participant identification centres    
will not be required to formally confirm capacity and capability before you may commence research activity at 
site. As such, you may commence the research at each organisation 35 days following sponsor provision to the 
site of the local information pack, so long as:  
• You have contacted participating NHS organisations (see below for details) 
• The NHS organisation has not provided a reason as to why they cannot participate 
• The NHS organisation has not requested additional time to confirm. 
 
You may start the research prior to the above deadline if the site positively confirms that the research 
may proceed. 
If not already done so, you should now provide the local information pack for your study to your 
participating NHS organisations. A current list of R&D contacts is accessible at the NHS RD Forum 
website and these contacts MUST be used for this purpose. After entering your IRAS ID you will be able 
to access a password protected document (password: White22). The password is updated on a monthly 
basis so please obtain the relevant contact information as soon as possible; please do not hesitate to 
contact me should you encounter any issues. 
Commencing research activities at any NHS organisation before providing them with the full local 
information pack and allowing them the agreed duration to opt-out, or to request additional time (unless 
you have received from their R&D department notification that you may commence), is a breach of the 
terms of HRA and HCRW Approval. Further information is provided in the “summary of assessment” 
section towards the end of this document. 
It is important that you involve both the research management function (e.g. R&D office) supporting 
each organisation and the local research team (where there is one) in setting up your study. Contact 
details of the research management function for each organisation can be accessed here. 
 
How should I work with participating NHS/HSC organisations in Northern Ireland and 
Scotland? 
HRA and HCRW Approval does not apply to NHS/HSC organisations within the devolved 
administrations of Northern Ireland and Scotland. 
 
If you indicated in your IRAS form that you do have participating organisations in either of these devolved 
administrations, the final document set and the study wide governance report (including this letter) has 
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been sent to the coordinating centre of each participating nation. You should work with the relevant 
national coordinating functions to ensure any nation specific checks are complete, and with each site so 
that they are able to give management permission for the study to begin 
Please see IRAS Help for information on working with NHS/HSC organisations in Northern Ireland and 
Scotland. 
How should I work with participating non-NHS organisations? 
HRA and HCRW Approval does not apply to non-NHS organisations. You should work with your non- 
NHS organisations to obtain local agreement in accordance with their procedures. 
 
What are my notification responsibilities during the study? 
The document “After Ethical Review – guidance for sponsors and investigators”, issued with your REC 
favourable opinion, gives detailed guidance on reporting expectations for studies, including: 
• Registration of research 
• Notifying amendments 
• Notifying the end of the study 
 
The HRA website also provides guidance on these topics, and is updated in the light of changes in 
reporting expectations or procedures. 
 
I am a participating NHS organisation in England or Wales. What should I do once I receive this letter? 
You should work with the applicant and sponsor to complete any outstanding arrangements so you are 
able to confirm capacity and capability in line with the information provided in this letter. 
The sponsor contact for this application is 




Who should I contact for further information? 
Please do not hesitate to contact me for assistance with this application. My contact details are below. Your 
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Appendix D: Parent contact letter 
Dr Caroline Richards: c.r.richards@bham.ac.uk, 0121 415 8098 
Laura Groves: LXG502@student.bham.ac.uk, 0121 414 9775 
Dear Parent/Carer, 
We are writing to let you know about a new research project that will be taking place at the Cerebra 
Centre for Neurodevelopmental disorders at the University of Birmingham.  
We have contacted you because your child attends a Special Needs School in the West Midlands. Your 
child’s Head Teacher has sent out this information on our behalf. Your personal details will not be 
known to us unless you decide to take part in the research study and contact us directly.  
The project is called ‘Behaviours of children with neurodevelopmental difficulties’ and aims to describe 
and assess different behaviours of children who are a delayed in some aspect of their development such 
as communication, social interaction or physical skills. The study involves the completion of a brief 10-
15 minute questionnaire, focussing on a wide spectrum of behaviours that your child may or may not 
demonstrate.  
We have enclosed an information sheet that gives you more details about what participation in this 
research will involve, what will happen to the information you provide and the benefits of participating. 
We have also enclosed a consent form, the questionnaire and two pre-paid envelopes.  If you would like 
to participate, we would very much appreciate it if you could complete the consent form and 
questionnaire and return them to the research team separately in the prepaid envelopes. This is to ensure 
your personal identifying information, cannot be linked to your questionnaire responses, without your 
personal identification number.  
If you have any questions / concerns about the research, please do not hesitate to contact Laura Groves. 
Due to our methods of recruitment, there is a small possibility you may have already been contacted by 
the Cerebra Centre to take part. If this is the case, please ignore the latest invitation to participate which 
has been sent to you.  
This research project has been approved by the North East Tyne & Wear South Research Ethics 
Committee and has all the necessary approvals (Health Research Authority reference number: 235418; 
Protocol number: RG_17 182; REC number: 18/NE/0249). 
Thank you very much for your time,  
Kind regards, Dr Caroline Richards, Dr Debbie Allen and Professor Chris Oliver 
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Appendix E: Participant Information Sheet 




Behaviours of children with neurodevelopmental difficulties  
Participant Information Sheet 
We would like to invite you to take part in a research study being conducted at the Centre for 
Neurodevelopmental Disorders (CNDD) in the School of Psychology at the University of Birmingham.  
Please read this information carefully before deciding whether you wish to take part in the research 
study. If you would like any more information about the study or you have any health and / or language 
difficulties which make it difficult for you to read this information please contact the research team or 
you can ask someone to contact the research team on your behalf (see details at the end of the 
information sheet).  
This research project has been approved by the North East Tyne & Wear South Research Ethics 
Committee and has all the necessary approvals (Health Research Authority reference number: 235418; 
Protocol number: RG_17 182; REC number: 18/NE/0249).  
What is the research study about and why is it important?   
This research project, led by Professor Chris Oliver, Laura Groves and Dr Caroline Richards, is based 
in the Cerebra Centre for Neurodevelopmental Disorders (CNDD) in the School of Psychology at the 
University of Birmingham. The study aims to better understand the various behaviours of children with 
neurodevelopmental difficulties. We will use the information provided by parents to understand 
whether particular characteristics, such as age or gender, make certain behaviours more or less likely. 
We are also seeking to test whether the questionnaire used in this study could be useful in a clinical 
setting, as a screening tool.  
In the future, the information obtained during this study could help us to identify ways in which we may 
be able prevent the onset of particular behaviours that have a negative impact on the quality of life of 
children with neurodevelopmental difficulties. 
Why have I been invited to take part in the study?  
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You have been invited to take part in this study because you are the parent / carer of a child aged 
between 2 and 11 years old who attend one of a range of educational and health facilities / services in 
the West Midlands specifically for children with neurodevelopmental difficulties.  You may also have 
received this invitation if your child is undergoing an assessment of their development or you have 
previously provided consent for your details to be held on the CNDD research participant database and 
to be contacted about future research projects.  Unless your details are already held on the CNDD 
participant database, we do not have your contact details and we do not know your name or your child’s 
name.  The health / education facility that your child attends has sent out this information on behalf of 
the research team so please be assured that we do not have access to any of your personal information. 
If I decide to participate in the research study, what will I be asked to do? 
If you would like to participate in the research, you will be asked to sign a consent form, and provide 
us with a few personal details (your name, postal address, telephone number, email address, and your 
child’s gender and age) you will then be asked to complete a short questionnaire about your child’s 
current behaviour. This questionnaire will take between 10-15 minutes to complete.  
You will be asked to complete the questionnaire and return it to the research team in a pre-paid envelope 
along with a completed consent form. Alternatively, you can contact a member of the research team and 
arrange to have the questionnaire administered over the telephone or, if you prefer, they may be able to 
visit you at home if you live within a reasonable travelling distance.  
You will be contacted by the research team again 12 months later (Time 2) to complete the same 
questionnaire that you did at Time 1. This is to help the study team understand how behaviour changes 
over time. The research team will post the questionnaire to your home address with a pre-paid envelope 
for you to return the completed questionnaire and / or telephone you to administer the questionnaire on 
the telephone.  Once again, a member of the research team may also be able to visit you at home 
Who will be involved in collecting the information? 
Members of the research team at the Cerebra Centre for Neurodevelopmental Disorders based at the 
University of Birmingham including experienced academic research staff and supervised undergraduate 
and postgraduate students. The research team will also include NHS Research Nurses. 
What are the possible benefits of taking part in this study? 
After you have completed the questionnaire, you will receive a summary report specific to your child 
based on your responses to the questionnaire and the opportunity to ask any questions. You will receive 
a similar report 12 month later, when you have completed the questionnaire for the second time.   
These individualised feedback reports may be useful for you and the health and education professionals 
involved with your child / the child you care for to highlight particular difficulties that your child might 
face and identify resources that might be useful for them. We happily share a copy of this report with 
any health / education professionals if you request this and provide us with written consent. 
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What are the possible disadvantages of taking part in this study? 
While the questionnaire is very brief, it includes questions about challenging behaviour which you 
might find upsetting. If this does happen and you feel that you do not want to continue with participation 
in the research, you can withdraw at any time. You will also be given the opportunity to contact the 
research team and discuss any concerns you have about the project at any stage during the 12-month 
research period who may be able to signpost you to helpful resources or professionals. 
If I decide to participate, what will happen to the information I provide? 
Personal identifying information, such as names, ages, addresses, telephone numbers and email 
addresses will be treated as strictly confidential and handled in accordance with the provisions of the 
Data Protection Act 1998 & 2018.  Personal identifying information will be stored for the duration of 
the study on a password protected portable hard drive that is kept in a locked filing cabinet at the 
University of Birmingham.  
Your completed questionnaires will be stored separately from the personal identifying information 
described above in a locked filing cabinet at the University of Birmingham. Your name will not appear 
on the completed questionnaires. Instead, each participant will be allocated a participant number and 
this will appear on the questionnaires instead of names. An electronic file will be created which links 
the participant number to the participant name which will be stored on a password protected portable 
hard drive kept in a locked filing cabinet at the University of Birmingham.  Only the research team have 
access to the research project filing cabinets. 
In the unlikely event that the research team have concerns about the welfare of a participant, information 
will be disclosed as necessary. 
What would happen to the information after the project ends? 
If you are not already on the existing participant database, your contact details will be destroyed at the 
end of the study (within 6 months of receipt of your Time 2 questionnaire or 6 months after the end of 
the Time data collection cut-off date) and you will not be contacted further unless your details are 
already stored on the CNDD database. Your anonymous completed questionnaires will be stored for up 
to 10 years following the end of the project. 
The research team will publish the findings from the study in scientific journals and will present the 
results at relevant conferences and in newsletters. Any published reports which use the information you 
have provided us, will be completely confidential, and will never use your child’s name.  
If I would like to participate in the project, what should I do now? 
Please remember that participation in the project is purely optional and the decision not to participate 
will not restrict access or affect the right to any education / health services.  When you are satisfied that 
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you have all of the information you need to be able to decide whether or not you / the person you care 
for would like to take part in the study and if you decide that you would like to participate, please 
complete the enclosed consent form and the questionnaire and return them to us separately in the two 
prepaid envelope provided. This is to ensure your responses and personal details cannot be matched 
except by the identified number on the envelopes. 
 
What if I change my mind about participating after I have provided consent? 
Even after you have provided consent to participate in the study, you can request to be withdrawn from 
the study and for your research data to be destroyed without giving a reason. This will not restrict access 
or affect the right to any education / health services. You will have up to 6 months after completion of 
the Time 2 questionnaire to indicate that you would like to withdraw from the study. This is purely for 
practical reasons as after your personal identifying information has been destroyed, your personal 
details will no longer be linked to the information collected as part of this study. This means that we 
would no longer be able to trace the results of your assessments back to you and withdraw you from the 
study. 
What can I do if I have any concerns about the research or there is a problem? 
In the unlikely event that you have any cause for concern about any aspect of the research, in the first 
instance, please contact Professor Chris Oliver (Chief Investigator) on 0121 414 4909, 
c.oliver@bham.ac.uk, Laura Groves (Research Assistant) on 0121 414 9775, 
LXG502@student.bham.ac.uk, or Dr Caroline Richards (Principal Investigator) on  0121 415 8098, 
c.r.richards@bham.ac.uk  at the University of Birmingham. If you wish to speak to someone who is 
independent to the research, or you have any concerns related to the research after contacting the Chief 
Investigator, Research Assistant or Principal Investigator, you can contact Birmingham Community 
Healthcare Foundation Trust team on: 
Tel - 0800 917 2855 
E-mail - complaints.bchc@nhs.net 
Write to - Complaints Team, 3 Priestley Wharf, Holt Street, Aston, Birmingham, B7 4BN. 
How do I contact the research team to find out more about the research study? 
Please contact Laura Groves on: 
Tel - 0121 414 9775 
E- mail - LXG502@student.bham.ac.uk 
Write to - Laura Groves, School of Psychology, 52 Pritchatts Road, University of Birmingham, 
Edgbaston, Birmingham, B15 2TT 
 
Or Dr Caroline Richards on: 
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Tel - 0121 415 8098 
E- mail - c.r.richards@bham.ac.uk 
Write to - Caroline Richards, School of Psychology, 52 Pritchatts Road, University of Birmingham, 
Edgbaston, Birmingham, B15 2TT 
 
Alternatively, you can contact Birmingham Community Healthcare Foundation Trust Customers 
Services Team for independent advice about the study on: 
Tel - 0800 917 2855 
E- mail - contact.bchc@nhs.net 
Write to - Customer Services Team, The Lodge, Moseley Hall Hospital, Alcester Road, Moseley, 
Birmingham, B13 8JL. 
 
The University of Birmingham is the sponsor for this study based in the United Kingdom. We will be using information from you in order to 
undertake this study and will act as the data controller for this study. This means that we are responsible for looking after your information 
and using it properly. The University of Birmingham will keep identifiable information about you for 6 months following receipt of your Time 
2 questionnaire to enable you to receive your Time 2 feedback report. If the Time 2 questionnaire isn’t completed, any identifiable data will 
be destroyed 6 months after the data collection window. 
Your rights to access, change or move your information are limited, as we need to manage information in specific ways in order for research 
to be reliable and accurate.  If you withdraw from the study, we will keep the information we have already obtained.  To safeguard your rights, 
we will use minimum personally-identifiable information possible.  
You can find out more information about how we use your information by contacting the Data Protection Officer at the University, Mrs 
Carolyn Pike (OBE) legalservices@contacts.bham.ac.uk 
The University of Birmingham will use your name, and contact details (and your child’s age and gender) to contact you about the research 
study and to oversee the quality of the study.  Individuals from the University of Birmingham and regulatory organisations may look at your 
research records check the accuracy of the research study.  The only people in the University of Birmingham who will have access to the 
information that identifies you will be the people who need to contact you about your participation in the study or audit the data collection 
process.   
Health and care research should serve the public interest, which means that we have to demonstrate that our research serves the interests of 
society as a whole. We do this by following the UK Policy Framework for Health and Social Care Research. 
If you wish to raise a complaint on how we have handled your personal data, you can contact our Data Protection Officer who will investigate 
the matter. Our Data Protection Officer is Mrs. Carolyn Pike OBE and you can contact them at legalservices@contacts.bham.ac.uk  If you 
are not satisfied with our response or believe we are processing your personal data in a way that is not lawful you can complain to the 
Information Commissioner’s Office (ICO). 
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Appendix F: Consent form 
                
Behaviours of Children with Neurodevelopmental Difficulties 
Parental Consent Form 
If you are reading this information on behalf of someone you care for who is a child ages 2-11, then we 
would like to ask you to decide whether or not you think that it is in your child’s best interests for them 
to participate in the study and whether you would like to provide your consent to participation on their 
behalf. If you would like your child/person you care for to participate in this study, please complete the 
consent form and return it to the research team in the prepaid envelope provided. 
PART 1                                                                                     Please initial box… 
1. I confirm that I have read and understood the information sheet dated V5 18.09.18 
for the above study. I have had the opportunity to consider the information, ask 
questions and have had these answered satisfactorily. 
2. I understand that participation involves completion of 1 short questionnaire now 
(Time 1) and that I will be contacted again in 12 months (Time 2) to complete the 
same questionnaire again, using the contact details I provide. 
3. I understand that my participation and that of my child/person I care for is voluntary 
and that I am free to withdraw at any time without giving any reason, without my 
or that of my child’s/person I care for’s medical care or legal rights being affected. 
4. I understand that all information collected during the study will be confidential. 
Only members of the research team at the Cerebra Centre for Neurodevelopmental 
disorders will know who has participated in the
study. All information collected during the study will be stored in locked cabinets and 
/ or on password protected portable hard drives that only members of the research team 
will have access to. No names will be published in any reports. Information will be 
treated as strictly confidential and handled in accordance with the provisions of the Data 
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5. I understand that my contact details will only be used by the research team for the 
purpose of this study only.  
6. I agree, on behalf of myself and the child I care for, to take part in the study 
‘Behaviours of Children with a Neurodevelopmental Difficulties’.  
 
Please complete the details below  
Name of Parent / Carer: ________________________________________________ 
Your relationship to the participant: _______________________________________ 
Signed: _____________________________________     Date: ___________    
Researcher name (if present)____________  Countersigned:______________________ 
PART 2 
Child’s gender:   Male     Female                                                                                                   
Age of Child: __________years __________months. 
 
Address: ____________________________________________________________ 
Landline Telephone Number: ____________________________________________ 
Mobile Telephone Number: ______________________________________________ 
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Appendix G: SAD-SQ Questionnaires given to children under age 6 
 
Child Health & Behaviour Screen 
Behaviours of Children with Neurodevelopmental Difficulties 
Dr Caroline Richards: c.r.richards@bham.ac.uk, 0121 415 8098 
Laura Groves: LXG502@student.bham.ac.uk, 0121 414 977 
 
 Today’s date: ................................................................  Participant ID Number:…………………… 
 
                    Child’s gender:            Male   ⁪         Female   ⁪             Child’s Age: __(Years)___(Months) 
                    Q1.Has any professional (e.g. doctor, geneticist, paediatrician etc.) said that the child you care for: 
                       (Please circle your response) 
                   Is autistic, has an autistic spectrum disorder, autistic like traits and/or features of autism?          Yes / No 
                   Has cerebral palsy or muscular dystrophy? ………………………………………………..        Yes / No 
             Has a genetic syndrome (e.g. Downs Syndrome, Fragile X, Cri du Chat etc.)?………………… Yes / No  
             If you answered Yes to genetic syndrome, please state which: ……………………………………… 
                  If you answered No to genetic syndrome, please state the cause of the child’s learning disability (if known): 
             ……………………………………………………………………………………………………………… 
                  Q2. Please name any prescribed medications the child is currently taking whilst at school:…………. 
                  ……………………………………………………………………………………………………………….. 
             Q3. Please give details of any contact/visits the child has had with any health professionals  
                   (e.g. dentists, schools nurses, psychologists etc.) in the last month regarding the child’s: 
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                Health:................................................................................................................................................................ 
                  Behaviour: …………………………………………………………………………………………………………….. 
                 Q4. Have you ever thought about seeking help regarding the child’s behaviour?  
 
           Yes and have made contact      ⁪ Yes but not made contact       ⁪.             No      ⁪   
 
                Q5. Please indicate the number of days that the child did not attend school in the last full term:  
 
  0-4       ⁪ 5-9       ⁪        10-14      ⁪ 15+    ⁪  
 
               Q6 Please circle the appropriate response regarding the child’s general development  
 
Smile spontaneously ............................. Yes/No Turn to a voice ............................................... Yes/No 
Feed self  ............................................... Yes/No Imitate speech sounds .................................... Yes/No 
Wave bye-bye ....................................... Yes/No  Say 2 words  ................................................... Yes/No 
Use spoon/fork  ..................................... Yes/No Point to pictures ............................................. Yes/No 
Put on clothing ...................................... Yes/No Name 1 colour  ............................................... Yes/No 
Grasp rattle ........................................... Yes/No Roll over  ....................................................... Yes/No 
Thumb and finger grasp ........................ Yes/No Stand holding on ............................................ Yes/No 
Scribbles ............................................... Yes/No Stand alone ..................................................... Yes/No 
Build a tower of two cubes  .................. Yes/No Run ................................................................  Yes/No 
Imitate drawing a vertical line  ............. Yes/No Jump up .......................................................... Yes/No 
 
Q7. To what extent have the following health problems affected the child in the last month? 
  Never Mild Moderate
 Severe 
Eye problems (e.g. infections) .................................... 0 1  2 3 
Ear problems (e.g. infections) ..................................... 0 1      2 3 
Dental problems (e.g. cavities/gum problems) ........... 0 1 2 3 
Digestive problems (e.g. reflux/stomach problems) ... 0 1 2 3 
Skin problems (e.g. eczema/dry skin) ......................... 0 1 2 3 
Respiratory problems (e.g. asthma/infections) ........... 0 1 2 3 
Epilepsy ...................................................................... 0 1 2 3 
Any other health or painful condition, (please specify) 
 .................................................................................... 0 1 2 3                    
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                      Q8.   Please circle the appropriate response to indicate whether your child is able to  
                     carry out each skill.   
           Is your child able to request Food?...........................................................................        Yes / No 
                                                                Toys?............................................................................Yes / No 
                                                       Activities?...........................................................................  Yes / No 
                 Is your child able to request help/ assistance?..........................................................  Yes / No                  
           Is your child able to request to take a break?............................................................        Yes / No 
           Is your child able to reject items/ activities?.............................................................        Yes / No 
             Is your child able to communicate Yes?....................................................................     Yes / No 
                                                                          No?....................................................................  Yes / No   
          Is your child able to respond appropriately to being asked to “wait”?.....................           Yes / No   
          Is your child able to respond to the following Visual Directions (gestures/ signs)?   
                                                                                  Respond to their name being signalled…... Yes / No 
                                                                              “Come here”………………………………..  Yes / No 
                                                                               “Stop”………………………………………. Yes / No 
                                                                                “Sit down”………………………………….  Yes / No 
                                                                                 “Give it to me”………………………...…… Yes / No 
                                                                                 “Go get…” (Familiar item)…………...……  Yes / No 
                                                                                 “Go to…” (Familiar location)……………...  Yes / No 
                                                                                 “Put it back/down” ………………………… Yes / No 








                                                                                                                                                                                                                                 




                   Is your child able to respond to the following Verbal Directions (spoken)? 
                                                                       To their name being called………………….. Yes / No 
                                                                         “Come here”……………………………..…  Yes / No 
                                                                         “Stop”……………………………………..... Yes / No   
                                                                          “Sit down”………………………………….. Yes / No 
                                                                            “Give it to me”…………………………….. Yes / No   
                                                                          “Go get…” (Familiar item)………………… Yes / No 
                                                                            “Go to…” (Familiar location)……………..  Yes / No 
                                                                            “Put it back/ down”………………………... Yes / No  
                                                                            “Let’s go/ come with me”…………………. Yes / No 
             Is your child able to react appropriately to changing activities?...............................  Yes  / No  




                                                                                                                                                                                                                                 









Appendix H: SAD-SQ Questionnaires given to children aged 6 and over 
 
Child Health & Behaviour Screen 
Behaviours of Children with Neurodevelopmental Difficulties 
Dr Caroline Richards: c.r.richards@bham.ac.uk, 0121 415 8098 
Laura Groves: LXG502@student.bham.ac.uk, 0121 414 977 
 
 Today’s date: ................................................................ Participant ID Number:…………………… 
 
            Child’s gender:            Male   ⁪         Female   ⁪ .  Child’s Age: __(Years)___(Months) 
           Q1.Has any professional (e.g. doctor, geneticist, paediatrician etc.) said that the child you care for: 
           (Please circle your response) 
           Is autistic, has an autistic spectrum disorder, autistic like traits and/or features of autism?          Yes / No 
           Has cerebral palsy or muscular dystrophy? ………………………………………………..        Yes / No 
     Has a genetic syndrome (e.g. Downs Syndrome, Fragile X, Cri du Chat etc.)?………………… Yes / N  
     If you answered Yes to genetic syndrome, please state which: ……………………………………… 
           If you answered No to genetic syndrome, please state the cause of the child’s learning disability (if known): 
     ……………………………………………………………………………………………………………… 
           Q2. Please name any prescribed medications the child is currently taking whilst at school:…………. 
           ……………………………………………………………………………………………………………….. 
      Q3. Please give details of any contact/visits the child has had with any health professionals  
            (e.g. dentists, schools nurses, psychologists etc.) in the last month regarding the child’s: 
 
            Health:................................................................................................................................................................ 




            
             Behaviour:……………………………………………………………………………………………………..                 
             Q4. Have you ever thought about seeking help with the child’s behaviour?  
              (Please circle your response)  
 
         Yes and have made contact      ⁪ Yes but not made contact       ⁪             No      ⁪
   
              Q5. Please indicate the number of days that the child you care for did not attend school  
               in the last full term. (Please circle your response)  
   
  0-4       ⁪ 5-9       ⁪        10-14      ⁪ 15+    ⁪  
               Q6.  Please circle the appropriate response regarding the child’s general development   
Walk without help 1…Not at all 2…Not upstairs            3…Upstairs and elsewhere 
Feed self 1…Not at all                 2…With help 3…Without help 
Wash self 1…Not at all 2…With help        3…Without help 
Dress self 1…Not at all 2…With help 3…Without help 
Wetting (days) 1…Frequently               2…Occasionally      3…Never 
Soiling (days) 1…Frequently              2…Occasionally 3…Never 
Reads 1…Nothing 2…A little                3…Newspapers and/or books 
Writes 1…Nothing 2…A little 3…Own correspondence 
Counts 1…Nothing 2…A little                  3…Understands money values 
Speech 1…Never a word           2…Odd words only        3…Sentences and normal 
Vision 1…Blind or almost        2…Poor 3…Normal 
Hearing 1…Deaf or almost         2…Poor    3…Normal 
 
             Q7. To what extent have the following health problems affected the child in the last month?  
             (Please circle your response) 
 Never Mild Moderate Severe 
Eye problems (e.g. infections) 0 1  2 3 
Ear problems (e.g. infections) 0 1      2 3 
Dental problems (e.g. cavities/gum problems) 0 1 2 3 
Digestive problems (e.g. reflux/stomach problems) 0 1 2 3 
Skin problems (e.g. eczema/dry skin) 0 1 2 3 
Respiratory problems (e.g. asthma/infections) 0 1 2 3 
Epilepsy 0 1 2 3 
Any other health or painful condition 0 1 2 3 
 
 
               Q8.   Please circle the appropriate response to indicate whether your child is able to carry out  




                each skill.   
       Is your child able to request Food?...........................................................................    Yes / No 
                                                    Toys?............................................................................    Yes / No 
                                              Activities?...........................................................................    Yes / No 
        Is your child able to request help/ assistance?..........................................................    Yes / No                  
        Is your child able to request to take a break?............................................................    Yes / No 
        Is your child able to reject items/ activities?.............................................................    Yes / No 
        Is your child able to communicate Yes?.....................................................................  Yes / No 
                                                                No?... .................................................................   Yes / No   
        Is your child able to respond appropriately to being asked to “wait”?.....................    Yes / No   
        Is your child able to respond to the following Visual Directions (gestures/ signs)?   
                                                                       Respond to their name being signalled…...   Yes / No 
                                                                      “Come here”………………………………..  Yes / No 
                                                                      “Stop”………………………………………. Yes / No 
                                                                      “Sit down”………………………………….  Yes / No 
                                                                      “Give it to me”………………………...…… Yes / No 
                                                                      “Go get…” (Familiar item)…………...……  Yes / No 
                                                                      “Go to…” (Familiar location)……………...  Yes / No 
                                                                      “Put it back/down” ………………………… Yes / No 









Is your child able to respond to the following Verbal Directions (spoken)? 
                                                                     To their name being called………………….. Yes / No 




                                                                      “Come here”……………………………..…  Yes / No 
                                                                      “Stop”……………………………………..... Yes / No   
                                                                      “Sit down”………………………………….. Yes / No 
                                                                       “Give it to me”…………………………….. Yes / No   
                                                                      “Go get…” (Familiar item)………………… Yes / No 
                                                                       “Go to…” (Familiar location)……………..  Yes / No 
                                                                       “Put it back/ down”………………………... Yes / No  
                                                                       “Let’s go/ come with me”…………………. Yes / No 
Is your child able to react appropriately to changing activities?.......................................  Yes  / No  
Is your child able to follow a visual schedule?.................................................................. . Yes / No
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